Type 3 diabetes (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Type 3 diabetes" in English language version.

refsWebsite

Global rank English rank

342nih.gov

4^th place

226doi.org

2^nd place

86semanticscholar.org

11^th place

8^th place

39web.archive.org

1^st place

15worldcat.org

5^th place

9handle.net

102^nd place

76^th place

7harvard.edu

18^th place

17^th place

4fda.gov

447^th place

338^th place

4nice.org.uk

3,258^th place

2,666^th place

3who.int

195^th place

302^nd place

3nytimes.com

7^th place

2nhs.uk

1,989^th place

1,528^th place

2zenodo.org

621^st place

380^th place

2theguardian.com

12^th place

11^th place

1uclahealth.org

low place

1mayoclinic.org

1,610^th place

1,279^th place

1alzheimer-europe.org

low place

1ucl.ac.uk

1,306^th place

885^th place

1diagnosticimaging.com

low place

1bbc.com

20^th place

30^th place

1aecid.es

low place

1uni-goettingen.de

2,594^th place

2,546^th place

1escholarship.org

1,523^rd place

976^th place

1medlineplus.gov

1,581^st place

1,299^th place

1businesswire.com

615^th place

407^th place

1archive.today

14^th place

1alz.org

low place

1books.google.com

3^rd place

1alzint.org

low place

1cdc.gov

218^th place

212^th place

1fdlp.gov

low place

1ajmc.com

low place

1metlife.com

low place

1archive.org

6^th place

1webindia123.com

5,561^st place

3,356^th place

1dfgdocs.com

low place

1bbc.co.uk

8^th place

10^th place

1factmag.com

3,025^th place

1,758^th place

1pitchfork.com

159^th place

112^th place

aecid.es

americanae.aecid.es

Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S (November 2008). "New insights into brain BDNF function in normal aging and Alzheimer disease". Brain Research Reviews. 59 (1): 201–220. doi:10.1016/j.brainresrev.2008.07.007. hdl:10533/142174. PMID 18708092. S2CID 6589846.

ajmc.com

Wong W (August 2020). "Economic burden of Alzheimer disease and managed care considerations". Am J Manag Care. 26 (8 Suppl): S177 – S183. doi:10.37765/ajmc.2020.88482. PMID 32840331. S2CID 221308149. Archived from the original on 25 February 2022. Retrieved 17 March 2022.

alz.org

"Treating Behavioral and Psychiatric Symptoms". Alzheimer's Association. 2006. Archived from the original on 25 September 2006. Retrieved 25 September 2006.

alzheimer-europe.org

"Horizon Europe research programme". www.alzheimer-europe.org.

alzint.org

"Nutrition and Dementia: A Review of Available Research" (PDF). Alzheimer's Disease International. 2014. Archived (PDF) from the original on 8 May 2024.

archive.org

Sparks N (1996). The notebook. Thorndike, Maine: Thorndike Press. p. 268. ISBN 978-0-7862-0821-0.

archive.today

"How Is Alzheimer's Disease Treated?". U.S. National Institute on Aging. 1 April 2023. Archived from the original on 18 June 2021. Retrieved 10 July 2023.

bbc.co.uk

"Malcolm and Barbara: A love story". BBC Cambridgeshire. Archived from the original on 10 November 2012. Retrieved 2 March 2008.

bbc.com

"Scientists discover how brain cells die in Alzheimer's". BBC News. 15 September 2023. Retrieved 27 September 2023.

books.google.com

Dudek SB (2007). Nutrition Essentials for Nursing Practice. Hagerstown, Maryland: Lippincott Williams & Wilkins. p. 360. ISBN 978-0-7817-6651-7. Retrieved 19 August 2008.

businesswire.com

"Alpha Cognition's Oral Therapy Zunveyl Receives FDA Approval to Treat Alzheimer's Disease" (Press release). Alpha Cognition. 29 July 2024. Retrieved 4 August 2024 – via Business Wire.

cdc.gov

"United States Life Tables, 2017" (PDF). National Vital Statistics Reports, CDC. Archived (PDF) from the original on 24 May 2021. Retrieved 10 June 2021.

dfgdocs.com

"Malcolm and Barbara: A love story". Dfgdocs. Archived from the original on 24 May 2008. Retrieved 24 January 2008.

diagnosticimaging.com

Moan R (July 2009). "MRI Software Accurately IDs Preclinical Alzheimer's Disease". Diagnostic Imaging. Archived from the original on 21 February 2022. Retrieved 21 February 2022.

doi.org

Knopman DS, Amieva H, Petersen RC, Chételat G, Holtzman DM, Hyman BT, et al. (May 2021). "Alzheimer disease". Nature Reviews Disease Primers. 7 (1) 33. doi:10.1038/s41572-021-00269-y. PMC 8574196. PMID 33986301.
Mendez MF (November 2012). "Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD". Archives of Medical Research. 43 (8): 677–685. doi:10.1016/j.arcmed.2012.11.009. PMC 3532551. PMID 23178565.
Yu JT, Xu W, Tan CC, Andrieu S, Suckling J, Evangelou E, et al. (November 2020). "Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials". Journal of Neurology, Neurosurgery, and Psychiatry. 91 (11): 1201–1209. doi:10.1136/jnnp-2019-321913. PMC 7569385. PMID 32690803.
Cheng ST (September 2016). "Cognitive Reserve and the Prevention of Dementia: the Role of Physical and Cognitive Activities". Current Psychiatry Reports (Review). 18 (9) 85. doi:10.1007/s11920-016-0721-2. PMC 4969323. PMID 27481112.
Viña J, Sanz-Ros J (October 2018). "Alzheimer's disease: Only prevention makes sense". European Journal of Clinical Investigation (Review). 48 (10): e13005. doi:10.1111/eci.13005. PMID 30028503. S2CID 51703879.
Gomperts SN (April 2016). "Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia". Continuum (Review). 22 (2 Dementia): 435–463. doi:10.1212/CON.0000000000000309. ISSN 1080-2371. PMC 5390937. PMID 27042903.
Lott IT, Head E (March 2019). "Dementia in Down syndrome: unique insights for Alzheimer disease research". Nat Rev Neurol. 15 (3): 135–147. doi:10.1038/s41582-018-0132-6. PMC 8061428. PMID 30733618.
Schaffert J, LoBue C, Hynan LS, Hart J, Rossetti H, Carlew AR, et al. (2022). "Predictors of Life Expectancy in Autopsy-Confirmed Alzheimer's Disease". Journal of Alzheimer's Disease. 86 (1): 271–281. doi:10.3233/JAD-215200. PMC 8966055. PMID 35034898.
Todd S, Barr S, Roberts M, Passmore AP (November 2013). "Survival in dementia and predictors of mortality: a review". International Journal of Geriatric Psychiatry. 28 (11): 1109–1124. doi:10.1002/gps.3946. PMID 23526458.
Breijyeh Z, Karaman R (December 2020). "Comprehensive Review on Alzheimer's Disease: Causes and Treatment". Molecules (Review). 25 (24): 5789. doi:10.3390/molecules25245789. PMC 7764106. PMID 33302541.
Burns A, Iliffe S (February 2009). "Alzheimer's disease". BMJ. 338: b158. doi:10.1136/bmj.b158. PMID 19196745. S2CID 8570146.
Long JM, Holtzman DM (October 2019). "Alzheimer Disease: An Update on Pathobiology and Treatment Strategies". Cell. 179 (2): 312–339. doi:10.1016/j.cell.2019.09.001. PMC 6778042. PMID 31564456.
Khan S, Barve KH, Kumar MS (2020). "Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease". Curr Neuropharmacol. 18 (11): 1106–1125. doi:10.2174/1570159X18666200528142429. PMC 7709159. PMID 32484110.
Gauthreaux K, Bonnett TA, Besser LM, Brenowitz WD, Teylan M, Mock C, et al. (May 2020). "Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy". Journal of Neuropathology and Experimental Neurology. 79 (5): 465–473. doi:10.1093/jnen/nlaa014. PMC 7160616. PMID 32186726.
Thompson CA, Spilsbury K, Hall J, Birks Y, Barnes C, Adamson J (July 2007). "Systematic review of information and support interventions for caregivers of people with dementia". BMC Geriatrics. 7 18. doi:10.1186/1471-2318-7-18. PMC 1951962. PMID 17662119.
Forbes D, Forbes SC, Blake CM, Thiessen EJ, Forbes S (April 2015). "Exercise programs for people with dementia". The Cochrane Database of Systematic Reviews (Submitted manuscript). 132 (4): CD006489. doi:10.1002/14651858.CD006489.pub4. PMC 9426996. PMID 25874613.
Zhu D, Montagne A, Zhao Z (June 2021). "Alzheimer's pathogenic mechanisms and underlying sex difference". Cell Mol Life Sci. 78 (11): 4907–4920. doi:10.1007/s00018-021-03830-w. PMC 8720296. PMID 33844047.
Berchtold NC, Cotman CW (1998). "Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s". Neurobiology of Aging. 19 (3): 173–189. doi:10.1016/S0197-4580(98)00052-9. PMID 9661992. S2CID 24808582.
Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, et al. (January 2007). "Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline". European Journal of Neurology. 14 (1): e1-26. doi:10.1111/j.1468-1331.2006.01605.x. PMID 17222085. S2CID 2725064.
Bäckman L, Jones S, Berger AK, Laukka EJ, Small BJ (September 2004). "Multiple cognitive deficits during the transition to Alzheimer's disease". Journal of Internal Medicine. 256 (3): 195–204. doi:10.1111/j.1365-2796.2004.01386.x. PMID 15324363. S2CID 37005854.
Nygård L (2003). "Instrumental activities of daily living: a stepping-stone towards Alzheimer's disease diagnosis in subjects with mild cognitive impairment?". Acta Neurologica Scandinavica. Supplementum. 179 (s179): 42–46. doi:10.1034/j.1600-0404.107.s179.8.x. PMID 12603250. S2CID 25313065.
Deardorff WJ, Grossberg GT (2019). "Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia". Psychopharmacology of Neurologic Disease. Handbook of Clinical Neurology. Vol. 165. Elsevier. pp. 5–32. doi:10.1016/B978-0-444-64012-3.00002-2. ISBN 978-0-444-64012-3. PMID 31727229. S2CID 208037448.
Petersen RC, Lopez O, Armstrong MJ, Getchius TS, Ganguli M, Gloss D, et al. (January 2018). "Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology". Neurology. 90 (3): 126–135. doi:10.1212/WNL.0000000000004826. PMC 5772157. PMID 29282327.
Atri A (March 2019). "The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management". The Medical Clinics of North America (Review). 103 (2): 263–293. doi:10.1016/j.mcna.2018.10.009. PMID 30704681. S2CID 73432842.
Förstl H, Kurz A (1999). "Clinical features of Alzheimer's disease". European Archives of Psychiatry and Clinical Neuroscience. 249 (6): 288–290. doi:10.1007/s004060050101. PMID 10653284. S2CID 26142779.
Carlesimo GA, Oscar-Berman M (June 1992). "Memory deficits in Alzheimer's patients: a comprehensive review". Neuropsychology Review. 3 (2): 119–169. doi:10.1007/BF01108841. PMID 1300219. S2CID 19548915.
Jelicic M, Bonebakker AE, Bonke B (1995). "Implicit memory performance of patients with Alzheimer's disease: a brief review". International Psychogeriatrics. 7 (3): 385–392. doi:10.1017/S1041610295002134. PMID 8821346. S2CID 9419442.
Taler V, Phillips NA (July 2008). "Language performance in Alzheimer's disease and mild cognitive impairment: a comparative review". Journal of Clinical and Experimental Neuropsychology. 30 (5): 501–556. doi:10.1080/13803390701550128. PMID 18569251. S2CID 37153159.
Volicer L, Harper DG, Manning BC, Goldstein R, Satlin A (May 2001). "Sundowning and circadian rhythms in Alzheimer's disease". The American Journal of Psychiatry. 158 (5): 704–711. doi:10.1176/appi.ajp.158.5.704. PMID 11329390. S2CID 10492607.
Gold DP, Reis MF, Markiewicz D, Andres D (January 1995). "When home caregiving ends: a longitudinal study of outcomes for caregivers of relatives with dementia". Journal of the American Geriatrics Society. 43 (1): 10–16. doi:10.1111/j.1532-5415.1995.tb06235.x. PMID 7806732. S2CID 29847950.
Mashour GA, Frank L, Batthyany A, Kolanowski AM, Nahm M, Schulman-Green D, et al. (August 2019). "Paradoxical lucidity: A potential paradigm shift for the neurobiology and treatment of severe dementias". Alzheimer's & Dementia. 15 (8): 1107–1114. doi:10.1016/j.jalz.2019.04.002. hdl:2027.42/153062. PMID 31229433. S2CID 195063786.
Tackenberg C, Kulic L, Nitsch RM (2020). "Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system". PLOS ONE. 15 (9): e0239584. Bibcode:2020PLoSO..1539584T. doi:10.1371/journal.pone.0239584. PMC 7510992. PMID 32966331.
Wang H, Kulas JA, Wang C, Holtzman DM, Ferris HA, Hansen SB (August 2021). "Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol". Proceedings of the National Academy of Sciences of the United States of America. 118 (33): e2102191118. Bibcode:2021PNAS..11802191W. doi:10.1073/pnas.2102191118. ISSN 0027-8424. PMC 8379952. PMID 34385305. S2CID 236998499.
Vilchez D, Saez I, Dillin A (December 2014). "The role of protein clearance mechanisms in organismal ageing and age-related diseases". Nature Communications. 5 5659. Bibcode:2014NatCo...5.5659V. doi:10.1038/ncomms6659. PMID 25482515.
Andrews SJ, Renton AE, Fulton-Howard B, Podlesny-Drabiniok A, Marcora E, Goate AM (April 2023). "The complex genetic architecture of Alzheimer's disease: novel insights and future directions". eBioMedicine. 90 104511. doi:10.1016/j.ebiom.2023.104511. PMC 10024184. PMID 36907103.
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, et al. (April 2021). "Alzheimer's disease". Lancet. 397 (10284): 1577–1590. doi:10.1016/S0140-6736(20)32205-4. PMC 8354300. PMID 33667416.
Chávez-Gutiérrez L, Szaruga M (September 2020). "Mechanisms of neurodegeneration - Insights from familial Alzheimer's disease". Semin Cell Dev Biol. 105: 75–85. doi:10.1016/j.semcdb.2020.03.005. PMID 32418657.
Piaceri I, Nacmias B, Sorbi S (January 2013). "Genetics of familial and sporadic Alzheimer's disease". Frontiers in Bioscience (Elite Edition). 5 (1) E605: 167–177. doi:10.2741/e605. PMID 23276979.
Perea JR, Bolós M, Avila J (October 2020). "Microglia in Alzheimer's Disease in the Context of Tau Pathology". Biomolecules. 10 (10): 1439. doi:10.3390/biom10101439. PMC 7602223. PMID 33066368.
Mahley RW, Weisgraber KH, Huang Y (April 2006). "Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease". Proceedings of the National Academy of Sciences of the United States of America. 103 (15): 5644–5651. Bibcode:2006PNAS..103.5644M. doi:10.1073/pnas.0600549103. PMC 1414631. PMID 16567625.
Blennow K, de Leon MJ, Zetterberg H (July 2006). "Alzheimer's disease". Lancet. 368 (9533): 387–403. doi:10.1016/S0140-6736(06)69113-7. PMID 16876668. S2CID 47544338.
Hall K, Murrell J, Ogunniyi A, Deeg M, Baiyewu O, Gao S, et al. (January 2006). "Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba". Neurology. 66 (2): 223–227. doi:10.1212/01.wnl.0000194507.39504.17. PMC 2860622. PMID 16434658.
Gureje O, Ogunniyi A, Baiyewu O, Price B, Unverzagt FW, Evans RM, et al. (January 2006). "APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians". Annals of Neurology. 59 (1): 182–185. doi:10.1002/ana.20694. PMC 2855121. PMID 16278853.
Schramm C, Wallon D, Nicolas G, Charbonnier C (1 May 2022). "What contribution can genetics make to predict the risk of Alzheimer's disease?". Revue Neurologique. International meeting of the French society of neurology : NeuroDegenerative Disease : What will the future bring ?. 178 (5): 414–421. doi:10.1016/j.neurol.2022.03.005. ISSN 0035-3787. PMID 35491248.
Goldman JS, Van Deerlin VM (1 October 2018). "Alzheimer's Disease and Frontotemporal Dementia: The Current State of Genetics and Genetic Testing Since the Advent of Next-Generation Sequencing". Molecular Diagnosis & Therapy. 22 (5): 505–513. doi:10.1007/s40291-018-0347-7. ISSN 1179-2000. PMC 6472481. PMID 29971646.
Piaceri I (2013). "Genetics of familial and sporadic Alzheimer s disease". Frontiers in Bioscience. E5 (1) E605: 167–177. doi:10.2741/E605. ISSN 1945-0494. PMID 23276979.
Selkoe DJ (June 1999). "Translating cell biology into therapeutic advances in Alzheimer's disease". Nature. 399 (6738 Suppl): A23 – A31. doi:10.1038/19866. PMID 10392577. S2CID 42287088.
Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, et al. (November 1996). "Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo". Neuron. 17 (5): 1005–1013. doi:10.1016/S0896-6273(00)80230-5. PMID 8938131. S2CID 18315650.
Kim JH (December 2018). "Genetics of Alzheimer's Disease". Dementia and Neurocognitive Disorders. 17 (4): 131–136. doi:10.12779/dnd.2018.17.4.131. PMC 6425887. PMID 30906402.
Carmona S, Zahs K, Wu E, Dakin K, Bras J, Guerreiro R (August 2018). "The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders". Lancet Neurol. 17 (8): 721–730. doi:10.1016/S1474-4422(18)30232-1. PMID 30033062. S2CID 51706988. Archived from the original on 27 March 2022. Retrieved 21 February 2022.
Tomiyama T, Nagata T, Shimada H, Teraoka R, Fukushima A, Kanemitsu H, et al. (March 2008). "A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia". Annals of Neurology. 63 (3): 377–387. doi:10.1002/ana.21321. PMID 18300294. S2CID 42311988.
Tomiyama T, Shimada H (February 2020). "APP Osaka Mutation in Familial Alzheimer's Disease-Its Discovery, Phenotypes, and Mechanism of Recessive Inheritance". International Journal of Molecular Sciences. 21 (4): 1413. doi:10.3390/ijms21041413. PMC 7073033. PMID 32093100.
Tzioras M, Davies C, Newman A, Jackson R, Spires-Jones T (June 2019). "Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease". Neuropathology and Applied Neurobiology. 45 (4): 327–346. doi:10.1111/nan.12529. PMC 6563457. PMID 30394574.
Sinyor B, Mineo J, Ochner C (June 2020). "Alzheimer's Disease, Inflammation, and the Role of Antioxidants". Journal of Alzheimer's Disease Reports. 4 (1): 175–183. doi:10.3233/ADR-200171. PMC 7369138. PMID 32715278.
Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT (2018). "Inflammation as a central mechanism in Alzheimer's disease". Alzheimer's & Dementia. 4: 575–590. doi:10.1016/j.trci.2018.06.014. PMC 6214864. PMID 30406177.
Lin X, Kapoor A, Gu Y, Chow MJ, Peng J, Zhao K, et al. (February 2020). "Contributions of DNA Damage to Alzheimer's Disease". Int J Mol Sci. 21 (5): 1666. doi:10.3390/ijms21051666. PMC 7084447. PMID 32121304.
Hardy J, Allsop D (October 1991). "Amyloid deposition as the central event in the aetiology of Alzheimer's disease". Trends in Pharmacological Sciences. 12 (10): 383–388. doi:10.1016/0165-6147(91)90609-V. PMID 1763432.
Mudher A, Lovestone S (January 2002). "Alzheimer's disease-do tauists and baptists finally shake hands?". Trends in Neurosciences. 25 (1): 22–26. doi:10.1016/S0166-2236(00)02031-2. PMID 11801334. S2CID 37380445.
Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, et al. (November 1995). "Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein". The New England Journal of Medicine. 333 (19): 1242–1247. doi:10.1056/NEJM199511093331902. PMID 7566000.
Irwin MR, Vitiello MV (March 2019). "Implications of sleep disturbance and inflammation for Alzheimer's disease dementia". The Lancet. Neurology. 18 (3): 296–306. doi:10.1016/S1474-4422(18)30450-2. PMID 30661858. S2CID 58546748.
Chen J, Peng G, Sun B (October 2024). "Alzheimer's disease and sleep disorders: A bidirectional relationship". Neuroscience. 557: 12–23. doi:10.1016/j.neuroscience.2024.08.008. PMID 39137870.
Lloret MA, Cervera-Ferri A, Nepomuceno M, Monllor P, Esteve D, Lloret A (February 2020). "Is Sleep Disruption a Cause or Consequence of Alzheimer's Disease? Reviewing Its Possible Role as a Biomarker". International Journal of Molecular Sciences. 21 (3): 1168. doi:10.3390/ijms21031168. PMC 7037733. PMID 32050587.
Huat TJ, Camats-Perna J, Newcombe EA, Valmas N, Kitazawa M, Medeiros R (April 2019). "Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation". J Mol Biol. 431 (9): 1843–1868. doi:10.1016/j.jmb.2019.01.018. PMC 6475603. PMID 30664867.
Eikelenboom P, van Exel E, Hoozemans JJ, Veerhuis R, Rozemuller AJ, van Gool WA (2010). "Neuroinflammation – an early event in both the history and pathogenesis of Alzheimer's disease". Neuro-Degenerative Diseases. 7 (1–3): 38–41. doi:10.1159/000283480. PMID 20160456. S2CID 40048333.
Alves GS, Oertel Knöchel V, Knöchel C, Carvalho AF, Pantel J, Engelhardt E, et al. (2015). "Integrating retrogenesis theory to Alzheimer's disease pathology: insight from DTI-TBSS investigation of the white matter microstructural integrity". BioMed Research International. 2015: 291658. doi:10.1155/2015/291658. PMC 4320890. PMID 25685779.
Reisberg B, Franssen EH, Hasan SM, Monteiro I, Boksay I, Souren LE, et al. (1999). "Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer's and other dementing processes". European Archives of Psychiatry and Clinical Neuroscience. 249 (3): 28–36. doi:10.1007/pl00014170. PMID 10654097. S2CID 23410069.
Bartzokis G (August 2011). "Alzheimer's disease as homeostatic responses to age-related myelin breakdown". Neurobiology of Aging. 32 (8): 1341–1371. doi:10.1016/j.neurobiolaging.2009.08.007. PMC 3128664. PMID 19775776.
Cai Z, Xiao M (2016). "Oligodendrocytes and Alzheimer's disease". The International Journal of Neuroscience. 126 (2): 97–104. doi:10.3109/00207454.2015.1025778. PMID 26000818. S2CID 21448714.
Luczynski P, Laule C, Hsiung GR, Moore GR, Tremlett H (January 2019). "Coexistence of Multiple Sclerosis and Alzheimer's disease: A review". Multiple Sclerosis and Related Disorders. 27: 232–238. doi:10.1016/j.msard.2018.10.109. PMID 30415025.
Zis P, Hadjivassiliou M (February 2019). "Treatment of Neurological Manifestations of Gluten Sensitivity and Coeliac Disease". Current Treatment Options in Neurology. 21 (3) 10. doi:10.1007/s11940-019-0552-7. PMID 30806821. S2CID 73466457.
Makhlouf S, Messelmani M, Zaouali J, Mrissa R (March 2018). "Cognitive impairment in celiac disease and non-celiac gluten sensitivity: review of literature on the main cognitive impairments, the imaging and the effect of gluten free diet". Acta Neurologica Belgica (Review). 118 (1): 21–27. doi:10.1007/s13760-017-0870-z. PMID 29247390. S2CID 3943047.
Zhou L, Miranda-Saksena M, Saksena NK (May 2013). "Viruses and neurodegeneration". Virology Journal. 10 (1) 172. doi:10.1186/1743-422X-10-172. PMC 3679988. PMID 23724961.
Gonzalez-Fernandez E, Huang J (September 2023). "Cognitive Aspects of COVID-19". Current Neurology and Neuroscience Reports. 23 (9): 531–538. doi:10.1007/s11910-023-01286-y. PMID 37490194. S2CID 260132167.
Farrer TJ, Moore JD, Chase M, Gale SD, Hedges DW (November 2024). "Infectious Disease as a Modifiable Risk Factor for Dementia: A Narrative Review". Pathogens. 13 (11): 974. doi:10.3390/pathogens13110974. PMC 11597442. PMID 39599527.
Biagio P, Isabella DF, Federica C, Elena S, Ivan G (May 2024). "Alzheimer's disease and herpes viruses: Current events and perspectives". Rev Med Virol. 34 (3): e2550. doi:10.1002/rmv.2550. PMID 38801246.
Rippee-Brooks MD, Wu W, Dong J, Pappolla M, Fang X, Bao X (March 2024). "Viral Infections, Are They a Trigger and Risk Factor of Alzheimer's Disease?". Pathogens. 13 (3): 240. doi:10.3390/pathogens13030240. PMC 10974111. PMID 38535583.
Kandimalla R, Thirumala V, Reddy PH (May 2017). "Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863 (5): 1078–1089. doi:10.1016/j.bbadis.2016.08.018. PMC 5344773. PMID 27567931.
Braak H, Del Tredici K (December 2012). "Where, when, and in what form does sporadic Alzheimer's disease begin?". Current Opinion in Neurology. 25 (6): 708–714. doi:10.1097/WCO.0b013e32835a3432. PMID 23160422.
Desikan RS, Cabral HJ, Hess CP, Dillon WP, Glastonbury CM, Weiner MW, et al. (August 2009). "Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease". Brain. 132 (Pt 8): 2048–2057. doi:10.1093/brain/awp123. PMC 2714061. PMID 19460794.
Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J (June 2004). "The importance of neuritic plaques and tangles to the development and evolution of AD". Neurology. 62 (11): 1984–1989. doi:10.1212/01.WNL.0000129697.01779.0A. PMID 15184601. S2CID 25017332.
DeTure MA, Dickson DW (August 2019). "The neuropathological diagnosis of Alzheimer's disease". Molecular Neurodegeneration. 14 (1) 32. doi:10.1186/s13024-019-0333-5. PMC 6679484. PMID 31375134.
Tiraboschi P, Sabbagh MN, Hansen LA, Salmon DP, Merdes A, Gamst A, et al. (April 2004). "Alzheimer disease without neocortical neurofibrillary tangles: "a second look"". Neurology. 62 (7): 1141–1147. doi:10.1212/01.wnl.0000118212.41542.e7. PMID 15079014. S2CID 22832110.
Bouras C, Hof PR, Giannakopoulos P, Michel JP, Morrison JH (1994). "Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital". Cerebral Cortex. 4 (2): 138–150. doi:10.1093/cercor/4.2.138. PMID 8038565.
Kotzbauer PT, Trojanowsk JQ, Lee VM (October 2001). "Lewy body pathology in Alzheimer's disease". Journal of Molecular Neuroscience. 17 (2): 225–232. doi:10.1385/JMN:17:2:225. PMID 11816795. S2CID 44407971.
Hernández F, Avila J (September 2007). "Tauopathies". Cellular and Molecular Life Sciences. 64 (17): 2219–2233. doi:10.1007/s00018-007-7220-x. PMC 11136052. PMID 17604998. S2CID 261121643.
Sun W, Samimi H, Gamez M, Zare H, Frost B (August 2018). "Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies". Nature Neuroscience. 21 (8): 1038–1048. doi:10.1038/s41593-018-0194-1. PMC 6095477. PMID 30038280.
Balusu S, Horré K, Thrupp N, Craessaerts K, Snellinx A, Serneels L, T'Syen D, Chrysidou I, Arranz AM, Sierksma A, Simrén J, Karikari TK, Zetterberg H, Chen WT, Thal DR, Salta E, Fiers M, De Strooper B. MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer's disease. Science. 2023 Sep 15;381(6663):1176-1182. doi:10.1126/science.abp9556 PMID 37708272
Van Broeck B, Van Broeckhoven C, Kumar-Singh S (2007). "Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches". Neuro-Degenerative Diseases. 4 (5): 349–365. doi:10.1159/000105156. PMID 17622778. S2CID 7949658.
Huang Y, Mucke L (March 2012). "Alzheimer mechanisms and therapeutic strategies". Cell. 148 (6): 1204–1222. doi:10.1016/j.cell.2012.02.040. PMC 3319071. PMID 22424230.
Yankner BA, Duffy LK, Kirschner DA (October 1990). "Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides". Science. 250 (4978): 279–282. Bibcode:1990Sci...250..279Y. doi:10.1126/science.2218531. PMID 2218531.
Chen X, Yan SD (December 2006). "Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease". IUBMB Life. 58 (12): 686–694. doi:10.1080/15216540601047767. PMID 17424907. S2CID 85423830.
Ramanan VK, Armstrong MJ, Choudhury P, Coerver KA, Hamilton RH, Klein BC, et al. (November 2023). "Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology". Neurology. 101 (19): 842–852. doi:10.1212/WNL.0000000000207757. PMC 10663011. PMID 37495380.
Ryan SK, Ugalde CL, Rolland AS, Skidmore J, Devos D, Hammond TR (October 2023). "Therapeutic inhibition of ferroptosis in neurodegenerative disease". Trends in Pharmacological Sciences. 44 (10): 674–688. doi:10.1016/j.tips.2023.07.007. PMID 37657967.
Greig NH, Mattson MP, Perry T, Chan SL, Giordano T, Sambamurti K, et al. (December 2004). "New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists". Annals of the New York Academy of Sciences. 1035 (1): 290–315. Bibcode:2004NYASA1035..290G. doi:10.1196/annals.1332.018. PMID 15681814. S2CID 84659695. Archived from the original on 3 June 2020. Retrieved 19 July 2019.
Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL (April 2015). "Neuroinflammation in Alzheimer's disease". The Lancet. Neurology. 14 (4): 388–405. doi:10.1016/S1474-4422(15)70016-5. PMC 5909703. PMID 25792098.
Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S (November 2008). "New insights into brain BDNF function in normal aging and Alzheimer disease". Brain Research Reviews. 59 (1): 201–220. doi:10.1016/j.brainresrev.2008.07.007. hdl:10533/142174. PMID 18708092. S2CID 6589846.
Schindowski K, Belarbi K, Buée L (February 2008). "Neurotrophic factors in Alzheimer's disease: role of axonal transport". Genes, Brain and Behavior. 7 (Suppl 1): 43–56. doi:10.1111/j.1601-183X.2007.00378.x. PMC 2228393. PMID 18184369.
Heneka MT, van der Flier WM, Jessen F, Hoozemanns J, Thal DR, Boche D (December 2024). "Neuroinflammation in Alzheimer disease". Nat Rev Immunol. 25 (5): 321–352. doi:10.1038/s41577-024-01104-7. PMID 39653749.
Boche D, Nicoll JA (December 2020). "Invited Review - Understanding cause and effect in Alzheimer's pathophysiology: Implications for clinical trials". Neuropathol Appl Neurobiol. 46 (7): 623–640. doi:10.1111/nan.12642. PMID 32643143.
Leng F, Edison P (March 2021). "Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?". Nat Rev Neurol. 17 (3): 157–172. doi:10.1038/s41582-020-00435-y. PMID 33318676.
Fruhwürth S, Zetterberg H, Paludan SR (May 2024). "Microglia and amyloid plaque formation in Alzheimer's disease - Evidence, possible mechanisms, and future challenges". J Neuroimmunol. 390 578342. doi:10.1016/j.jneuroim.2024.578342. PMID 38640827.
Sachdev PS, Blacker D, Blazer DG, Ganguli M, Jeste DV, Paulsen JS, et al. (November 2014). "Classifying neurocognitive disorders: the DSM-5 approach". Nature Reviews. Neurology. 10 (11): 634–642. doi:10.1038/nrneurol.2014.181. hdl:1959.4/unsworks_39077. PMID 25266297. S2CID 20635070. Archived from the original on 20 March 2022. Retrieved 27 November 2021.
Arvanitakis Z, Shah RC, Bennett DA (October 2019). "Diagnosis and Management of Dementia: Review". JAMA. 322 (16): 1589–1599. doi:10.1001/jama.2019.4782. PMC 7462122. PMID 31638686.
Mendez MF (2006). "The accurate diagnosis of early-onset dementia". International Journal of Psychiatry in Medicine. 36 (4): 401–412. doi:10.2190/Q6J4-R143-P630-KW41. PMID 17407994. S2CID 43715976. Archived from the original on 3 June 2020. Retrieved 25 May 2020.
Klafki HW, Staufenbiel M, Kornhuber J, Wiltfang J (November 2006). "Therapeutic approaches to Alzheimer's disease". Brain. 129 (Pt 11): 2840–2855. doi:10.1093/brain/awl280. PMID 17018549.
Schroeter ML, Stein T, Maslowski N, Neumann J (October 2009). "Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients". NeuroImage. 47 (4): 1196–1206. doi:10.1016/j.neuroimage.2009.05.037. PMC 2730171. PMID 19463961.
Jie CV, Treyer V, Schibli R, Mu L (January 2021). "Tauvid: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease". Pharmaceuticals. 14 (2): 110. doi:10.3390/ph14020110. PMC 7911942. PMID 33573211.
Weller J, Budson A (2018). "Current understanding of Alzheimer's disease diagnosis and treatment". F1000Research (Review). 7: 1161. doi:10.12688/f1000research.14506.1. PMC 6073093. PMID 30135715.
Silva MV, Loures CM, Alves LC, de Souza LC, Borges KB, Carvalho MD (May 2019). "Alzheimer's disease: risk factors and potentially protective measures". Journal of Biomedical Science. 26 (1) 33. doi:10.1186/s12929-019-0524-y. PMC 6507104. PMID 31072403.
Sachs-Ericsson N, Blazer DG (January 2015). "The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment". Aging & Mental Health. 19 (1): 2–12. doi:10.1080/13607863.2014.920303. PMID 24914889. S2CID 46244321.
Stokin GB, Krell-Roesch J, Petersen RC, Geda YE (2015). "Mild Neurocognitive Disorder: An Old Wine in a New Bottle". Harvard Review of Psychiatry (Review). 23 (5): 368–376. doi:10.1097/HRP.0000000000000084. PMC 4894762. PMID 26332219.
Sperry L, Carlson J, Sauerheber J, Sperry J, eds. (2014). Psychopathology and Psychotherapy: DSM-5 Diagnosis, Case Conceptualization, and Treatment (3rd ed.). New York: Routledge. pp. 342–343. doi:10.4324/9780203772287. ISBN 978-0-203-77228-7.
Bradfield NI, Ames D (April 2020). "Mild cognitive impairment: narrative review of taxonomies and systematic review of their prediction of incident Alzheimer's disease dementia". BJPsych Bulletin (Review). 44 (2): 67–74. doi:10.1192/bjb.2019.77. PMC 7283119. PMID 31724527.
Vega JN, Newhouse PA (October 2014). "Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments". Current Psychiatry Reports. 16 (10) 490. SpringerLink. doi:10.1007/s11920-014-0490-8. PMC 4169219. PMID 25160795.
Parnetti L, Chipi E, Salvadori N, D'Andrea K, Eusebi P (January 2019). "Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis". Alzheimer's Research & Therapy. 11 (1) 7. Springer Nature. doi:10.1186/s13195-018-0459-7. PMC 6334406. PMID 30646955.
Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. (April 2018). "NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease". Alzheimer's & Dementia. 14 (4): 535–562. doi:10.1016/j.jalz.2018.02.018. PMC 5958625. PMID 29653606.
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. (May 2011). "Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease". Alzheimer's & Dementia. 7 (3): 280–292. doi:10.1016/j.jalz.2011.03.003. PMC 3220946. PMID 21514248.
Cheng YW, Chen TF, Chiu MJ (16 February 2017). "From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution". Neuropsychiatric Disease and Treatment. 13. Dove Medical Press Limited: 491–498. doi:10.2147/NDT.S123428. PMC 5317337. PMID 28243102.
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. (May 2011). "The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease". Alzheimer's & Dementia. 7 (3): 270–279. doi:10.1016/j.jalz.2011.03.008. PMC 3312027. PMID 21514249.
Chertkow H, Feldman HH, Jacova C, Massoud F (July 2013). "Definitions of dementia and predementia states in Alzheimer's disease and vascular cognitive impairment: consensus from the Canadian conference on diagnosis of dementia". Alzheimer's Research & Therapy. 5 (Suppl 1). BMC: S2. doi:10.1186/alzrt198. PMC 3981054. PMID 24565215.
Tombaugh TN, McIntyre NJ (September 1992). "The mini-mental state examination: a comprehensive review". Journal of the American Geriatrics Society. 40 (9): 922–935. doi:10.1111/j.1532-5415.1992.tb01992.x. PMID 1512391. S2CID 25169596.
Pasquier F (January 1999). "Early diagnosis of dementia: neuropsychology". Journal of Neurology. 246 (1): 6–15. doi:10.1007/s004150050299. PMID 9987708. S2CID 2108587.
Harvey PD, Moriarty PJ, Kleinman L, Coyne K, Sadowsky CH, Chen M, et al. (2005). "The validation of a caregiver assessment of dementia: the Dementia Severity Scale". Alzheimer Disease and Associated Disorders. 19 (4): 186–194. doi:10.1097/01.wad.0000189034.43203.60. PMID 16327345. S2CID 20238911.
Antoine C, Antoine P, Guermonprez P, Frigard B (2004). "[Awareness of deficits and anosognosia in Alzheimer's disease]". L'Encéphale (in French). 30 (6): 570–577. doi:10.1016/S0013-7006(04)95472-3. PMID 15738860.
Sun X, Steffens DC, Au R, Folstein M, Summergrad P, Yee J, et al. (May 2008). "Amyloid-associated depression: a prodromal depression of Alzheimer disease?". Archives of General Psychiatry. 65 (5): 542–550. doi:10.1001/archpsyc.65.5.542. PMC 3042807. PMID 18458206.
Geldmacher DS, Whitehouse PJ (May 1997). "Differential diagnosis of Alzheimer's disease". Neurology. 48 (5 Suppl 6): S2 – S9. doi:10.1212/WNL.48.5_Suppl_6.2S. PMID 9153154. S2CID 30018544.
Potter GG, Steffens DC (May 2007). "Contribution of depression to cognitive impairment and dementia in older adults". The Neurologist. 13 (3): 105–117. doi:10.1097/01.nrl.0000252947.15389.a9. PMID 17495754. S2CID 24569198.
Zhang S, Smailagic N, Hyde C, Noel-Storr AH, Takwoingi Y, McShane R, et al. (July 2014). "(11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)". The Cochrane Database of Systematic Reviews. 2014 (7): CD010386. doi:10.1002/14651858.CD010386.pub2. PMC 6464750. PMID 25052054.
Smailagic N, Vacante M, Hyde C, Martin S, Ukoumunne O, Sachpekidis C (January 2015). "¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)". The Cochrane Database of Systematic Reviews. 1 (1): CD010632. doi:10.1002/14651858.CD010632.pub2. PMC 7081123. PMID 25629415.
Hsu D, Marshall GA (2017). "Primary and secondary prevention trials in Alzheimer disease: looking back, moving forward". Curr Alzheimer Res. 14 (4): 426–440. doi:10.2174/1567205013666160930112125. PMC 5329133. PMID 27697063.
Patterson C, Feightner JW, Garcia A, Hsiung GY, MacKnight C, Sadovnick AD (February 2008). "Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease". CMAJ. 178 (5): 548–556. doi:10.1503/cmaj.070796. PMC 2244657. PMID 18299540.
Rosendorff C, Beeri MS, Silverman JM (2007). "Cardiovascular risk factors for Alzheimer's disease". The American Journal of Geriatric Cardiology. 16 (3): 143–149. doi:10.1111/j.1076-7460.2007.06696.x. PMID 17483665.
Chu CS, Tseng PT, Stubbs B, Chen TY, Tang CH, Li DJ, et al. (April 2018). "Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis". Scientific Reports. 8 (1) 5804. Bibcode:2018NatSR...8.5804C. doi:10.1038/s41598-018-24248-8. PMC 5895617. PMID 29643479.
Ungvari Z, Toth P, Tarantini S, Prodan CI, Sorond F, Merkely B, et al. (October 2021). "Hypertension-induced cognitive impairment: from pathophysiology to public health". Nature Reviews Nephrology. 17 (10): 639–654. doi:10.1038/s41581-021-00430-6. PMC 8202227. PMID 34127835.
Lethaby A, Hogervorst E, Richards M, Yesufu A, Yaffe K (January 2008). "Hormone replacement therapy for cognitive function in postmenopausal women". Cochrane Database Syst Rev. 2008 (1): CD003122. doi:10.1002/14651858.CD003122.pub2. PMC 6599876. PMID 18254016.
Farina N, Rusted J, Tabet N (January 2014). "The effect of exercise interventions on cognitive outcome in Alzheimer's disease: a systematic review". International Psychogeriatrics (Review). 26 (1): 9–18. doi:10.1017/S1041610213001385. PMID 23962667. S2CID 24936334.
Ribarič S (March 2022). "Physical Exercise, a Potential Non-Pharmacological Intervention for Attenuating Neuroinflammation and Cognitive Decline in Alzheimer's Disease Patients". Int J Mol Sci. 23 (6): 3245. doi:10.3390/ijms23063245. PMC 8952567. PMID 35328666.
Barnard ND, Bush AI, Ceccarelli A, Cooper J, de Jager CA, Erickson KI, et al. (September 2014). "Dietary and lifestyle guidelines for the prevention of Alzheimer's disease". Neurobiology of Aging. 35 (Suppl 2): S74 – S78. doi:10.1016/j.neurobiolaging.2014.03.033. hdl:11343/52774. PMID 24913896. S2CID 8265377.
Bhatti GK, Reddy AP, Reddy PH, Bhatti JS (2019). "Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer's Disease". Frontiers in Aging Neuroscience (Review). 11: 369. doi:10.3389/fnagi.2019.00369. PMC 6966236. PMID 31998117.
López-Ortiz S, Lista S, Valenzuela PL, Pinto-Fraga J, Carmona R, Caraci F, et al. (November 2022). "Effects of physical activity and exercise interventions on Alzheimer's disease: an umbrella review of existing meta-analyses". Journal of Neurology. 270 (2): 711–725. doi:10.1007/s00415-022-11454-8. hdl:2108/325384. PMID 36342524. S2CID 253382289.
Imtiaz B, Tolppanen AM, Kivipelto M, Soininen H (April 2014). "Future directions in Alzheimer's disease from risk factors to prevention". Biochem Pharmacol. 88 (4): 661–70. doi:10.1016/j.bcp.2014.01.003. PMID 24418410.
Kivipelto M, Mangialasche F, Ngandu T (November 2018). "Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease". Nat Rev Neurol. 14 (11): 653–666. doi:10.1038/s41582-018-0070-3. PMID 30291317. S2CID 52925352.
Borges CR, Poyares D, Piovezan R, Nitrini R, Brucki S (November 2019). "Alzheimer's disease and sleep disturbances: a review". Arq Neuropsiquiatr. 77 (11): 815–824. doi:10.1590/0004-282X20190149. PMID 31826138. S2CID 209327994.
Uddin MS, Tewari D, Mamun AA, Kabir MT, Niaz K, Wahed MI, et al. (July 2020). "Circadian and sleep dysfunction in Alzheimer's disease". Ageing Research Reviews. 60 101046. doi:10.1016/j.arr.2020.101046. hdl:10072/414227. PMID 32171783. S2CID 212729131.
Lacerda RA, Desio JA, Kammers CM, Henkes S, Freitas de Sá M, de Souza EF, et al. (November 2024). "Sleep disorders and risk of alzheimer's disease: A two-way road". Ageing Res Rev. 101 102514. doi:10.1016/j.arr.2024.102514. PMID 39317268.
Rasmussen MK, Mestre H, Nedergaard M (November 2018). "The glymphatic pathway in neurological disorders". Lancet Neurol. 17 (11): 1016–1024. doi:10.1016/S1474-4422(18)30318-1. PMC 6261373. PMID 30353860.
Hampel H, Vergallo A, Aguilar LF, Benda N, Broich K, Cuello AC, et al. (April 2018). "Precision pharmacology for Alzheimer's disease". Pharmacological Research. 130: 331–365. doi:10.1016/j.phrs.2018.02.014. PMC 8505114. PMID 29458203.
Chen Y, Zhang J, Zhang T, Cao L, You Y, Zhang C, et al. (March 2020). "Meditation treatment of Alzheimer disease and mild cognitive impairment: A protocol for systematic review". Medicine. 99 (10): e19313. doi:10.1097/MD.0000000000019313. PMC 7478420. PMID 32150066.
Winkelman MJ, Szabo A, Frecska E (November 2023). "The potential of psychedelics for the treatment of Alzheimer's disease and related dementias". European Neuropsychopharmacology. 76: 3–16. doi:10.1016/j.euroneuro.2023.07.003. hdl:10852/108211. PMID 37451163.
Birks JS, Harvey RJ (June 2018). "Donepezil for dementia due to Alzheimer's disease". The Cochrane Database of Systematic Reviews. 2018 (6): CD001190. doi:10.1002/14651858.CD001190.pub3. PMC 6513124. PMID 29923184.
Fink HA, Linskens EJ, MacDonald R, Silverman PC, McCarten JR, Talley KM, et al. (May 2020). "Benefits and Harms of Prescription Drugs and Supplements for Treatment of Clinical Alzheimer-Type Dementia". Annals of Internal Medicine. 172 (10): 656–668. doi:10.7326/M19-3887. PMID 32340037. S2CID 216595473.
Geula C, Mesulam MM (1995). "Cholinesterases and the pathology of Alzheimer disease". Alzheimer Disease and Associated Disorders. 9 (Suppl 2): 23–28. doi:10.1097/00002093-199501002-00005. PMID 8534419.
Stahl SM (November 2000). "The new cholinesterase inhibitors for Alzheimer's disease, Part 2: illustrating their mechanisms of action". The Journal of Clinical Psychiatry. 61 (11): 813–814. doi:10.4088/JCP.v61n1101. PMID 11105732.
Birks J (January 2006). Birks J (ed.). "Cholinesterase inhibitors for Alzheimer's disease". The Cochrane Database of Systematic Reviews. 2016 (1): CD005593. doi:10.1002/14651858.CD005593. PMC 9006343. PMID 16437532.
Raschetti R, Albanese E, Vanacore N, Maggini M (November 2007). "Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials". PLOS Medicine. 4 (11): e338. doi:10.1371/journal.pmed.0040338. PMC 2082649. PMID 18044984.
Lipton SA (February 2006). "Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond". Nature Reviews. Drug Discovery. 5 (2): 160–170. doi:10.1038/nrd1958. PMID 16424917. S2CID 21379258.
McShane R, Westby MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE, et al. (March 2019). "Memantine for dementia". The Cochrane Database of Systematic Reviews. 3 (3): CD003154. doi:10.1002/14651858.CD003154.pub6. PMC 6425228. PMID 30891742.
Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, et al. (March 2008). "Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline". Annals of Internal Medicine. 148 (5): 379–397. doi:10.7326/0003-4819-148-5-200803040-00009. PMID 18316756. S2CID 22235353.
Kandiah N, Ong PA, Yuda T, Ng LL, Mamun K, Merchant RA, et al. (February 2019). "Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761". CNS Neuroscience & Therapeutics. 25 (2): 288–298. doi:10.1111/cns.13095. PMC 6488894. PMID 30648358.
McKeage K, Lyseng-Williamson KA (2018). "Ginkgo biloba extract EGb 761 in the symptomatic treatment of mild-to-moderate dementia: a profile of its use". Drugs & Therapy Perspectives. 34 (8): 358–366. doi:10.1007/s40267-018-0537-8. PMC 6267544. PMID 30546253.
Yang G, Wang Y, Sun J, Zhang K, Liu J (22 October 2015). "Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials". Current Topics in Medicinal Chemistry. 16 (5): 520–528. doi:10.2174/1568026615666150813143520. PMID 26268332.
Ballard C, Waite J (January 2006). Ballard CG (ed.). "The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease". The Cochrane Database of Systematic Reviews (1): CD003476. doi:10.1002/14651858.CD003476.pub2. PMC 11365591. PMID 16437455.
Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, et al. (February 2009). "The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial". The Lancet. Neurology. 8 (2): 151–157. doi:10.1016/S1474-4422(08)70295-3. PMID 19138567. S2CID 23000439. See lay summary, January 2009.
Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, et al. (March 2013). "Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia". The Cochrane Database of Systematic Reviews. 3 (3): CD007726. doi:10.1002/14651858.CD007726.pub2. hdl:1854/LU-3109108. PMID 23543555.
Shi M, Chu F, Zhu F, Zhu J (2022). "Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer's Disease: A Focus on Aducanumab and Lecanemab". Frontiers in Aging Neuroscience. 14: 870517. doi:10.3389/fnagi.2022.870517. PMC 9039457. PMID 35493943.
Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F (2023). "Alzheimer's disease drug development pipeline: 2023". Alzheimer's & Dementia. 9 (2): e12385. doi:10.1002/trc2.12385. PMC 10210334. PMID 37251912.
Bottino CM, Carvalho IA, Alvarez AM, Avila R, Zukauskas PR, Bustamante SE, et al. (December 2005). "Cognitive rehabilitation combined with drug treatment in Alzheimer's disease patients: a pilot study". Clinical Rehabilitation. 19 (8): 861–869. doi:10.1191/0269215505cr911oa. PMID 16323385. S2CID 21290731.
Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, et al. (May 2001). "Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology". Neurology. 56 (9): 1154–1166. doi:10.1212/WNL.56.9.1154. PMID 11342679. S2CID 10711725.
Hermans DG, Htay UH, McShane R (January 2007). "Non-pharmacological interventions for wandering of people with dementia in the domestic setting". The Cochrane Database of Systematic Reviews. 2010 (1): CD005994. doi:10.1002/14651858.CD005994.pub2. PMC 6669244. PMID 17253573.
Robinson L, Hutchings D, Dickinson HO, Corner L, Beyer F, Finch T, et al. (January 2007). "Effectiveness and acceptability of non-pharmacological interventions to reduce wandering in dementia: a systematic review". International Journal of Geriatric Psychiatry. 22 (1): 9–22. doi:10.1002/gps.1643. PMID 17096455. S2CID 45660235.
Abraha I, Rimland JM, Trotta FM, Dell'Aquila G, Cruz-Jentoft A, Petrovic M, et al. (March 2017). "Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series". BMJ Open. 7 (3): e012759. doi:10.1136/bmjopen-2016-012759. PMC 5372076. PMID 28302633.
Chung JC, Lai CK, Chung PM, French HP (2002). "Snoezelen for dementia". The Cochrane Database of Systematic Reviews. 2010 (4): CD003152. doi:10.1002/14651858.CD003152. PMC 9002239. PMID 12519587.
Woods B, O'Philbin L, Farrell EM, Spector AE, Orrell M (March 2018). "Reminiscence therapy for dementia". The Cochrane Database of Systematic Reviews. 2018 (3): CD001120. doi:10.1002/14651858.CD001120.pub3. PMC 6494367. PMID 29493789.
Zetteler J (November 2008). "Effectiveness of simulated presence therapy for individuals with dementia: a systematic review and meta-analysis". Aging & Mental Health. 12 (6): 779–785. doi:10.1080/13607860802380631. PMID 19023729. S2CID 39529938.
Spector A, Thorgrimsen L, Woods B, Royan L, Davies S, Butterworth M, et al. (September 2003). "Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial". The British Journal of Psychiatry. 183 (3): 248–254. doi:10.1192/bjp.183.3.248. PMID 12948999.
Gitlin LN, Corcoran M, Winter L, Boyce A, Hauck WW (February 2001). "A randomized, controlled trial of a home environmental intervention: effect on efficacy and upset in caregivers and on daily function of persons with dementia". The Gerontologist. 41 (1): 4–14. doi:10.1093/geront/41.1.4. PMID 11220813.
Gitlin LN, Hauck WW, Dennis MP, Winter L (March 2005). "Maintenance of effects of the home environmental skill-building program for family caregivers and individuals with Alzheimer's disease and related disorders". The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 60 (3): 368–374. doi:10.1093/gerona/60.3.368. PMID 15860476.
Dunne TE, Neargarder SA, Cipolloni PB, Cronin-Golomb A (August 2004). "Visual contrast enhances food and liquid intake in advanced Alzheimer's disease". Clinical Nutrition. 23 (4): 533–538. doi:10.1016/j.clnu.2003.09.015. PMID 15297089.
Dennehy C (2006). "Analysis of patients' rights: dementia and PEG insertion". British Journal of Nursing. 15 (1): 18–20. doi:10.12968/bjon.2006.15.1.20303. PMID 16415742.
Chernoff R (April 2006). "Tube feeding patients with dementia". Nutrition in Clinical Practice. 21 (2): 142–146. doi:10.1177/0115426506021002142. PMID 16556924. S2CID 20841502.
Shega JW, Levin A, Hougham GW, Cox-Hayley D, Luchins D, Hanrahan P, et al. (April 2003). "Palliative Excellence in Alzheimer Care Efforts (PEACE): a program description". Journal of Palliative Medicine. 6 (2): 315–320. doi:10.1089/109662103764978641. PMID 12854952. S2CID 6072807.
Dominguez LJ, Barbagallo M (June 2018). "Nutritional prevention of cognitive decline and dementia". Acta Bio-Medica. 89 (2): 276–290. doi:10.23750/abm.v89i2.7401. PMC 6179018. PMID 29957766.
Zanetti O, Solerte SB, Cantoni F (2009). "Life expectancy in Alzheimer's disease (AD)". Archives of Gerontology and Geriatrics. 49 (Suppl 1): 237–243. doi:10.1016/j.archger.2009.09.035. PMID 19836639.
Mölsä PK, Marttila RJ, Rinne UK (March 1995). "Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia". Acta Neurologica Scandinavica. 91 (3): 159–164. doi:10.1111/j.1600-0404.1995.tb00426.x. PMID 7793228. S2CID 19724937.
Bowen JD, Malter AD, Sheppard L, Kukull WA, McCormick WC, Teri L, et al. (August 1996). "Predictors of mortality in patients diagnosed with probable Alzheimer's disease". Neurology. 47 (2): 433–439. doi:10.1212/wnl.47.2.433. PMID 8757016. S2CID 24961809.
Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, et al. (April 2004). "Survival after initial diagnosis of Alzheimer disease". Annals of Internal Medicine. 140 (7): 501–509. doi:10.7326/0003-4819-140-7-200404060-00008. PMID 15068977. S2CID 27410149.
Jagger C, Clarke M, Stone A (January 1995). "Predictors of survival with Alzheimer's disease: a community-based study". Psychological Medicine. 25 (1): 171–177. doi:10.1017/S0033291700028191. PMID 7792352. S2CID 34066330.
Dodge HH, Shen C, Pandav R, DeKosky ST, Ganguli M (February 2003). "Functional transitions and active life expectancy associated with Alzheimer disease". Archives of Neurology. 60 (2): 253–259. doi:10.1001/archneur.60.2.253. PMID 12580712.
Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST (May 2005). "Alzheimer disease and mortality: a 15-year epidemiological study". Archives of Neurology. 62 (5): 779–784. doi:10.1001/archneur.62.5.779. PMID 15883266.
Lanni C, Masi M, Racchi M, Govoni S (January 2021). "Cancer and Alzheimer's disease inverse relationship: an age-associated diverging derailment of shared pathways". Molecular Psychiatry. 26 (1): 280–295. doi:10.1038/s41380-020-0760-2. PMID 32382138.
Bermejo-Pareja F, Benito-León J, Vega S, Medrano MJ, Román GC (January 2008). "Incidence and subtypes of dementia in three elderly populations of central Spain". Journal of the Neurological Sciences. 264 (1–2): 63–72. doi:10.1016/j.jns.2007.07.021. PMID 17727890. S2CID 34341344.
Di Carlo A, Baldereschi M, Amaducci L, Lepore V, Bracco L, Maggi S, et al. (January 2002). "Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study". Journal of the American Geriatrics Society. 50 (1): 41–48. doi:10.1046/j.1532-5415.2002.50006.x. PMID 12028245. S2CID 22576935.
Reitz C, Rogaeva E, Beecham GW (October 2020). "Late-onset vs nonmendelian early-onset Alzheimer disease: A distinction without a difference?". Neurology. Genetics. 6 (5): e512. doi:10.1212/NXG.0000000000000512. PMC 7673282. PMID 33225065.
Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G (February 2013). "Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy". Nature Reviews. Neurology. 9 (2): 106–118. doi:10.1038/nrneurol.2012.263. PMC 3726719. PMID 23296339.
Massett HA, Mitchell AK, Alley L, Simoneau E, Burke P, Han SH, et al. (29 June 2021). "Facilitators, Challenges, and Messaging Strategies for Hispanic/Latino Populations Participating in Alzheimer's Disease and Related Dementias Clinical Research: A Literature Review". Journal of Alzheimer's Disease. 82 (1): 107–127. doi:10.3233/JAD-201463. PMID 33998537. S2CID 234745473.
Huynh RA, Mohan C (2017). "Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid". Frontiers in Neurology. 8: 102. doi:10.3389/fneur.2017.00102. PMC 5357660. PMID 28373857.
Rajan KB, Weuve J, Barnes LL, McAninch EA, Wilson RS, Evans DA (May 2021). "Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060)". Alzheimer's & Dementia. 17 (12): 1966–1975. doi:10.1002/alz.12362. PMC 9013315. PMID 34043283. S2CID 235215290.
Rizzi L, Rosset I, Roriz-Cruz M (2014). "Global epidemiology of dementia: Alzheimer's and vascular types". Biomed Res Int. 2014: 908915. doi:10.1155/2014/908915. PMC 4095986. PMID 25089278.
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. (December 2005). "Global prevalence of dementia: a Delphi consensus study". Lancet. 366 (9503): 2112–2117. doi:10.1016/S0140-6736(05)67889-0. PMC 2850264. PMID 16360788.
Li F, Qin W, Zhu M, Jia J (1 January 2021). "Model-Based Projection of Dementia Prevalence in China and Worldwide: 2020-2050". Journal of Alzheimer's Disease. 82 (4). IOS Press: 1823–1831. doi:10.3233/JAD-210493. PMID 34219732. S2CID 235735045.
Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. (February 2022). "Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019". Lancet Public Health. 7 (2): e105 – e125. doi:10.1016/S2468-2667(21)00249-8. PMC 8810394. PMID 34998485.{{cite journal}}: CS1 maint: overridden setting (link)
Berrios GE (1990). "Alzheimer's Disease: A Conceptual History". Int. J. Geriatr. Psychiatry. 5 (6): 355–365. doi:10.1002/gps.930050603. S2CID 145155424.
Boller F, Forbes MM (June 1998). "History of dementia and dementia in history: an overview". Journal of the Neurological Sciences. 158 (2): 125–133. doi:10.1016/S0022-510X(98)00128-2. PMID 9702682. S2CID 42399340.
Amaducci LA, Rocca WA, Schoenberg BS (November 1986). "Origin of the distinction between Alzheimer's disease and senile dementia: how history can clarify nosology". Neurology. 36 (11): 1497–1499. doi:10.1212/wnl.36.11.1497. PMID 3531918. S2CID 7689479.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (July 1984). "Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease". Neurology. 34 (7): 939–944. doi:10.1212/wnl.34.7.939. PMID 6610841. S2CID 11646075.
Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. (August 2007). "Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria". The Lancet. Neurology. 6 (8): 734–746. doi:10.1016/S1474-4422(07)70178-3. PMID 17616482. S2CID 7356809.
Blacker D, Albert MS, Bassett SS, Go RC, Harrell LE, Folstein MF (December 1994). "Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative". Archives of Neurology. 51 (12): 1198–1204. doi:10.1001/archneur.1994.00540240042014. PMID 7986174.
El-Hayek YH, Wiley RE, Khoury CP, Daya RP, Ballard C, Evans AR, et al. (2019). "Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders". Journal of Alzheimer's Disease. 70 (2): 323–341. doi:10.3233/JAD-190426. PMC 6700654. PMID 31256142.
Wong W (August 2020). "Economic burden of Alzheimer disease and managed care considerations". Am J Manag Care. 26 (8 Suppl): S177 – S183. doi:10.37765/ajmc.2020.88482. PMID 32840331. S2CID 221308149. Archived from the original on 25 February 2022. Retrieved 17 March 2022.
Tahami Monfared AA, Byrnes MJ, White LA, Zhang Q (February 2022). "The Humanistic and Economic Burden of Alzheimer's Disease". Neurol Ther. 11 (2): 525–551. doi:10.1007/s40120-022-00335-x. PMC 9095804. PMID 35192176. S2CID 247014076.
Kosaner Kließ M, Martins R, Connolly MP (2021). "Major Cost Drivers in Assessing the Economic Burden of Alzheimer's Disease: A Structured, Rapid Review". J Prev Alzheimers Dis. 8 (3): 362–370. doi:10.14283/jpad.2021.17. PMID 34101795. S2CID 233403683.
Demirbas M, Hahn-Pedersen JH, Jørgensen HL (August 2023). "Comparison Between Burden of Care Partners of Individuals with Alzheimer's Disease Versus Individuals with Other Chronic Diseases". Neurology and Therapy. 12 (4): 1051–1068. doi:10.1007/s40120-023-00493-6. PMC 10310688. PMID 37222859.
Schneider J, Murray J, Banerjee S, Mann A (August 1999). "EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer's disease: I—Factors associated with carer burden". International Journal of Geriatric Psychiatry. 14 (8): 651–661. doi:10.1002/(SICI)1099-1166(199908)14:8<651::AID-GPS992>3.0.CO;2-B. PMID 10489656. S2CID 27346798.
Murray J, Schneider J, Banerjee S, Mann A (August 1999). "EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer's disease: II—A qualitative analysis of the experience of caregiving". International Journal of Geriatric Psychiatry. 14 (8): 662–667. doi:10.1002/(SICI)1099-1166(199908)14:8<662::AID-GPS993>3.0.CO;2-4. PMID 10489657. S2CID 41741923.
Zhu CW, Sano M (2006). "Economic considerations in the management of Alzheimer's disease". Clinical Interventions in Aging. 1 (2): 143–154. doi:10.2147/ciia.2006.1.2.143. PMC 2695165. PMID 18044111.
Gaugler JE, Kane RL, Kane RA, Newcomer R (April 2005). "Early community-based service utilization and its effects on institutionalization in dementia caregiving". The Gerontologist. 45 (2): 177–185. doi:10.1093/geront/45.2.177. PMID 15799982.
Ritchie K, Lovestone S (November 2002). "The dementias". Lancet. 360 (9347): 1759–1766. doi:10.1016/S0140-6736(02)11667-9. PMID 12480441. S2CID 21404062.
Brodaty H, Hadzi-Pavlovic D (September 1990). "Psychosocial effects on carers of living with persons with dementia". The Australian and New Zealand Journal of Psychiatry. 24 (3): 351–361. doi:10.3109/00048679009077702. PMID 2241719. S2CID 11788466.
Donaldson C, Tarrier N, Burns A (April 1998). "Determinants of carer stress in Alzheimer's disease". International Journal of Geriatric Psychiatry. 13 (4): 248–256. doi:10.1002/(SICI)1099-1166(199804)13:4<248::AID-GPS770>3.0.CO;2-0. PMID 9646153. S2CID 22187694.
Nandi A, Counts N, Bröker J, Malik S, Chen S, Han R, et al. (February 2024). "Cost of care for Alzheimer's disease and related dementias in the United States: 2016 to 2060". npj Aging. 10 (1) 13. doi:10.1038/s41514-024-00136-6. PMC 10853249. PMID 38331952.
Pusey H, Richards D (May 2001). "A systematic review of the effectiveness of psychosocial interventions for carers of people with dementia". Aging & Mental Health. 5 (2): 107–119. doi:10.1080/13607860120038302. PMID 11511058. S2CID 32517015.
McDade E, Llibre-Guerra JJ, Holtzman DM, Morris JC, Bateman RJ (July 2021). "The informed road map to prevention of Alzheimer Disease: A call to arms". Molecular Neurodegeneration. 16 (1) 49. doi:10.1186/s13024-021-00467-y. PMC 8293489. PMID 34289882.
Lemche E (November 2018). "Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review". Curr Genomics. 19 (7): 522–602. doi:10.2174/1389202919666171229145156. PMC 6194433. PMID 30386171.
Galle SA, Geraedts IK, Deijen JB, Milders MV, Drent ML (2020). "The Interrelationship between Insulin-Like Growth Factor 1, Apolipoprotein E ε4, Lifestyle Factors, and the Aging Body and Brain". J Prev Alzheimers Dis. 7 (4): 265–273. doi:10.14283/jpad.2020.11. hdl:1765/130733. PMID 32920629. S2CID 214784366.
Li Q, Yang X, Xu J, Guo Y, He X, Hu H, et al. (February 2023). "Early prediction of Alzheimer's disease and related dementias using real-world electronic health records". Alzheimer's & Dementia. 19 (8): 3506–3518. doi:10.1002/alz.12967. PMC 10976442. PMID 36815661. S2CID 257101613.
Cummings JL, Zhou Y, Lee G, Zhong K, Fonseca J, Leisgang-Osse AM, et al. (2025). "Alzheimer's disease drug development pipeline: 2025". Alzheimer's & Dementia: Translational Research & Clinical Interventions. 11 (2): e70098. doi:10.1002/trc2.70098. ISSN 2352-8737. PMC 12131090. PMID 40463637.

escholarship.org

Sachdev PS, Blacker D, Blazer DG, Ganguli M, Jeste DV, Paulsen JS, et al. (November 2014). "Classifying neurocognitive disorders: the DSM-5 approach". Nature Reviews. Neurology. 10 (11): 634–642. doi:10.1038/nrneurol.2014.181. hdl:1959.4/unsworks_39077. PMID 25266297. S2CID 20635070. Archived from the original on 20 March 2022. Retrieved 27 November 2021.

factmag.com

"The Caretaker: Persistent Repetition of Phrases". Fact. 26 August 2009. Archived from the original on 15 April 2021. Retrieved 9 April 2021.

fda.gov

"Information for Healthcare Professionals: Conventional Antipsychotics". US Food and Drug Administration. 16 June 2008. Archived from the original on 29 November 2014. Retrieved 29 November 2014.
Commissioner Oo (16 May 2025). "FDA Clears First Blood Test Used in Diagnosing Alzheimer's Disease". FDA. Archived from the original on 16 May 2025. Retrieved 21 May 2025.
"FDA Converts Novel Alzheimer's Disease Treatment to Traditional Approval". U.S. Food and Drug Administration (FDA) (Press release). 6 July 2023. Archived from the original on 6 July 2023. Retrieved 6 July 2023. This article incorporates text from this source, which is in the public domain.
"FDA approves treatment for adults with Alzheimer's disease". U.S. Food and Drug Administration (FDA) (Press release). 2 July 2024. Archived from the original on 2 July 2024. Retrieved 2 July 2024.

fdlp.gov

purl.fdlp.gov

Tejada-Vera B. (2013). Mortality from Alzheimer's Disease in the United States: Data for 2000 and 2010. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics.

handle.net

hdl.handle.net

Mashour GA, Frank L, Batthyany A, Kolanowski AM, Nahm M, Schulman-Green D, et al. (August 2019). "Paradoxical lucidity: A potential paradigm shift for the neurobiology and treatment of severe dementias". Alzheimer's & Dementia. 15 (8): 1107–1114. doi:10.1016/j.jalz.2019.04.002. hdl:2027.42/153062. PMID 31229433. S2CID 195063786.
Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S (November 2008). "New insights into brain BDNF function in normal aging and Alzheimer disease". Brain Research Reviews. 59 (1): 201–220. doi:10.1016/j.brainresrev.2008.07.007. hdl:10533/142174. PMID 18708092. S2CID 6589846.
Sachdev PS, Blacker D, Blazer DG, Ganguli M, Jeste DV, Paulsen JS, et al. (November 2014). "Classifying neurocognitive disorders: the DSM-5 approach". Nature Reviews. Neurology. 10 (11): 634–642. doi:10.1038/nrneurol.2014.181. hdl:1959.4/unsworks_39077. PMID 25266297. S2CID 20635070. Archived from the original on 20 March 2022. Retrieved 27 November 2021.
Barnard ND, Bush AI, Ceccarelli A, Cooper J, de Jager CA, Erickson KI, et al. (September 2014). "Dietary and lifestyle guidelines for the prevention of Alzheimer's disease". Neurobiology of Aging. 35 (Suppl 2): S74 – S78. doi:10.1016/j.neurobiolaging.2014.03.033. hdl:11343/52774. PMID 24913896. S2CID 8265377.
López-Ortiz S, Lista S, Valenzuela PL, Pinto-Fraga J, Carmona R, Caraci F, et al. (November 2022). "Effects of physical activity and exercise interventions on Alzheimer's disease: an umbrella review of existing meta-analyses". Journal of Neurology. 270 (2): 711–725. doi:10.1007/s00415-022-11454-8. hdl:2108/325384. PMID 36342524. S2CID 253382289.
Uddin MS, Tewari D, Mamun AA, Kabir MT, Niaz K, Wahed MI, et al. (July 2020). "Circadian and sleep dysfunction in Alzheimer's disease". Ageing Research Reviews. 60 101046. doi:10.1016/j.arr.2020.101046. hdl:10072/414227. PMID 32171783. S2CID 212729131.
Winkelman MJ, Szabo A, Frecska E (November 2023). "The potential of psychedelics for the treatment of Alzheimer's disease and related dementias". European Neuropsychopharmacology. 76: 3–16. doi:10.1016/j.euroneuro.2023.07.003. hdl:10852/108211. PMID 37451163.
Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, et al. (March 2013). "Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia". The Cochrane Database of Systematic Reviews. 3 (3): CD007726. doi:10.1002/14651858.CD007726.pub2. hdl:1854/LU-3109108. PMID 23543555.
Galle SA, Geraedts IK, Deijen JB, Milders MV, Drent ML (2020). "The Interrelationship between Insulin-Like Growth Factor 1, Apolipoprotein E ε4, Lifestyle Factors, and the Aging Body and Brain". J Prev Alzheimers Dis. 7 (4): 265–273. doi:10.14283/jpad.2020.11. hdl:1765/130733. PMID 32920629. S2CID 214784366.

harvard.edu

ui.adsabs.harvard.edu

Tackenberg C, Kulic L, Nitsch RM (2020). "Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system". PLOS ONE. 15 (9): e0239584. Bibcode:2020PLoSO..1539584T. doi:10.1371/journal.pone.0239584. PMC 7510992. PMID 32966331.
Wang H, Kulas JA, Wang C, Holtzman DM, Ferris HA, Hansen SB (August 2021). "Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol". Proceedings of the National Academy of Sciences of the United States of America. 118 (33): e2102191118. Bibcode:2021PNAS..11802191W. doi:10.1073/pnas.2102191118. ISSN 0027-8424. PMC 8379952. PMID 34385305. S2CID 236998499.
Vilchez D, Saez I, Dillin A (December 2014). "The role of protein clearance mechanisms in organismal ageing and age-related diseases". Nature Communications. 5 5659. Bibcode:2014NatCo...5.5659V. doi:10.1038/ncomms6659. PMID 25482515.
Mahley RW, Weisgraber KH, Huang Y (April 2006). "Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease". Proceedings of the National Academy of Sciences of the United States of America. 103 (15): 5644–5651. Bibcode:2006PNAS..103.5644M. doi:10.1073/pnas.0600549103. PMC 1414631. PMID 16567625.
Yankner BA, Duffy LK, Kirschner DA (October 1990). "Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides". Science. 250 (4978): 279–282. Bibcode:1990Sci...250..279Y. doi:10.1126/science.2218531. PMID 2218531.
Greig NH, Mattson MP, Perry T, Chan SL, Giordano T, Sambamurti K, et al. (December 2004). "New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists". Annals of the New York Academy of Sciences. 1035 (1): 290–315. Bibcode:2004NYASA1035..290G. doi:10.1196/annals.1332.018. PMID 15681814. S2CID 84659695. Archived from the original on 3 June 2020. Retrieved 19 July 2019.
Chu CS, Tseng PT, Stubbs B, Chen TY, Tang CH, Li DJ, et al. (April 2018). "Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis". Scientific Reports. 8 (1) 5804. Bibcode:2018NatSR...8.5804C. doi:10.1038/s41598-018-24248-8. PMC 5895617. PMID 29643479.

mayoclinic.org

"How Alzheimer's drugs help manage symptoms". Mayo Clinic. 30 August 2023. Retrieved 19 March 2024.

medlineplus.gov

"Memantine". US National Library of Medicine (Medline). 4 January 2004. Archived from the original on 22 February 2010. Retrieved 3 February 2010.

metlife.com

"The MetLife study of Alzheimer's disease: The caregiving experience" (PDF). MetLife Mature Market Institute. August 2006. Archived from the original (PDF) on 8 January 2011. Retrieved 5 February 2011.

nhs.uk

"Alzheimer's disease – Symptoms". National Health Service (NHS). 10 May 2018. Archived from the original on 30 January 2021. Retrieved 25 January 2021.
"Alzheimer's disease – Causes". National Health Service (NHS). 24 April 2023. Archived from the original on 29 September 2020. Retrieved 10 July 2023.

nice.org.uk

Dementia: assessment, management and support for people living with dementia and their carers (Report). National Institute for Health and Care Excellence (NICE). 20 June 2018. NG97. Retrieved 8 July 2023.
"Low-dose antipsychotics in people with dementia". National Institute for Health and Care Excellence (NICE). Archived from the original on 5 December 2014. Retrieved 29 November 2014.
Dementia: Quick Reference Guide (PDF). London: (UK) National Institute for Health and Clinical Excellence. 2006. ISBN 978-1-84629-312-2. Archived from the original (PDF) on 27 February 2008. Retrieved 22 February 2008.

pathways.nice.org.uk

"Dementia diagnosis and assessment" (PDF). National Institute for Health and Care Excellence (NICE). Archived from the original (PDF) on 5 December 2014. Retrieved 30 November 2014.

nih.gov

pubmed.ncbi.nlm.nih.gov

Knopman DS, Amieva H, Petersen RC, Chételat G, Holtzman DM, Hyman BT, et al. (May 2021). "Alzheimer disease". Nature Reviews Disease Primers. 7 (1) 33. doi:10.1038/s41572-021-00269-y. PMC 8574196. PMID 33986301.
Mendez MF (November 2012). "Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD". Archives of Medical Research. 43 (8): 677–685. doi:10.1016/j.arcmed.2012.11.009. PMC 3532551. PMID 23178565.
Yu JT, Xu W, Tan CC, Andrieu S, Suckling J, Evangelou E, et al. (November 2020). "Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials". Journal of Neurology, Neurosurgery, and Psychiatry. 91 (11): 1201–1209. doi:10.1136/jnnp-2019-321913. PMC 7569385. PMID 32690803.
Cheng ST (September 2016). "Cognitive Reserve and the Prevention of Dementia: the Role of Physical and Cognitive Activities". Current Psychiatry Reports (Review). 18 (9) 85. doi:10.1007/s11920-016-0721-2. PMC 4969323. PMID 27481112.
Viña J, Sanz-Ros J (October 2018). "Alzheimer's disease: Only prevention makes sense". European Journal of Clinical Investigation (Review). 48 (10): e13005. doi:10.1111/eci.13005. PMID 30028503. S2CID 51703879.
Gomperts SN (April 2016). "Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia". Continuum (Review). 22 (2 Dementia): 435–463. doi:10.1212/CON.0000000000000309. ISSN 1080-2371. PMC 5390937. PMID 27042903.
Lott IT, Head E (March 2019). "Dementia in Down syndrome: unique insights for Alzheimer disease research". Nat Rev Neurol. 15 (3): 135–147. doi:10.1038/s41582-018-0132-6. PMC 8061428. PMID 30733618.
Schaffert J, LoBue C, Hynan LS, Hart J, Rossetti H, Carlew AR, et al. (2022). "Predictors of Life Expectancy in Autopsy-Confirmed Alzheimer's Disease". Journal of Alzheimer's Disease. 86 (1): 271–281. doi:10.3233/JAD-215200. PMC 8966055. PMID 35034898.
Todd S, Barr S, Roberts M, Passmore AP (November 2013). "Survival in dementia and predictors of mortality: a review". International Journal of Geriatric Psychiatry. 28 (11): 1109–1124. doi:10.1002/gps.3946. PMID 23526458.
Breijyeh Z, Karaman R (December 2020). "Comprehensive Review on Alzheimer's Disease: Causes and Treatment". Molecules (Review). 25 (24): 5789. doi:10.3390/molecules25245789. PMC 7764106. PMID 33302541.
Burns A, Iliffe S (February 2009). "Alzheimer's disease". BMJ. 338: b158. doi:10.1136/bmj.b158. PMID 19196745. S2CID 8570146.
Long JM, Holtzman DM (October 2019). "Alzheimer Disease: An Update on Pathobiology and Treatment Strategies". Cell. 179 (2): 312–339. doi:10.1016/j.cell.2019.09.001. PMC 6778042. PMID 31564456.
Khan S, Barve KH, Kumar MS (2020). "Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease". Curr Neuropharmacol. 18 (11): 1106–1125. doi:10.2174/1570159X18666200528142429. PMC 7709159. PMID 32484110.
Gauthreaux K, Bonnett TA, Besser LM, Brenowitz WD, Teylan M, Mock C, et al. (May 2020). "Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy". Journal of Neuropathology and Experimental Neurology. 79 (5): 465–473. doi:10.1093/jnen/nlaa014. PMC 7160616. PMID 32186726.
Thompson CA, Spilsbury K, Hall J, Birks Y, Barnes C, Adamson J (July 2007). "Systematic review of information and support interventions for caregivers of people with dementia". BMC Geriatrics. 7 18. doi:10.1186/1471-2318-7-18. PMC 1951962. PMID 17662119.
Forbes D, Forbes SC, Blake CM, Thiessen EJ, Forbes S (April 2015). "Exercise programs for people with dementia". The Cochrane Database of Systematic Reviews (Submitted manuscript). 132 (4): CD006489. doi:10.1002/14651858.CD006489.pub4. PMC 9426996. PMID 25874613.
Zhu D, Montagne A, Zhao Z (June 2021). "Alzheimer's pathogenic mechanisms and underlying sex difference". Cell Mol Life Sci. 78 (11): 4907–4920. doi:10.1007/s00018-021-03830-w. PMC 8720296. PMID 33844047.
Berchtold NC, Cotman CW (1998). "Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s". Neurobiology of Aging. 19 (3): 173–189. doi:10.1016/S0197-4580(98)00052-9. PMID 9661992. S2CID 24808582.
Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, et al. (January 2007). "Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline". European Journal of Neurology. 14 (1): e1-26. doi:10.1111/j.1468-1331.2006.01605.x. PMID 17222085. S2CID 2725064.
Bäckman L, Jones S, Berger AK, Laukka EJ, Small BJ (September 2004). "Multiple cognitive deficits during the transition to Alzheimer's disease". Journal of Internal Medicine. 256 (3): 195–204. doi:10.1111/j.1365-2796.2004.01386.x. PMID 15324363. S2CID 37005854.
Nygård L (2003). "Instrumental activities of daily living: a stepping-stone towards Alzheimer's disease diagnosis in subjects with mild cognitive impairment?". Acta Neurologica Scandinavica. Supplementum. 179 (s179): 42–46. doi:10.1034/j.1600-0404.107.s179.8.x. PMID 12603250. S2CID 25313065.
Deardorff WJ, Grossberg GT (2019). "Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia". Psychopharmacology of Neurologic Disease. Handbook of Clinical Neurology. Vol. 165. Elsevier. pp. 5–32. doi:10.1016/B978-0-444-64012-3.00002-2. ISBN 978-0-444-64012-3. PMID 31727229. S2CID 208037448.
Petersen RC, Lopez O, Armstrong MJ, Getchius TS, Ganguli M, Gloss D, et al. (January 2018). "Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology". Neurology. 90 (3): 126–135. doi:10.1212/WNL.0000000000004826. PMC 5772157. PMID 29282327.
Atri A (March 2019). "The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management". The Medical Clinics of North America (Review). 103 (2): 263–293. doi:10.1016/j.mcna.2018.10.009. PMID 30704681. S2CID 73432842.
Förstl H, Kurz A (1999). "Clinical features of Alzheimer's disease". European Archives of Psychiatry and Clinical Neuroscience. 249 (6): 288–290. doi:10.1007/s004060050101. PMID 10653284. S2CID 26142779.
Carlesimo GA, Oscar-Berman M (June 1992). "Memory deficits in Alzheimer's patients: a comprehensive review". Neuropsychology Review. 3 (2): 119–169. doi:10.1007/BF01108841. PMID 1300219. S2CID 19548915.
Jelicic M, Bonebakker AE, Bonke B (1995). "Implicit memory performance of patients with Alzheimer's disease: a brief review". International Psychogeriatrics. 7 (3): 385–392. doi:10.1017/S1041610295002134. PMID 8821346. S2CID 9419442.
Taler V, Phillips NA (July 2008). "Language performance in Alzheimer's disease and mild cognitive impairment: a comparative review". Journal of Clinical and Experimental Neuropsychology. 30 (5): 501–556. doi:10.1080/13803390701550128. PMID 18569251. S2CID 37153159.
Frank EM (September 1994). "Effect of Alzheimer's disease on communication function". Journal of the South Carolina Medical Association. 90 (9): 417–423. PMID 7967534.
Volicer L, Harper DG, Manning BC, Goldstein R, Satlin A (May 2001). "Sundowning and circadian rhythms in Alzheimer's disease". The American Journal of Psychiatry. 158 (5): 704–711. doi:10.1176/appi.ajp.158.5.704. PMID 11329390. S2CID 10492607.
Gold DP, Reis MF, Markiewicz D, Andres D (January 1995). "When home caregiving ends: a longitudinal study of outcomes for caregivers of relatives with dementia". Journal of the American Geriatrics Society. 43 (1): 10–16. doi:10.1111/j.1532-5415.1995.tb06235.x. PMID 7806732. S2CID 29847950.
Mashour GA, Frank L, Batthyany A, Kolanowski AM, Nahm M, Schulman-Green D, et al. (August 2019). "Paradoxical lucidity: A potential paradigm shift for the neurobiology and treatment of severe dementias". Alzheimer's & Dementia. 15 (8): 1107–1114. doi:10.1016/j.jalz.2019.04.002. hdl:2027.42/153062. PMID 31229433. S2CID 195063786.
Tackenberg C, Kulic L, Nitsch RM (2020). "Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system". PLOS ONE. 15 (9): e0239584. Bibcode:2020PLoSO..1539584T. doi:10.1371/journal.pone.0239584. PMC 7510992. PMID 32966331.
Wang H, Kulas JA, Wang C, Holtzman DM, Ferris HA, Hansen SB (August 2021). "Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol". Proceedings of the National Academy of Sciences of the United States of America. 118 (33): e2102191118. Bibcode:2021PNAS..11802191W. doi:10.1073/pnas.2102191118. ISSN 0027-8424. PMC 8379952. PMID 34385305. S2CID 236998499.
Vilchez D, Saez I, Dillin A (December 2014). "The role of protein clearance mechanisms in organismal ageing and age-related diseases". Nature Communications. 5 5659. Bibcode:2014NatCo...5.5659V. doi:10.1038/ncomms6659. PMID 25482515.
Andrews SJ, Renton AE, Fulton-Howard B, Podlesny-Drabiniok A, Marcora E, Goate AM (April 2023). "The complex genetic architecture of Alzheimer's disease: novel insights and future directions". eBioMedicine. 90 104511. doi:10.1016/j.ebiom.2023.104511. PMC 10024184. PMID 36907103.
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, et al. (April 2021). "Alzheimer's disease". Lancet. 397 (10284): 1577–1590. doi:10.1016/S0140-6736(20)32205-4. PMC 8354300. PMID 33667416.
Chávez-Gutiérrez L, Szaruga M (September 2020). "Mechanisms of neurodegeneration - Insights from familial Alzheimer's disease". Semin Cell Dev Biol. 105: 75–85. doi:10.1016/j.semcdb.2020.03.005. PMID 32418657.
Piaceri I, Nacmias B, Sorbi S (January 2013). "Genetics of familial and sporadic Alzheimer's disease". Frontiers in Bioscience (Elite Edition). 5 (1) E605: 167–177. doi:10.2741/e605. PMID 23276979.
Perea JR, Bolós M, Avila J (October 2020). "Microglia in Alzheimer's Disease in the Context of Tau Pathology". Biomolecules. 10 (10): 1439. doi:10.3390/biom10101439. PMC 7602223. PMID 33066368.
Mahley RW, Weisgraber KH, Huang Y (April 2006). "Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease". Proceedings of the National Academy of Sciences of the United States of America. 103 (15): 5644–5651. Bibcode:2006PNAS..103.5644M. doi:10.1073/pnas.0600549103. PMC 1414631. PMID 16567625.
Blennow K, de Leon MJ, Zetterberg H (July 2006). "Alzheimer's disease". Lancet. 368 (9533): 387–403. doi:10.1016/S0140-6736(06)69113-7. PMID 16876668. S2CID 47544338.
Hall K, Murrell J, Ogunniyi A, Deeg M, Baiyewu O, Gao S, et al. (January 2006). "Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba". Neurology. 66 (2): 223–227. doi:10.1212/01.wnl.0000194507.39504.17. PMC 2860622. PMID 16434658.
Gureje O, Ogunniyi A, Baiyewu O, Price B, Unverzagt FW, Evans RM, et al. (January 2006). "APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians". Annals of Neurology. 59 (1): 182–185. doi:10.1002/ana.20694. PMC 2855121. PMID 16278853.
Schramm C, Wallon D, Nicolas G, Charbonnier C (1 May 2022). "What contribution can genetics make to predict the risk of Alzheimer's disease?". Revue Neurologique. International meeting of the French society of neurology : NeuroDegenerative Disease : What will the future bring ?. 178 (5): 414–421. doi:10.1016/j.neurol.2022.03.005. ISSN 0035-3787. PMID 35491248.
Goldman JS, Van Deerlin VM (1 October 2018). "Alzheimer's Disease and Frontotemporal Dementia: The Current State of Genetics and Genetic Testing Since the Advent of Next-Generation Sequencing". Molecular Diagnosis & Therapy. 22 (5): 505–513. doi:10.1007/s40291-018-0347-7. ISSN 1179-2000. PMC 6472481. PMID 29971646.
Piaceri I (2013). "Genetics of familial and sporadic Alzheimer s disease". Frontiers in Bioscience. E5 (1) E605: 167–177. doi:10.2741/E605. ISSN 1945-0494. PMID 23276979.
Selkoe DJ (June 1999). "Translating cell biology into therapeutic advances in Alzheimer's disease". Nature. 399 (6738 Suppl): A23 – A31. doi:10.1038/19866. PMID 10392577. S2CID 42287088.
Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, et al. (November 1996). "Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo". Neuron. 17 (5): 1005–1013. doi:10.1016/S0896-6273(00)80230-5. PMID 8938131. S2CID 18315650.
Kim JH (December 2018). "Genetics of Alzheimer's Disease". Dementia and Neurocognitive Disorders. 17 (4): 131–136. doi:10.12779/dnd.2018.17.4.131. PMC 6425887. PMID 30906402.
Carmona S, Zahs K, Wu E, Dakin K, Bras J, Guerreiro R (August 2018). "The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders". Lancet Neurol. 17 (8): 721–730. doi:10.1016/S1474-4422(18)30232-1. PMID 30033062. S2CID 51706988. Archived from the original on 27 March 2022. Retrieved 21 February 2022.
Tomiyama T (July 2010). "[Involvement of beta-amyloid in the etiology of Alzheimer's disease]". Brain and Nerve = Shinkei Kenkyu No Shinpo. 62 (7): 691–699. PMID 20675873.
Tomiyama T, Nagata T, Shimada H, Teraoka R, Fukushima A, Kanemitsu H, et al. (March 2008). "A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia". Annals of Neurology. 63 (3): 377–387. doi:10.1002/ana.21321. PMID 18300294. S2CID 42311988.
Tomiyama T, Shimada H (February 2020). "APP Osaka Mutation in Familial Alzheimer's Disease-Its Discovery, Phenotypes, and Mechanism of Recessive Inheritance". International Journal of Molecular Sciences. 21 (4): 1413. doi:10.3390/ijms21041413. PMC 7073033. PMID 32093100.
Tzioras M, Davies C, Newman A, Jackson R, Spires-Jones T (June 2019). "Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease". Neuropathology and Applied Neurobiology. 45 (4): 327–346. doi:10.1111/nan.12529. PMC 6563457. PMID 30394574.
Sinyor B, Mineo J, Ochner C (June 2020). "Alzheimer's Disease, Inflammation, and the Role of Antioxidants". Journal of Alzheimer's Disease Reports. 4 (1): 175–183. doi:10.3233/ADR-200171. PMC 7369138. PMID 32715278.
Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT (2018). "Inflammation as a central mechanism in Alzheimer's disease". Alzheimer's & Dementia. 4: 575–590. doi:10.1016/j.trci.2018.06.014. PMC 6214864. PMID 30406177.
Lin X, Kapoor A, Gu Y, Chow MJ, Peng J, Zhao K, et al. (February 2020). "Contributions of DNA Damage to Alzheimer's Disease". Int J Mol Sci. 21 (5): 1666. doi:10.3390/ijms21051666. PMC 7084447. PMID 32121304.
Hardy J, Allsop D (October 1991). "Amyloid deposition as the central event in the aetiology of Alzheimer's disease". Trends in Pharmacological Sciences. 12 (10): 383–388. doi:10.1016/0165-6147(91)90609-V. PMID 1763432.
Mudher A, Lovestone S (January 2002). "Alzheimer's disease-do tauists and baptists finally shake hands?". Trends in Neurosciences. 25 (1): 22–26. doi:10.1016/S0166-2236(00)02031-2. PMID 11801334. S2CID 37380445.
Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, et al. (November 1995). "Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein". The New England Journal of Medicine. 333 (19): 1242–1247. doi:10.1056/NEJM199511093331902. PMID 7566000.
Irwin MR, Vitiello MV (March 2019). "Implications of sleep disturbance and inflammation for Alzheimer's disease dementia". The Lancet. Neurology. 18 (3): 296–306. doi:10.1016/S1474-4422(18)30450-2. PMID 30661858. S2CID 58546748.
Chen J, Peng G, Sun B (October 2024). "Alzheimer's disease and sleep disorders: A bidirectional relationship". Neuroscience. 557: 12–23. doi:10.1016/j.neuroscience.2024.08.008. PMID 39137870.
Lloret MA, Cervera-Ferri A, Nepomuceno M, Monllor P, Esteve D, Lloret A (February 2020). "Is Sleep Disruption a Cause or Consequence of Alzheimer's Disease? Reviewing Its Possible Role as a Biomarker". International Journal of Molecular Sciences. 21 (3): 1168. doi:10.3390/ijms21031168. PMC 7037733. PMID 32050587.
Huat TJ, Camats-Perna J, Newcombe EA, Valmas N, Kitazawa M, Medeiros R (April 2019). "Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation". J Mol Biol. 431 (9): 1843–1868. doi:10.1016/j.jmb.2019.01.018. PMC 6475603. PMID 30664867.
Eikelenboom P, van Exel E, Hoozemans JJ, Veerhuis R, Rozemuller AJ, van Gool WA (2010). "Neuroinflammation – an early event in both the history and pathogenesis of Alzheimer's disease". Neuro-Degenerative Diseases. 7 (1–3): 38–41. doi:10.1159/000283480. PMID 20160456. S2CID 40048333.
Alves GS, Oertel Knöchel V, Knöchel C, Carvalho AF, Pantel J, Engelhardt E, et al. (2015). "Integrating retrogenesis theory to Alzheimer's disease pathology: insight from DTI-TBSS investigation of the white matter microstructural integrity". BioMed Research International. 2015: 291658. doi:10.1155/2015/291658. PMC 4320890. PMID 25685779.
Reisberg B, Franssen EH, Hasan SM, Monteiro I, Boksay I, Souren LE, et al. (1999). "Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer's and other dementing processes". European Archives of Psychiatry and Clinical Neuroscience. 249 (3): 28–36. doi:10.1007/pl00014170. PMID 10654097. S2CID 23410069.
Bartzokis G (August 2011). "Alzheimer's disease as homeostatic responses to age-related myelin breakdown". Neurobiology of Aging. 32 (8): 1341–1371. doi:10.1016/j.neurobiolaging.2009.08.007. PMC 3128664. PMID 19775776.
Cai Z, Xiao M (2016). "Oligodendrocytes and Alzheimer's disease". The International Journal of Neuroscience. 126 (2): 97–104. doi:10.3109/00207454.2015.1025778. PMID 26000818. S2CID 21448714.
Luczynski P, Laule C, Hsiung GR, Moore GR, Tremlett H (January 2019). "Coexistence of Multiple Sclerosis and Alzheimer's disease: A review". Multiple Sclerosis and Related Disorders. 27: 232–238. doi:10.1016/j.msard.2018.10.109. PMID 30415025.
Zis P, Hadjivassiliou M (February 2019). "Treatment of Neurological Manifestations of Gluten Sensitivity and Coeliac Disease". Current Treatment Options in Neurology. 21 (3) 10. doi:10.1007/s11940-019-0552-7. PMID 30806821. S2CID 73466457.
Makhlouf S, Messelmani M, Zaouali J, Mrissa R (March 2018). "Cognitive impairment in celiac disease and non-celiac gluten sensitivity: review of literature on the main cognitive impairments, the imaging and the effect of gluten free diet". Acta Neurologica Belgica (Review). 118 (1): 21–27. doi:10.1007/s13760-017-0870-z. PMID 29247390. S2CID 3943047.
Zhou L, Miranda-Saksena M, Saksena NK (May 2013). "Viruses and neurodegeneration". Virology Journal. 10 (1) 172. doi:10.1186/1743-422X-10-172. PMC 3679988. PMID 23724961.
Gonzalez-Fernandez E, Huang J (September 2023). "Cognitive Aspects of COVID-19". Current Neurology and Neuroscience Reports. 23 (9): 531–538. doi:10.1007/s11910-023-01286-y. PMID 37490194. S2CID 260132167.
Farrer TJ, Moore JD, Chase M, Gale SD, Hedges DW (November 2024). "Infectious Disease as a Modifiable Risk Factor for Dementia: A Narrative Review". Pathogens. 13 (11): 974. doi:10.3390/pathogens13110974. PMC 11597442. PMID 39599527.
Biagio P, Isabella DF, Federica C, Elena S, Ivan G (May 2024). "Alzheimer's disease and herpes viruses: Current events and perspectives". Rev Med Virol. 34 (3): e2550. doi:10.1002/rmv.2550. PMID 38801246.
Rippee-Brooks MD, Wu W, Dong J, Pappolla M, Fang X, Bao X (March 2024). "Viral Infections, Are They a Trigger and Risk Factor of Alzheimer's Disease?". Pathogens. 13 (3): 240. doi:10.3390/pathogens13030240. PMC 10974111. PMID 38535583.
Kandimalla R, Thirumala V, Reddy PH (May 2017). "Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863 (5): 1078–1089. doi:10.1016/j.bbadis.2016.08.018. PMC 5344773. PMID 27567931.
Wenk GL (2003). "Neuropathologic changes in Alzheimer's disease". The Journal of Clinical Psychiatry. 64 (Suppl 9): 7–10. PMID 12934968.
Braak H, Del Tredici K (December 2012). "Where, when, and in what form does sporadic Alzheimer's disease begin?". Current Opinion in Neurology. 25 (6): 708–714. doi:10.1097/WCO.0b013e32835a3432. PMID 23160422.
Desikan RS, Cabral HJ, Hess CP, Dillon WP, Glastonbury CM, Weiner MW, et al. (August 2009). "Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease". Brain. 132 (Pt 8): 2048–2057. doi:10.1093/brain/awp123. PMC 2714061. PMID 19460794.
Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J (June 2004). "The importance of neuritic plaques and tangles to the development and evolution of AD". Neurology. 62 (11): 1984–1989. doi:10.1212/01.WNL.0000129697.01779.0A. PMID 15184601. S2CID 25017332.
DeTure MA, Dickson DW (August 2019). "The neuropathological diagnosis of Alzheimer's disease". Molecular Neurodegeneration. 14 (1) 32. doi:10.1186/s13024-019-0333-5. PMC 6679484. PMID 31375134.
Tiraboschi P, Sabbagh MN, Hansen LA, Salmon DP, Merdes A, Gamst A, et al. (April 2004). "Alzheimer disease without neocortical neurofibrillary tangles: "a second look"". Neurology. 62 (7): 1141–1147. doi:10.1212/01.wnl.0000118212.41542.e7. PMID 15079014. S2CID 22832110.
Bouras C, Hof PR, Giannakopoulos P, Michel JP, Morrison JH (1994). "Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital". Cerebral Cortex. 4 (2): 138–150. doi:10.1093/cercor/4.2.138. PMID 8038565.
Kotzbauer PT, Trojanowsk JQ, Lee VM (October 2001). "Lewy body pathology in Alzheimer's disease". Journal of Molecular Neuroscience. 17 (2): 225–232. doi:10.1385/JMN:17:2:225. PMID 11816795. S2CID 44407971.
Hernández F, Avila J (September 2007). "Tauopathies". Cellular and Molecular Life Sciences. 64 (17): 2219–2233. doi:10.1007/s00018-007-7220-x. PMC 11136052. PMID 17604998. S2CID 261121643.
Sun W, Samimi H, Gamez M, Zare H, Frost B (August 2018). "Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies". Nature Neuroscience. 21 (8): 1038–1048. doi:10.1038/s41593-018-0194-1. PMC 6095477. PMID 30038280.
Balusu S, Horré K, Thrupp N, Craessaerts K, Snellinx A, Serneels L, T'Syen D, Chrysidou I, Arranz AM, Sierksma A, Simrén J, Karikari TK, Zetterberg H, Chen WT, Thal DR, Salta E, Fiers M, De Strooper B. MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer's disease. Science. 2023 Sep 15;381(6663):1176-1182. doi:10.1126/science.abp9556 PMID 37708272
Van Broeck B, Van Broeckhoven C, Kumar-Singh S (2007). "Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches". Neuro-Degenerative Diseases. 4 (5): 349–365. doi:10.1159/000105156. PMID 17622778. S2CID 7949658.
Huang Y, Mucke L (March 2012). "Alzheimer mechanisms and therapeutic strategies". Cell. 148 (6): 1204–1222. doi:10.1016/j.cell.2012.02.040. PMC 3319071. PMID 22424230.
Yankner BA, Duffy LK, Kirschner DA (October 1990). "Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides". Science. 250 (4978): 279–282. Bibcode:1990Sci...250..279Y. doi:10.1126/science.2218531. PMID 2218531.
Chen X, Yan SD (December 2006). "Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease". IUBMB Life. 58 (12): 686–694. doi:10.1080/15216540601047767. PMID 17424907. S2CID 85423830.
Ramanan VK, Armstrong MJ, Choudhury P, Coerver KA, Hamilton RH, Klein BC, et al. (November 2023). "Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology". Neurology. 101 (19): 842–852. doi:10.1212/WNL.0000000000207757. PMC 10663011. PMID 37495380.
Ryan SK, Ugalde CL, Rolland AS, Skidmore J, Devos D, Hammond TR (October 2023). "Therapeutic inhibition of ferroptosis in neurodegenerative disease". Trends in Pharmacological Sciences. 44 (10): 674–688. doi:10.1016/j.tips.2023.07.007. PMID 37657967.
Greig NH, Mattson MP, Perry T, Chan SL, Giordano T, Sambamurti K, et al. (December 2004). "New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists". Annals of the New York Academy of Sciences. 1035 (1): 290–315. Bibcode:2004NYASA1035..290G. doi:10.1196/annals.1332.018. PMID 15681814. S2CID 84659695. Archived from the original on 3 June 2020. Retrieved 19 July 2019.
Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL (April 2015). "Neuroinflammation in Alzheimer's disease". The Lancet. Neurology. 14 (4): 388–405. doi:10.1016/S1474-4422(15)70016-5. PMC 5909703. PMID 25792098.
Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S (November 2008). "New insights into brain BDNF function in normal aging and Alzheimer disease". Brain Research Reviews. 59 (1): 201–220. doi:10.1016/j.brainresrev.2008.07.007. hdl:10533/142174. PMID 18708092. S2CID 6589846.
Schindowski K, Belarbi K, Buée L (February 2008). "Neurotrophic factors in Alzheimer's disease: role of axonal transport". Genes, Brain and Behavior. 7 (Suppl 1): 43–56. doi:10.1111/j.1601-183X.2007.00378.x. PMC 2228393. PMID 18184369.
Heneka MT, van der Flier WM, Jessen F, Hoozemanns J, Thal DR, Boche D (December 2024). "Neuroinflammation in Alzheimer disease". Nat Rev Immunol. 25 (5): 321–352. doi:10.1038/s41577-024-01104-7. PMID 39653749.
Boche D, Nicoll JA (December 2020). "Invited Review - Understanding cause and effect in Alzheimer's pathophysiology: Implications for clinical trials". Neuropathol Appl Neurobiol. 46 (7): 623–640. doi:10.1111/nan.12642. PMID 32643143.
Leng F, Edison P (March 2021). "Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?". Nat Rev Neurol. 17 (3): 157–172. doi:10.1038/s41582-020-00435-y. PMID 33318676.
Fruhwürth S, Zetterberg H, Paludan SR (May 2024). "Microglia and amyloid plaque formation in Alzheimer's disease - Evidence, possible mechanisms, and future challenges". J Neuroimmunol. 390 578342. doi:10.1016/j.jneuroim.2024.578342. PMID 38640827.
Sachdev PS, Blacker D, Blazer DG, Ganguli M, Jeste DV, Paulsen JS, et al. (November 2014). "Classifying neurocognitive disorders: the DSM-5 approach". Nature Reviews. Neurology. 10 (11): 634–642. doi:10.1038/nrneurol.2014.181. hdl:1959.4/unsworks_39077. PMID 25266297. S2CID 20635070. Archived from the original on 20 March 2022. Retrieved 27 November 2021.
Arvanitakis Z, Shah RC, Bennett DA (October 2019). "Diagnosis and Management of Dementia: Review". JAMA. 322 (16): 1589–1599. doi:10.1001/jama.2019.4782. PMC 7462122. PMID 31638686.
Mendez MF (2006). "The accurate diagnosis of early-onset dementia". International Journal of Psychiatry in Medicine. 36 (4): 401–412. doi:10.2190/Q6J4-R143-P630-KW41. PMID 17407994. S2CID 43715976. Archived from the original on 3 June 2020. Retrieved 25 May 2020.
Klafki HW, Staufenbiel M, Kornhuber J, Wiltfang J (November 2006). "Therapeutic approaches to Alzheimer's disease". Brain. 129 (Pt 11): 2840–2855. doi:10.1093/brain/awl280. PMID 17018549.
Schroeter ML, Stein T, Maslowski N, Neumann J (October 2009). "Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients". NeuroImage. 47 (4): 1196–1206. doi:10.1016/j.neuroimage.2009.05.037. PMC 2730171. PMID 19463961.
Jie CV, Treyer V, Schibli R, Mu L (January 2021). "Tauvid: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease". Pharmaceuticals. 14 (2): 110. doi:10.3390/ph14020110. PMC 7911942. PMID 33573211.
Weller J, Budson A (2018). "Current understanding of Alzheimer's disease diagnosis and treatment". F1000Research (Review). 7: 1161. doi:10.12688/f1000research.14506.1. PMC 6073093. PMID 30135715.
Silva MV, Loures CM, Alves LC, de Souza LC, Borges KB, Carvalho MD (May 2019). "Alzheimer's disease: risk factors and potentially protective measures". Journal of Biomedical Science. 26 (1) 33. doi:10.1186/s12929-019-0524-y. PMC 6507104. PMID 31072403.
Sachs-Ericsson N, Blazer DG (January 2015). "The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment". Aging & Mental Health. 19 (1): 2–12. doi:10.1080/13607863.2014.920303. PMID 24914889. S2CID 46244321.
Stokin GB, Krell-Roesch J, Petersen RC, Geda YE (2015). "Mild Neurocognitive Disorder: An Old Wine in a New Bottle". Harvard Review of Psychiatry (Review). 23 (5): 368–376. doi:10.1097/HRP.0000000000000084. PMC 4894762. PMID 26332219.
Fink HA, Hemmy LS, Linskens EJ, Silverman PC, MacDonald R, McCarten JR, et al. (2020). Diagnosis and Treatment of Clinical Alzheimer's-Type Dementia: A Systematic Review. AHRQ Comparative Effectiveness Reviews. Rockville (MD): Agency for Healthcare Research and Quality (US). PMID 32369312. Archived from the original on 7 July 2023. Retrieved 16 November 2021.
Bradfield NI, Ames D (April 2020). "Mild cognitive impairment: narrative review of taxonomies and systematic review of their prediction of incident Alzheimer's disease dementia". BJPsych Bulletin (Review). 44 (2): 67–74. doi:10.1192/bjb.2019.77. PMC 7283119. PMID 31724527.
Vega JN, Newhouse PA (October 2014). "Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments". Current Psychiatry Reports. 16 (10) 490. SpringerLink. doi:10.1007/s11920-014-0490-8. PMC 4169219. PMID 25160795.
Parnetti L, Chipi E, Salvadori N, D'Andrea K, Eusebi P (January 2019). "Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis". Alzheimer's Research & Therapy. 11 (1) 7. Springer Nature. doi:10.1186/s13195-018-0459-7. PMC 6334406. PMID 30646955.
Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. (April 2018). "NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease". Alzheimer's & Dementia. 14 (4): 535–562. doi:10.1016/j.jalz.2018.02.018. PMC 5958625. PMID 29653606.
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. (May 2011). "Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease". Alzheimer's & Dementia. 7 (3): 280–292. doi:10.1016/j.jalz.2011.03.003. PMC 3220946. PMID 21514248.
Cheng YW, Chen TF, Chiu MJ (16 February 2017). "From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution". Neuropsychiatric Disease and Treatment. 13. Dove Medical Press Limited: 491–498. doi:10.2147/NDT.S123428. PMC 5317337. PMID 28243102.
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. (May 2011). "The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease". Alzheimer's & Dementia. 7 (3): 270–279. doi:10.1016/j.jalz.2011.03.008. PMC 3312027. PMID 21514249.
Chertkow H, Feldman HH, Jacova C, Massoud F (July 2013). "Definitions of dementia and predementia states in Alzheimer's disease and vascular cognitive impairment: consensus from the Canadian conference on diagnosis of dementia". Alzheimer's Research & Therapy. 5 (Suppl 1). BMC: S2. doi:10.1186/alzrt198. PMC 3981054. PMID 24565215.
Tombaugh TN, McIntyre NJ (September 1992). "The mini-mental state examination: a comprehensive review". Journal of the American Geriatrics Society. 40 (9): 922–935. doi:10.1111/j.1532-5415.1992.tb01992.x. PMID 1512391. S2CID 25169596.
Pasquier F (January 1999). "Early diagnosis of dementia: neuropsychology". Journal of Neurology. 246 (1): 6–15. doi:10.1007/s004150050299. PMID 9987708. S2CID 2108587.
Harvey PD, Moriarty PJ, Kleinman L, Coyne K, Sadowsky CH, Chen M, et al. (2005). "The validation of a caregiver assessment of dementia: the Dementia Severity Scale". Alzheimer Disease and Associated Disorders. 19 (4): 186–194. doi:10.1097/01.wad.0000189034.43203.60. PMID 16327345. S2CID 20238911.
Antoine C, Antoine P, Guermonprez P, Frigard B (2004). "[Awareness of deficits and anosognosia in Alzheimer's disease]". L'Encéphale (in French). 30 (6): 570–577. doi:10.1016/S0013-7006(04)95472-3. PMID 15738860.
Cruz VT, Pais J, Teixeira A, Nunes B (2004). "[The initial symptoms of Alzheimer disease: caregiver perception]". Acta Médica Portuguesa (in Portuguese). 17 (6): 435–444. PMID 16197855.
Sun X, Steffens DC, Au R, Folstein M, Summergrad P, Yee J, et al. (May 2008). "Amyloid-associated depression: a prodromal depression of Alzheimer disease?". Archives of General Psychiatry. 65 (5): 542–550. doi:10.1001/archpsyc.65.5.542. PMC 3042807. PMID 18458206.
Geldmacher DS, Whitehouse PJ (May 1997). "Differential diagnosis of Alzheimer's disease". Neurology. 48 (5 Suppl 6): S2 – S9. doi:10.1212/WNL.48.5_Suppl_6.2S. PMID 9153154. S2CID 30018544.
Potter GG, Steffens DC (May 2007). "Contribution of depression to cognitive impairment and dementia in older adults". The Neurologist. 13 (3): 105–117. doi:10.1097/01.nrl.0000252947.15389.a9. PMID 17495754. S2CID 24569198.
Zhang S, Smailagic N, Hyde C, Noel-Storr AH, Takwoingi Y, McShane R, et al. (July 2014). "(11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)". The Cochrane Database of Systematic Reviews. 2014 (7): CD010386. doi:10.1002/14651858.CD010386.pub2. PMC 6464750. PMID 25052054.
Smailagic N, Vacante M, Hyde C, Martin S, Ukoumunne O, Sachpekidis C (January 2015). "¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)". The Cochrane Database of Systematic Reviews. 1 (1): CD010632. doi:10.1002/14651858.CD010632.pub2. PMC 7081123. PMID 25629415.
Hsu D, Marshall GA (2017). "Primary and secondary prevention trials in Alzheimer disease: looking back, moving forward". Curr Alzheimer Res. 14 (4): 426–440. doi:10.2174/1567205013666160930112125. PMC 5329133. PMID 27697063.
Patterson C, Feightner JW, Garcia A, Hsiung GY, MacKnight C, Sadovnick AD (February 2008). "Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease". CMAJ. 178 (5): 548–556. doi:10.1503/cmaj.070796. PMC 2244657. PMID 18299540.
Rosendorff C, Beeri MS, Silverman JM (2007). "Cardiovascular risk factors for Alzheimer's disease". The American Journal of Geriatric Cardiology. 16 (3): 143–149. doi:10.1111/j.1076-7460.2007.06696.x. PMID 17483665.
Chu CS, Tseng PT, Stubbs B, Chen TY, Tang CH, Li DJ, et al. (April 2018). "Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis". Scientific Reports. 8 (1) 5804. Bibcode:2018NatSR...8.5804C. doi:10.1038/s41598-018-24248-8. PMC 5895617. PMID 29643479.
Ungvari Z, Toth P, Tarantini S, Prodan CI, Sorond F, Merkely B, et al. (October 2021). "Hypertension-induced cognitive impairment: from pathophysiology to public health". Nature Reviews Nephrology. 17 (10): 639–654. doi:10.1038/s41581-021-00430-6. PMC 8202227. PMID 34127835.
Lethaby A, Hogervorst E, Richards M, Yesufu A, Yaffe K (January 2008). "Hormone replacement therapy for cognitive function in postmenopausal women". Cochrane Database Syst Rev. 2008 (1): CD003122. doi:10.1002/14651858.CD003122.pub2. PMC 6599876. PMID 18254016.
Farina N, Rusted J, Tabet N (January 2014). "The effect of exercise interventions on cognitive outcome in Alzheimer's disease: a systematic review". International Psychogeriatrics (Review). 26 (1): 9–18. doi:10.1017/S1041610213001385. PMID 23962667. S2CID 24936334.
Ribarič S (March 2022). "Physical Exercise, a Potential Non-Pharmacological Intervention for Attenuating Neuroinflammation and Cognitive Decline in Alzheimer's Disease Patients". Int J Mol Sci. 23 (6): 3245. doi:10.3390/ijms23063245. PMC 8952567. PMID 35328666.
Barnard ND, Bush AI, Ceccarelli A, Cooper J, de Jager CA, Erickson KI, et al. (September 2014). "Dietary and lifestyle guidelines for the prevention of Alzheimer's disease". Neurobiology of Aging. 35 (Suppl 2): S74 – S78. doi:10.1016/j.neurobiolaging.2014.03.033. hdl:11343/52774. PMID 24913896. S2CID 8265377.
Bhatti GK, Reddy AP, Reddy PH, Bhatti JS (2019). "Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer's Disease". Frontiers in Aging Neuroscience (Review). 11: 369. doi:10.3389/fnagi.2019.00369. PMC 6966236. PMID 31998117.
López-Ortiz S, Lista S, Valenzuela PL, Pinto-Fraga J, Carmona R, Caraci F, et al. (November 2022). "Effects of physical activity and exercise interventions on Alzheimer's disease: an umbrella review of existing meta-analyses". Journal of Neurology. 270 (2): 711–725. doi:10.1007/s00415-022-11454-8. hdl:2108/325384. PMID 36342524. S2CID 253382289.
Imtiaz B, Tolppanen AM, Kivipelto M, Soininen H (April 2014). "Future directions in Alzheimer's disease from risk factors to prevention". Biochem Pharmacol. 88 (4): 661–70. doi:10.1016/j.bcp.2014.01.003. PMID 24418410.
Kivipelto M, Mangialasche F, Ngandu T (November 2018). "Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease". Nat Rev Neurol. 14 (11): 653–666. doi:10.1038/s41582-018-0070-3. PMID 30291317. S2CID 52925352.
Borges CR, Poyares D, Piovezan R, Nitrini R, Brucki S (November 2019). "Alzheimer's disease and sleep disturbances: a review". Arq Neuropsiquiatr. 77 (11): 815–824. doi:10.1590/0004-282X20190149. PMID 31826138. S2CID 209327994.
Uddin MS, Tewari D, Mamun AA, Kabir MT, Niaz K, Wahed MI, et al. (July 2020). "Circadian and sleep dysfunction in Alzheimer's disease". Ageing Research Reviews. 60 101046. doi:10.1016/j.arr.2020.101046. hdl:10072/414227. PMID 32171783. S2CID 212729131.
Lacerda RA, Desio JA, Kammers CM, Henkes S, Freitas de Sá M, de Souza EF, et al. (November 2024). "Sleep disorders and risk of alzheimer's disease: A two-way road". Ageing Res Rev. 101 102514. doi:10.1016/j.arr.2024.102514. PMID 39317268.
Rasmussen MK, Mestre H, Nedergaard M (November 2018). "The glymphatic pathway in neurological disorders". Lancet Neurol. 17 (11): 1016–1024. doi:10.1016/S1474-4422(18)30318-1. PMC 6261373. PMID 30353860.
Hampel H, Vergallo A, Aguilar LF, Benda N, Broich K, Cuello AC, et al. (April 2018). "Precision pharmacology for Alzheimer's disease". Pharmacological Research. 130: 331–365. doi:10.1016/j.phrs.2018.02.014. PMC 8505114. PMID 29458203.
Chen Y, Zhang J, Zhang T, Cao L, You Y, Zhang C, et al. (March 2020). "Meditation treatment of Alzheimer disease and mild cognitive impairment: A protocol for systematic review". Medicine. 99 (10): e19313. doi:10.1097/MD.0000000000019313. PMC 7478420. PMID 32150066.
Winkelman MJ, Szabo A, Frecska E (November 2023). "The potential of psychedelics for the treatment of Alzheimer's disease and related dementias". European Neuropsychopharmacology. 76: 3–16. doi:10.1016/j.euroneuro.2023.07.003. hdl:10852/108211. PMID 37451163.
Birks JS, Harvey RJ (June 2018). "Donepezil for dementia due to Alzheimer's disease". The Cochrane Database of Systematic Reviews. 2018 (6): CD001190. doi:10.1002/14651858.CD001190.pub3. PMC 6513124. PMID 29923184.
Fink HA, Linskens EJ, MacDonald R, Silverman PC, McCarten JR, Talley KM, et al. (May 2020). "Benefits and Harms of Prescription Drugs and Supplements for Treatment of Clinical Alzheimer-Type Dementia". Annals of Internal Medicine. 172 (10): 656–668. doi:10.7326/M19-3887. PMID 32340037. S2CID 216595473.
Geula C, Mesulam MM (1995). "Cholinesterases and the pathology of Alzheimer disease". Alzheimer Disease and Associated Disorders. 9 (Suppl 2): 23–28. doi:10.1097/00002093-199501002-00005. PMID 8534419.
Stahl SM (November 2000). "The new cholinesterase inhibitors for Alzheimer's disease, Part 2: illustrating their mechanisms of action". The Journal of Clinical Psychiatry. 61 (11): 813–814. doi:10.4088/JCP.v61n1101. PMID 11105732.
Birks J (January 2006). Birks J (ed.). "Cholinesterase inhibitors for Alzheimer's disease". The Cochrane Database of Systematic Reviews. 2016 (1): CD005593. doi:10.1002/14651858.CD005593. PMC 9006343. PMID 16437532.
Raschetti R, Albanese E, Vanacore N, Maggini M (November 2007). "Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials". PLOS Medicine. 4 (11): e338. doi:10.1371/journal.pmed.0040338. PMC 2082649. PMID 18044984.
Lipton SA (February 2006). "Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond". Nature Reviews. Drug Discovery. 5 (2): 160–170. doi:10.1038/nrd1958. PMID 16424917. S2CID 21379258.
McShane R, Westby MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE, et al. (March 2019). "Memantine for dementia". The Cochrane Database of Systematic Reviews. 3 (3): CD003154. doi:10.1002/14651858.CD003154.pub6. PMC 6425228. PMID 30891742.
Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, et al. (March 2008). "Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline". Annals of Internal Medicine. 148 (5): 379–397. doi:10.7326/0003-4819-148-5-200803040-00009. PMID 18316756. S2CID 22235353.
Kandiah N, Ong PA, Yuda T, Ng LL, Mamun K, Merchant RA, et al. (February 2019). "Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761". CNS Neuroscience & Therapeutics. 25 (2): 288–298. doi:10.1111/cns.13095. PMC 6488894. PMID 30648358.
McKeage K, Lyseng-Williamson KA (2018). "Ginkgo biloba extract EGb 761 in the symptomatic treatment of mild-to-moderate dementia: a profile of its use". Drugs & Therapy Perspectives. 34 (8): 358–366. doi:10.1007/s40267-018-0537-8. PMC 6267544. PMID 30546253.
Yang G, Wang Y, Sun J, Zhang K, Liu J (22 October 2015). "Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials". Current Topics in Medicinal Chemistry. 16 (5): 520–528. doi:10.2174/1568026615666150813143520. PMID 26268332.
Ballard C, Waite J (January 2006). Ballard CG (ed.). "The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease". The Cochrane Database of Systematic Reviews (1): CD003476. doi:10.1002/14651858.CD003476.pub2. PMC 11365591. PMID 16437455.
Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, et al. (February 2009). "The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial". The Lancet. Neurology. 8 (2): 151–157. doi:10.1016/S1474-4422(08)70295-3. PMID 19138567. S2CID 23000439. See lay summary, January 2009.
Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, et al. (March 2013). "Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia". The Cochrane Database of Systematic Reviews. 3 (3): CD007726. doi:10.1002/14651858.CD007726.pub2. hdl:1854/LU-3109108. PMID 23543555.
Shi M, Chu F, Zhu F, Zhu J (2022). "Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer's Disease: A Focus on Aducanumab and Lecanemab". Frontiers in Aging Neuroscience. 14: 870517. doi:10.3389/fnagi.2022.870517. PMC 9039457. PMID 35493943.
Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F (2023). "Alzheimer's disease drug development pipeline: 2023". Alzheimer's & Dementia. 9 (2): e12385. doi:10.1002/trc2.12385. PMC 10210334. PMID 37251912.
^{[needs update]} Rabins PV, Blacker D, Rovner BW, Rummans T, Schneider LS, Tariot PN, et al. (Steering Committee on Practice Guidelines) (December 2007). "American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition". The American Journal of Psychiatry. 164 (12 Suppl): 5–56. PMID 18340692.
Bottino CM, Carvalho IA, Alvarez AM, Avila R, Zukauskas PR, Bustamante SE, et al. (December 2005). "Cognitive rehabilitation combined with drug treatment in Alzheimer's disease patients: a pilot study". Clinical Rehabilitation. 19 (8): 861–869. doi:10.1191/0269215505cr911oa. PMID 16323385. S2CID 21290731.
Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, et al. (May 2001). "Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology". Neurology. 56 (9): 1154–1166. doi:10.1212/WNL.56.9.1154. PMID 11342679. S2CID 10711725.
Hermans DG, Htay UH, McShane R (January 2007). "Non-pharmacological interventions for wandering of people with dementia in the domestic setting". The Cochrane Database of Systematic Reviews. 2010 (1): CD005994. doi:10.1002/14651858.CD005994.pub2. PMC 6669244. PMID 17253573.
Robinson L, Hutchings D, Dickinson HO, Corner L, Beyer F, Finch T, et al. (January 2007). "Effectiveness and acceptability of non-pharmacological interventions to reduce wandering in dementia: a systematic review". International Journal of Geriatric Psychiatry. 22 (1): 9–22. doi:10.1002/gps.1643. PMID 17096455. S2CID 45660235.
Abraha I, Rimland JM, Trotta FM, Dell'Aquila G, Cruz-Jentoft A, Petrovic M, et al. (March 2017). "Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series". BMJ Open. 7 (3): e012759. doi:10.1136/bmjopen-2016-012759. PMC 5372076. PMID 28302633.
Chung JC, Lai CK, Chung PM, French HP (2002). "Snoezelen for dementia". The Cochrane Database of Systematic Reviews. 2010 (4): CD003152. doi:10.1002/14651858.CD003152. PMC 9002239. PMID 12519587.
Woods B, O'Philbin L, Farrell EM, Spector AE, Orrell M (March 2018). "Reminiscence therapy for dementia". The Cochrane Database of Systematic Reviews. 2018 (3): CD001120. doi:10.1002/14651858.CD001120.pub3. PMC 6494367. PMID 29493789.
Zetteler J (November 2008). "Effectiveness of simulated presence therapy for individuals with dementia: a systematic review and meta-analysis". Aging & Mental Health. 12 (6): 779–785. doi:10.1080/13607860802380631. PMID 19023729. S2CID 39529938.
Spector A, Thorgrimsen L, Woods B, Royan L, Davies S, Butterworth M, et al. (September 2003). "Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial". The British Journal of Psychiatry. 183 (3): 248–254. doi:10.1192/bjp.183.3.248. PMID 12948999.
Gitlin LN, Corcoran M, Winter L, Boyce A, Hauck WW (February 2001). "A randomized, controlled trial of a home environmental intervention: effect on efficacy and upset in caregivers and on daily function of persons with dementia". The Gerontologist. 41 (1): 4–14. doi:10.1093/geront/41.1.4. PMID 11220813.
Gitlin LN, Hauck WW, Dennis MP, Winter L (March 2005). "Maintenance of effects of the home environmental skill-building program for family caregivers and individuals with Alzheimer's disease and related disorders". The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 60 (3): 368–374. doi:10.1093/gerona/60.3.368. PMID 15860476.
Dunne TE, Neargarder SA, Cipolloni PB, Cronin-Golomb A (August 2004). "Visual contrast enhances food and liquid intake in advanced Alzheimer's disease". Clinical Nutrition. 23 (4): 533–538. doi:10.1016/j.clnu.2003.09.015. PMID 15297089.
Dennehy C (2006). "Analysis of patients' rights: dementia and PEG insertion". British Journal of Nursing. 15 (1): 18–20. doi:10.12968/bjon.2006.15.1.20303. PMID 16415742.
Chernoff R (April 2006). "Tube feeding patients with dementia". Nutrition in Clinical Practice. 21 (2): 142–146. doi:10.1177/0115426506021002142. PMID 16556924. S2CID 20841502.
Shega JW, Levin A, Hougham GW, Cox-Hayley D, Luchins D, Hanrahan P, et al. (April 2003). "Palliative Excellence in Alzheimer Care Efforts (PEACE): a program description". Journal of Palliative Medicine. 6 (2): 315–320. doi:10.1089/109662103764978641. PMID 12854952. S2CID 6072807.
Dominguez LJ, Barbagallo M (June 2018). "Nutritional prevention of cognitive decline and dementia". Acta Bio-Medica. 89 (2): 276–290. doi:10.23750/abm.v89i2.7401. PMC 6179018. PMID 29957766.
Zanetti O, Solerte SB, Cantoni F (2009). "Life expectancy in Alzheimer's disease (AD)". Archives of Gerontology and Geriatrics. 49 (Suppl 1): 237–243. doi:10.1016/j.archger.2009.09.035. PMID 19836639.
Mölsä PK, Marttila RJ, Rinne UK (March 1995). "Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia". Acta Neurologica Scandinavica. 91 (3): 159–164. doi:10.1111/j.1600-0404.1995.tb00426.x. PMID 7793228. S2CID 19724937.
Bowen JD, Malter AD, Sheppard L, Kukull WA, McCormick WC, Teri L, et al. (August 1996). "Predictors of mortality in patients diagnosed with probable Alzheimer's disease". Neurology. 47 (2): 433–439. doi:10.1212/wnl.47.2.433. PMID 8757016. S2CID 24961809.
Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, et al. (April 2004). "Survival after initial diagnosis of Alzheimer disease". Annals of Internal Medicine. 140 (7): 501–509. doi:10.7326/0003-4819-140-7-200404060-00008. PMID 15068977. S2CID 27410149.
Jagger C, Clarke M, Stone A (January 1995). "Predictors of survival with Alzheimer's disease: a community-based study". Psychological Medicine. 25 (1): 171–177. doi:10.1017/S0033291700028191. PMID 7792352. S2CID 34066330.
Dodge HH, Shen C, Pandav R, DeKosky ST, Ganguli M (February 2003). "Functional transitions and active life expectancy associated with Alzheimer disease". Archives of Neurology. 60 (2): 253–259. doi:10.1001/archneur.60.2.253. PMID 12580712.
Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST (May 2005). "Alzheimer disease and mortality: a 15-year epidemiological study". Archives of Neurology. 62 (5): 779–784. doi:10.1001/archneur.62.5.779. PMID 15883266.
Lanni C, Masi M, Racchi M, Govoni S (January 2021). "Cancer and Alzheimer's disease inverse relationship: an age-associated diverging derailment of shared pathways". Molecular Psychiatry. 26 (1): 280–295. doi:10.1038/s41380-020-0760-2. PMID 32382138.
Bermejo-Pareja F, Benito-León J, Vega S, Medrano MJ, Román GC (January 2008). "Incidence and subtypes of dementia in three elderly populations of central Spain". Journal of the Neurological Sciences. 264 (1–2): 63–72. doi:10.1016/j.jns.2007.07.021. PMID 17727890. S2CID 34341344.
Di Carlo A, Baldereschi M, Amaducci L, Lepore V, Bracco L, Maggi S, et al. (January 2002). "Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study". Journal of the American Geriatrics Society. 50 (1): 41–48. doi:10.1046/j.1532-5415.2002.50006.x. PMID 12028245. S2CID 22576935.
Reitz C, Rogaeva E, Beecham GW (October 2020). "Late-onset vs nonmendelian early-onset Alzheimer disease: A distinction without a difference?". Neurology. Genetics. 6 (5): e512. doi:10.1212/NXG.0000000000000512. PMC 7673282. PMID 33225065.
Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G (February 2013). "Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy". Nature Reviews. Neurology. 9 (2): 106–118. doi:10.1038/nrneurol.2012.263. PMC 3726719. PMID 23296339.
Massett HA, Mitchell AK, Alley L, Simoneau E, Burke P, Han SH, et al. (29 June 2021). "Facilitators, Challenges, and Messaging Strategies for Hispanic/Latino Populations Participating in Alzheimer's Disease and Related Dementias Clinical Research: A Literature Review". Journal of Alzheimer's Disease. 82 (1): 107–127. doi:10.3233/JAD-201463. PMID 33998537. S2CID 234745473.
Huynh RA, Mohan C (2017). "Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid". Frontiers in Neurology. 8: 102. doi:10.3389/fneur.2017.00102. PMC 5357660. PMID 28373857.
Rajan KB, Weuve J, Barnes LL, McAninch EA, Wilson RS, Evans DA (May 2021). "Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060)". Alzheimer's & Dementia. 17 (12): 1966–1975. doi:10.1002/alz.12362. PMC 9013315. PMID 34043283. S2CID 235215290.
Rizzi L, Rosset I, Roriz-Cruz M (2014). "Global epidemiology of dementia: Alzheimer's and vascular types". Biomed Res Int. 2014: 908915. doi:10.1155/2014/908915. PMC 4095986. PMID 25089278.
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. (December 2005). "Global prevalence of dementia: a Delphi consensus study". Lancet. 366 (9503): 2112–2117. doi:10.1016/S0140-6736(05)67889-0. PMC 2850264. PMID 16360788.
Li F, Qin W, Zhu M, Jia J (1 January 2021). "Model-Based Projection of Dementia Prevalence in China and Worldwide: 2020-2050". Journal of Alzheimer's Disease. 82 (4). IOS Press: 1823–1831. doi:10.3233/JAD-210493. PMID 34219732. S2CID 235735045.
Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. (February 2022). "Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019". Lancet Public Health. 7 (2): e105 – e125. doi:10.1016/S2468-2667(21)00249-8. PMC 8810394. PMID 34998485.{{cite journal}}: CS1 maint: overridden setting (link)
Boller F, Forbes MM (June 1998). "History of dementia and dementia in history: an overview". Journal of the Neurological Sciences. 158 (2): 125–133. doi:10.1016/S0022-510X(98)00128-2. PMID 9702682. S2CID 42399340.
Amaducci LA, Rocca WA, Schoenberg BS (November 1986). "Origin of the distinction between Alzheimer's disease and senile dementia: how history can clarify nosology". Neurology. 36 (11): 1497–1499. doi:10.1212/wnl.36.11.1497. PMID 3531918. S2CID 7689479.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (July 1984). "Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease". Neurology. 34 (7): 939–944. doi:10.1212/wnl.34.7.939. PMID 6610841. S2CID 11646075.
Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. (August 2007). "Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria". The Lancet. Neurology. 6 (8): 734–746. doi:10.1016/S1474-4422(07)70178-3. PMID 17616482. S2CID 7356809.
Blacker D, Albert MS, Bassett SS, Go RC, Harrell LE, Folstein MF (December 1994). "Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative". Archives of Neurology. 51 (12): 1198–1204. doi:10.1001/archneur.1994.00540240042014. PMID 7986174.
El-Hayek YH, Wiley RE, Khoury CP, Daya RP, Ballard C, Evans AR, et al. (2019). "Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders". Journal of Alzheimer's Disease. 70 (2): 323–341. doi:10.3233/JAD-190426. PMC 6700654. PMID 31256142.
Wong W (August 2020). "Economic burden of Alzheimer disease and managed care considerations". Am J Manag Care. 26 (8 Suppl): S177 – S183. doi:10.37765/ajmc.2020.88482. PMID 32840331. S2CID 221308149. Archived from the original on 25 February 2022. Retrieved 17 March 2022.
Tahami Monfared AA, Byrnes MJ, White LA, Zhang Q (February 2022). "The Humanistic and Economic Burden of Alzheimer's Disease". Neurol Ther. 11 (2): 525–551. doi:10.1007/s40120-022-00335-x. PMC 9095804. PMID 35192176. S2CID 247014076.
Kosaner Kließ M, Martins R, Connolly MP (2021). "Major Cost Drivers in Assessing the Economic Burden of Alzheimer's Disease: A Structured, Rapid Review". J Prev Alzheimers Dis. 8 (3): 362–370. doi:10.14283/jpad.2021.17. PMID 34101795. S2CID 233403683.
Demirbas M, Hahn-Pedersen JH, Jørgensen HL (August 2023). "Comparison Between Burden of Care Partners of Individuals with Alzheimer's Disease Versus Individuals with Other Chronic Diseases". Neurology and Therapy. 12 (4): 1051–1068. doi:10.1007/s40120-023-00493-6. PMC 10310688. PMID 37222859.
Schneider J, Murray J, Banerjee S, Mann A (August 1999). "EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer's disease: I—Factors associated with carer burden". International Journal of Geriatric Psychiatry. 14 (8): 651–661. doi:10.1002/(SICI)1099-1166(199908)14:8<651::AID-GPS992>3.0.CO;2-B. PMID 10489656. S2CID 27346798.
Murray J, Schneider J, Banerjee S, Mann A (August 1999). "EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer's disease: II—A qualitative analysis of the experience of caregiving". International Journal of Geriatric Psychiatry. 14 (8): 662–667. doi:10.1002/(SICI)1099-1166(199908)14:8<662::AID-GPS993>3.0.CO;2-4. PMID 10489657. S2CID 41741923.
Zhu CW, Sano M (2006). "Economic considerations in the management of Alzheimer's disease". Clinical Interventions in Aging. 1 (2): 143–154. doi:10.2147/ciia.2006.1.2.143. PMC 2695165. PMID 18044111.
Gaugler JE, Kane RL, Kane RA, Newcomer R (April 2005). "Early community-based service utilization and its effects on institutionalization in dementia caregiving". The Gerontologist. 45 (2): 177–185. doi:10.1093/geront/45.2.177. PMID 15799982.
Ritchie K, Lovestone S (November 2002). "The dementias". Lancet. 360 (9347): 1759–1766. doi:10.1016/S0140-6736(02)11667-9. PMID 12480441. S2CID 21404062.
Brodaty H, Hadzi-Pavlovic D (September 1990). "Psychosocial effects on carers of living with persons with dementia". The Australian and New Zealand Journal of Psychiatry. 24 (3): 351–361. doi:10.3109/00048679009077702. PMID 2241719. S2CID 11788466.
Donaldson C, Tarrier N, Burns A (April 1998). "Determinants of carer stress in Alzheimer's disease". International Journal of Geriatric Psychiatry. 13 (4): 248–256. doi:10.1002/(SICI)1099-1166(199804)13:4<248::AID-GPS770>3.0.CO;2-0. PMID 9646153. S2CID 22187694.
Nandi A, Counts N, Bröker J, Malik S, Chen S, Han R, et al. (February 2024). "Cost of care for Alzheimer's disease and related dementias in the United States: 2016 to 2060". npj Aging. 10 (1) 13. doi:10.1038/s41514-024-00136-6. PMC 10853249. PMID 38331952.
Pusey H, Richards D (May 2001). "A systematic review of the effectiveness of psychosocial interventions for carers of people with dementia". Aging & Mental Health. 5 (2): 107–119. doi:10.1080/13607860120038302. PMID 11511058. S2CID 32517015.
McDade E, Llibre-Guerra JJ, Holtzman DM, Morris JC, Bateman RJ (July 2021). "The informed road map to prevention of Alzheimer Disease: A call to arms". Molecular Neurodegeneration. 16 (1) 49. doi:10.1186/s13024-021-00467-y. PMC 8293489. PMID 34289882.
Lemche E (November 2018). "Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review". Curr Genomics. 19 (7): 522–602. doi:10.2174/1389202919666171229145156. PMC 6194433. PMID 30386171.
Galle SA, Geraedts IK, Deijen JB, Milders MV, Drent ML (2020). "The Interrelationship between Insulin-Like Growth Factor 1, Apolipoprotein E ε4, Lifestyle Factors, and the Aging Body and Brain". J Prev Alzheimers Dis. 7 (4): 265–273. doi:10.14283/jpad.2020.11. hdl:1765/130733. PMID 32920629. S2CID 214784366.
Li Q, Yang X, Xu J, Guo Y, He X, Hu H, et al. (February 2023). "Early prediction of Alzheimer's disease and related dementias using real-world electronic health records". Alzheimer's & Dementia. 19 (8): 3506–3518. doi:10.1002/alz.12967. PMC 10976442. PMID 36815661. S2CID 257101613.
Cummings JL, Zhou Y, Lee G, Zhong K, Fonseca J, Leisgang-Osse AM, et al. (2025). "Alzheimer's disease drug development pipeline: 2025". Alzheimer's & Dementia: Translational Research & Clinical Interventions. 11 (2): e70098. doi:10.1002/trc2.70098. ISSN 2352-8737. PMC 12131090. PMID 40463637.

ncbi.nlm.nih.gov

Knopman DS, Amieva H, Petersen RC, Chételat G, Holtzman DM, Hyman BT, et al. (May 2021). "Alzheimer disease". Nature Reviews Disease Primers. 7 (1) 33. doi:10.1038/s41572-021-00269-y. PMC 8574196. PMID 33986301.
Mendez MF (November 2012). "Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD". Archives of Medical Research. 43 (8): 677–685. doi:10.1016/j.arcmed.2012.11.009. PMC 3532551. PMID 23178565.
Yu JT, Xu W, Tan CC, Andrieu S, Suckling J, Evangelou E, et al. (November 2020). "Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials". Journal of Neurology, Neurosurgery, and Psychiatry. 91 (11): 1201–1209. doi:10.1136/jnnp-2019-321913. PMC 7569385. PMID 32690803.
Cheng ST (September 2016). "Cognitive Reserve and the Prevention of Dementia: the Role of Physical and Cognitive Activities". Current Psychiatry Reports (Review). 18 (9) 85. doi:10.1007/s11920-016-0721-2. PMC 4969323. PMID 27481112.
Gomperts SN (April 2016). "Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia". Continuum (Review). 22 (2 Dementia): 435–463. doi:10.1212/CON.0000000000000309. ISSN 1080-2371. PMC 5390937. PMID 27042903.
Lott IT, Head E (March 2019). "Dementia in Down syndrome: unique insights for Alzheimer disease research". Nat Rev Neurol. 15 (3): 135–147. doi:10.1038/s41582-018-0132-6. PMC 8061428. PMID 30733618.
Schaffert J, LoBue C, Hynan LS, Hart J, Rossetti H, Carlew AR, et al. (2022). "Predictors of Life Expectancy in Autopsy-Confirmed Alzheimer's Disease". Journal of Alzheimer's Disease. 86 (1): 271–281. doi:10.3233/JAD-215200. PMC 8966055. PMID 35034898.
Breijyeh Z, Karaman R (December 2020). "Comprehensive Review on Alzheimer's Disease: Causes and Treatment". Molecules (Review). 25 (24): 5789. doi:10.3390/molecules25245789. PMC 7764106. PMID 33302541.
Long JM, Holtzman DM (October 2019). "Alzheimer Disease: An Update on Pathobiology and Treatment Strategies". Cell. 179 (2): 312–339. doi:10.1016/j.cell.2019.09.001. PMC 6778042. PMID 31564456.
Khan S, Barve KH, Kumar MS (2020). "Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease". Curr Neuropharmacol. 18 (11): 1106–1125. doi:10.2174/1570159X18666200528142429. PMC 7709159. PMID 32484110.
Gauthreaux K, Bonnett TA, Besser LM, Brenowitz WD, Teylan M, Mock C, et al. (May 2020). "Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy". Journal of Neuropathology and Experimental Neurology. 79 (5): 465–473. doi:10.1093/jnen/nlaa014. PMC 7160616. PMID 32186726.
Thompson CA, Spilsbury K, Hall J, Birks Y, Barnes C, Adamson J (July 2007). "Systematic review of information and support interventions for caregivers of people with dementia". BMC Geriatrics. 7 18. doi:10.1186/1471-2318-7-18. PMC 1951962. PMID 17662119.
Forbes D, Forbes SC, Blake CM, Thiessen EJ, Forbes S (April 2015). "Exercise programs for people with dementia". The Cochrane Database of Systematic Reviews (Submitted manuscript). 132 (4): CD006489. doi:10.1002/14651858.CD006489.pub4. PMC 9426996. PMID 25874613.
Zhu D, Montagne A, Zhao Z (June 2021). "Alzheimer's pathogenic mechanisms and underlying sex difference". Cell Mol Life Sci. 78 (11): 4907–4920. doi:10.1007/s00018-021-03830-w. PMC 8720296. PMID 33844047.
Petersen RC, Lopez O, Armstrong MJ, Getchius TS, Ganguli M, Gloss D, et al. (January 2018). "Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology". Neurology. 90 (3): 126–135. doi:10.1212/WNL.0000000000004826. PMC 5772157. PMID 29282327.
Tackenberg C, Kulic L, Nitsch RM (2020). "Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system". PLOS ONE. 15 (9): e0239584. Bibcode:2020PLoSO..1539584T. doi:10.1371/journal.pone.0239584. PMC 7510992. PMID 32966331.
Wang H, Kulas JA, Wang C, Holtzman DM, Ferris HA, Hansen SB (August 2021). "Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol". Proceedings of the National Academy of Sciences of the United States of America. 118 (33): e2102191118. Bibcode:2021PNAS..11802191W. doi:10.1073/pnas.2102191118. ISSN 0027-8424. PMC 8379952. PMID 34385305. S2CID 236998499.
Andrews SJ, Renton AE, Fulton-Howard B, Podlesny-Drabiniok A, Marcora E, Goate AM (April 2023). "The complex genetic architecture of Alzheimer's disease: novel insights and future directions". eBioMedicine. 90 104511. doi:10.1016/j.ebiom.2023.104511. PMC 10024184. PMID 36907103.
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, et al. (April 2021). "Alzheimer's disease". Lancet. 397 (10284): 1577–1590. doi:10.1016/S0140-6736(20)32205-4. PMC 8354300. PMID 33667416.
Perea JR, Bolós M, Avila J (October 2020). "Microglia in Alzheimer's Disease in the Context of Tau Pathology". Biomolecules. 10 (10): 1439. doi:10.3390/biom10101439. PMC 7602223. PMID 33066368.
Mahley RW, Weisgraber KH, Huang Y (April 2006). "Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease". Proceedings of the National Academy of Sciences of the United States of America. 103 (15): 5644–5651. Bibcode:2006PNAS..103.5644M. doi:10.1073/pnas.0600549103. PMC 1414631. PMID 16567625.
Hall K, Murrell J, Ogunniyi A, Deeg M, Baiyewu O, Gao S, et al. (January 2006). "Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba". Neurology. 66 (2): 223–227. doi:10.1212/01.wnl.0000194507.39504.17. PMC 2860622. PMID 16434658.
Gureje O, Ogunniyi A, Baiyewu O, Price B, Unverzagt FW, Evans RM, et al. (January 2006). "APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians". Annals of Neurology. 59 (1): 182–185. doi:10.1002/ana.20694. PMC 2855121. PMID 16278853.
Goldman JS, Van Deerlin VM (1 October 2018). "Alzheimer's Disease and Frontotemporal Dementia: The Current State of Genetics and Genetic Testing Since the Advent of Next-Generation Sequencing". Molecular Diagnosis & Therapy. 22 (5): 505–513. doi:10.1007/s40291-018-0347-7. ISSN 1179-2000. PMC 6472481. PMID 29971646.
Kim JH (December 2018). "Genetics of Alzheimer's Disease". Dementia and Neurocognitive Disorders. 17 (4): 131–136. doi:10.12779/dnd.2018.17.4.131. PMC 6425887. PMID 30906402.
Tomiyama T, Shimada H (February 2020). "APP Osaka Mutation in Familial Alzheimer's Disease-Its Discovery, Phenotypes, and Mechanism of Recessive Inheritance". International Journal of Molecular Sciences. 21 (4): 1413. doi:10.3390/ijms21041413. PMC 7073033. PMID 32093100.
Tzioras M, Davies C, Newman A, Jackson R, Spires-Jones T (June 2019). "Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease". Neuropathology and Applied Neurobiology. 45 (4): 327–346. doi:10.1111/nan.12529. PMC 6563457. PMID 30394574.
Sinyor B, Mineo J, Ochner C (June 2020). "Alzheimer's Disease, Inflammation, and the Role of Antioxidants". Journal of Alzheimer's Disease Reports. 4 (1): 175–183. doi:10.3233/ADR-200171. PMC 7369138. PMID 32715278.
Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT (2018). "Inflammation as a central mechanism in Alzheimer's disease". Alzheimer's & Dementia. 4: 575–590. doi:10.1016/j.trci.2018.06.014. PMC 6214864. PMID 30406177.
Lin X, Kapoor A, Gu Y, Chow MJ, Peng J, Zhao K, et al. (February 2020). "Contributions of DNA Damage to Alzheimer's Disease". Int J Mol Sci. 21 (5): 1666. doi:10.3390/ijms21051666. PMC 7084447. PMID 32121304.
Lloret MA, Cervera-Ferri A, Nepomuceno M, Monllor P, Esteve D, Lloret A (February 2020). "Is Sleep Disruption a Cause or Consequence of Alzheimer's Disease? Reviewing Its Possible Role as a Biomarker". International Journal of Molecular Sciences. 21 (3): 1168. doi:10.3390/ijms21031168. PMC 7037733. PMID 32050587.
Huat TJ, Camats-Perna J, Newcombe EA, Valmas N, Kitazawa M, Medeiros R (April 2019). "Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation". J Mol Biol. 431 (9): 1843–1868. doi:10.1016/j.jmb.2019.01.018. PMC 6475603. PMID 30664867.
Alves GS, Oertel Knöchel V, Knöchel C, Carvalho AF, Pantel J, Engelhardt E, et al. (2015). "Integrating retrogenesis theory to Alzheimer's disease pathology: insight from DTI-TBSS investigation of the white matter microstructural integrity". BioMed Research International. 2015: 291658. doi:10.1155/2015/291658. PMC 4320890. PMID 25685779.
Bartzokis G (August 2011). "Alzheimer's disease as homeostatic responses to age-related myelin breakdown". Neurobiology of Aging. 32 (8): 1341–1371. doi:10.1016/j.neurobiolaging.2009.08.007. PMC 3128664. PMID 19775776.
Zhou L, Miranda-Saksena M, Saksena NK (May 2013). "Viruses and neurodegeneration". Virology Journal. 10 (1) 172. doi:10.1186/1743-422X-10-172. PMC 3679988. PMID 23724961.
Farrer TJ, Moore JD, Chase M, Gale SD, Hedges DW (November 2024). "Infectious Disease as a Modifiable Risk Factor for Dementia: A Narrative Review". Pathogens. 13 (11): 974. doi:10.3390/pathogens13110974. PMC 11597442. PMID 39599527.
Rippee-Brooks MD, Wu W, Dong J, Pappolla M, Fang X, Bao X (March 2024). "Viral Infections, Are They a Trigger and Risk Factor of Alzheimer's Disease?". Pathogens. 13 (3): 240. doi:10.3390/pathogens13030240. PMC 10974111. PMID 38535583.
Kandimalla R, Thirumala V, Reddy PH (May 2017). "Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863 (5): 1078–1089. doi:10.1016/j.bbadis.2016.08.018. PMC 5344773. PMID 27567931.
Desikan RS, Cabral HJ, Hess CP, Dillon WP, Glastonbury CM, Weiner MW, et al. (August 2009). "Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease". Brain. 132 (Pt 8): 2048–2057. doi:10.1093/brain/awp123. PMC 2714061. PMID 19460794.
DeTure MA, Dickson DW (August 2019). "The neuropathological diagnosis of Alzheimer's disease". Molecular Neurodegeneration. 14 (1) 32. doi:10.1186/s13024-019-0333-5. PMC 6679484. PMID 31375134.
Hernández F, Avila J (September 2007). "Tauopathies". Cellular and Molecular Life Sciences. 64 (17): 2219–2233. doi:10.1007/s00018-007-7220-x. PMC 11136052. PMID 17604998. S2CID 261121643.
Sun W, Samimi H, Gamez M, Zare H, Frost B (August 2018). "Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies". Nature Neuroscience. 21 (8): 1038–1048. doi:10.1038/s41593-018-0194-1. PMC 6095477. PMID 30038280.
Huang Y, Mucke L (March 2012). "Alzheimer mechanisms and therapeutic strategies". Cell. 148 (6): 1204–1222. doi:10.1016/j.cell.2012.02.040. PMC 3319071. PMID 22424230.
Ramanan VK, Armstrong MJ, Choudhury P, Coerver KA, Hamilton RH, Klein BC, et al. (November 2023). "Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology". Neurology. 101 (19): 842–852. doi:10.1212/WNL.0000000000207757. PMC 10663011. PMID 37495380.
Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL (April 2015). "Neuroinflammation in Alzheimer's disease". The Lancet. Neurology. 14 (4): 388–405. doi:10.1016/S1474-4422(15)70016-5. PMC 5909703. PMID 25792098.
Schindowski K, Belarbi K, Buée L (February 2008). "Neurotrophic factors in Alzheimer's disease: role of axonal transport". Genes, Brain and Behavior. 7 (Suppl 1): 43–56. doi:10.1111/j.1601-183X.2007.00378.x. PMC 2228393. PMID 18184369.
Arvanitakis Z, Shah RC, Bennett DA (October 2019). "Diagnosis and Management of Dementia: Review". JAMA. 322 (16): 1589–1599. doi:10.1001/jama.2019.4782. PMC 7462122. PMID 31638686.
Schroeter ML, Stein T, Maslowski N, Neumann J (October 2009). "Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients". NeuroImage. 47 (4): 1196–1206. doi:10.1016/j.neuroimage.2009.05.037. PMC 2730171. PMID 19463961.
Jie CV, Treyer V, Schibli R, Mu L (January 2021). "Tauvid: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease". Pharmaceuticals. 14 (2): 110. doi:10.3390/ph14020110. PMC 7911942. PMID 33573211.
Weller J, Budson A (2018). "Current understanding of Alzheimer's disease diagnosis and treatment". F1000Research (Review). 7: 1161. doi:10.12688/f1000research.14506.1. PMC 6073093. PMID 30135715.
Silva MV, Loures CM, Alves LC, de Souza LC, Borges KB, Carvalho MD (May 2019). "Alzheimer's disease: risk factors and potentially protective measures". Journal of Biomedical Science. 26 (1) 33. doi:10.1186/s12929-019-0524-y. PMC 6507104. PMID 31072403.
Stokin GB, Krell-Roesch J, Petersen RC, Geda YE (2015). "Mild Neurocognitive Disorder: An Old Wine in a New Bottle". Harvard Review of Psychiatry (Review). 23 (5): 368–376. doi:10.1097/HRP.0000000000000084. PMC 4894762. PMID 26332219.
Fink HA, Hemmy LS, Linskens EJ, Silverman PC, MacDonald R, McCarten JR, et al. (2020). Diagnosis and Treatment of Clinical Alzheimer's-Type Dementia: A Systematic Review. AHRQ Comparative Effectiveness Reviews. Rockville (MD): Agency for Healthcare Research and Quality (US). PMID 32369312. Archived from the original on 7 July 2023. Retrieved 16 November 2021.
Bradfield NI, Ames D (April 2020). "Mild cognitive impairment: narrative review of taxonomies and systematic review of their prediction of incident Alzheimer's disease dementia". BJPsych Bulletin (Review). 44 (2): 67–74. doi:10.1192/bjb.2019.77. PMC 7283119. PMID 31724527.
Vega JN, Newhouse PA (October 2014). "Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments". Current Psychiatry Reports. 16 (10) 490. SpringerLink. doi:10.1007/s11920-014-0490-8. PMC 4169219. PMID 25160795.
Parnetti L, Chipi E, Salvadori N, D'Andrea K, Eusebi P (January 2019). "Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis". Alzheimer's Research & Therapy. 11 (1) 7. Springer Nature. doi:10.1186/s13195-018-0459-7. PMC 6334406. PMID 30646955.
Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. (April 2018). "NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease". Alzheimer's & Dementia. 14 (4): 535–562. doi:10.1016/j.jalz.2018.02.018. PMC 5958625. PMID 29653606.
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. (May 2011). "Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease". Alzheimer's & Dementia. 7 (3): 280–292. doi:10.1016/j.jalz.2011.03.003. PMC 3220946. PMID 21514248.
Cheng YW, Chen TF, Chiu MJ (16 February 2017). "From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution". Neuropsychiatric Disease and Treatment. 13. Dove Medical Press Limited: 491–498. doi:10.2147/NDT.S123428. PMC 5317337. PMID 28243102.
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. (May 2011). "The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease". Alzheimer's & Dementia. 7 (3): 270–279. doi:10.1016/j.jalz.2011.03.008. PMC 3312027. PMID 21514249.
Chertkow H, Feldman HH, Jacova C, Massoud F (July 2013). "Definitions of dementia and predementia states in Alzheimer's disease and vascular cognitive impairment: consensus from the Canadian conference on diagnosis of dementia". Alzheimer's Research & Therapy. 5 (Suppl 1). BMC: S2. doi:10.1186/alzrt198. PMC 3981054. PMID 24565215.
Sun X, Steffens DC, Au R, Folstein M, Summergrad P, Yee J, et al. (May 2008). "Amyloid-associated depression: a prodromal depression of Alzheimer disease?". Archives of General Psychiatry. 65 (5): 542–550. doi:10.1001/archpsyc.65.5.542. PMC 3042807. PMID 18458206.
Zhang S, Smailagic N, Hyde C, Noel-Storr AH, Takwoingi Y, McShane R, et al. (July 2014). "(11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)". The Cochrane Database of Systematic Reviews. 2014 (7): CD010386. doi:10.1002/14651858.CD010386.pub2. PMC 6464750. PMID 25052054.
Smailagic N, Vacante M, Hyde C, Martin S, Ukoumunne O, Sachpekidis C (January 2015). "¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)". The Cochrane Database of Systematic Reviews. 1 (1): CD010632. doi:10.1002/14651858.CD010632.pub2. PMC 7081123. PMID 25629415.
Hsu D, Marshall GA (2017). "Primary and secondary prevention trials in Alzheimer disease: looking back, moving forward". Curr Alzheimer Res. 14 (4): 426–440. doi:10.2174/1567205013666160930112125. PMC 5329133. PMID 27697063.
Patterson C, Feightner JW, Garcia A, Hsiung GY, MacKnight C, Sadovnick AD (February 2008). "Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease". CMAJ. 178 (5): 548–556. doi:10.1503/cmaj.070796. PMC 2244657. PMID 18299540.
Chu CS, Tseng PT, Stubbs B, Chen TY, Tang CH, Li DJ, et al. (April 2018). "Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis". Scientific Reports. 8 (1) 5804. Bibcode:2018NatSR...8.5804C. doi:10.1038/s41598-018-24248-8. PMC 5895617. PMID 29643479.
Ungvari Z, Toth P, Tarantini S, Prodan CI, Sorond F, Merkely B, et al. (October 2021). "Hypertension-induced cognitive impairment: from pathophysiology to public health". Nature Reviews Nephrology. 17 (10): 639–654. doi:10.1038/s41581-021-00430-6. PMC 8202227. PMID 34127835.
Lethaby A, Hogervorst E, Richards M, Yesufu A, Yaffe K (January 2008). "Hormone replacement therapy for cognitive function in postmenopausal women". Cochrane Database Syst Rev. 2008 (1): CD003122. doi:10.1002/14651858.CD003122.pub2. PMC 6599876. PMID 18254016.
Ribarič S (March 2022). "Physical Exercise, a Potential Non-Pharmacological Intervention for Attenuating Neuroinflammation and Cognitive Decline in Alzheimer's Disease Patients". Int J Mol Sci. 23 (6): 3245. doi:10.3390/ijms23063245. PMC 8952567. PMID 35328666.
Bhatti GK, Reddy AP, Reddy PH, Bhatti JS (2019). "Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer's Disease". Frontiers in Aging Neuroscience (Review). 11: 369. doi:10.3389/fnagi.2019.00369. PMC 6966236. PMID 31998117.
Rasmussen MK, Mestre H, Nedergaard M (November 2018). "The glymphatic pathway in neurological disorders". Lancet Neurol. 17 (11): 1016–1024. doi:10.1016/S1474-4422(18)30318-1. PMC 6261373. PMID 30353860.
Hampel H, Vergallo A, Aguilar LF, Benda N, Broich K, Cuello AC, et al. (April 2018). "Precision pharmacology for Alzheimer's disease". Pharmacological Research. 130: 331–365. doi:10.1016/j.phrs.2018.02.014. PMC 8505114. PMID 29458203.
Chen Y, Zhang J, Zhang T, Cao L, You Y, Zhang C, et al. (March 2020). "Meditation treatment of Alzheimer disease and mild cognitive impairment: A protocol for systematic review". Medicine. 99 (10): e19313. doi:10.1097/MD.0000000000019313. PMC 7478420. PMID 32150066.
Birks JS, Harvey RJ (June 2018). "Donepezil for dementia due to Alzheimer's disease". The Cochrane Database of Systematic Reviews. 2018 (6): CD001190. doi:10.1002/14651858.CD001190.pub3. PMC 6513124. PMID 29923184.
Birks J (January 2006). Birks J (ed.). "Cholinesterase inhibitors for Alzheimer's disease". The Cochrane Database of Systematic Reviews. 2016 (1): CD005593. doi:10.1002/14651858.CD005593. PMC 9006343. PMID 16437532.
Raschetti R, Albanese E, Vanacore N, Maggini M (November 2007). "Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials". PLOS Medicine. 4 (11): e338. doi:10.1371/journal.pmed.0040338. PMC 2082649. PMID 18044984.
McShane R, Westby MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE, et al. (March 2019). "Memantine for dementia". The Cochrane Database of Systematic Reviews. 3 (3): CD003154. doi:10.1002/14651858.CD003154.pub6. PMC 6425228. PMID 30891742.
Kandiah N, Ong PA, Yuda T, Ng LL, Mamun K, Merchant RA, et al. (February 2019). "Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761". CNS Neuroscience & Therapeutics. 25 (2): 288–298. doi:10.1111/cns.13095. PMC 6488894. PMID 30648358.
McKeage K, Lyseng-Williamson KA (2018). "Ginkgo biloba extract EGb 761 in the symptomatic treatment of mild-to-moderate dementia: a profile of its use". Drugs & Therapy Perspectives. 34 (8): 358–366. doi:10.1007/s40267-018-0537-8. PMC 6267544. PMID 30546253.
Ballard C, Waite J (January 2006). Ballard CG (ed.). "The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease". The Cochrane Database of Systematic Reviews (1): CD003476. doi:10.1002/14651858.CD003476.pub2. PMC 11365591. PMID 16437455.
Shi M, Chu F, Zhu F, Zhu J (2022). "Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer's Disease: A Focus on Aducanumab and Lecanemab". Frontiers in Aging Neuroscience. 14: 870517. doi:10.3389/fnagi.2022.870517. PMC 9039457. PMID 35493943.
Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F (2023). "Alzheimer's disease drug development pipeline: 2023". Alzheimer's & Dementia. 9 (2): e12385. doi:10.1002/trc2.12385. PMC 10210334. PMID 37251912.
Hermans DG, Htay UH, McShane R (January 2007). "Non-pharmacological interventions for wandering of people with dementia in the domestic setting". The Cochrane Database of Systematic Reviews. 2010 (1): CD005994. doi:10.1002/14651858.CD005994.pub2. PMC 6669244. PMID 17253573.
Abraha I, Rimland JM, Trotta FM, Dell'Aquila G, Cruz-Jentoft A, Petrovic M, et al. (March 2017). "Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series". BMJ Open. 7 (3): e012759. doi:10.1136/bmjopen-2016-012759. PMC 5372076. PMID 28302633.
Chung JC, Lai CK, Chung PM, French HP (2002). "Snoezelen for dementia". The Cochrane Database of Systematic Reviews. 2010 (4): CD003152. doi:10.1002/14651858.CD003152. PMC 9002239. PMID 12519587.
Woods B, O'Philbin L, Farrell EM, Spector AE, Orrell M (March 2018). "Reminiscence therapy for dementia". The Cochrane Database of Systematic Reviews. 2018 (3): CD001120. doi:10.1002/14651858.CD001120.pub3. PMC 6494367. PMID 29493789.
Dominguez LJ, Barbagallo M (June 2018). "Nutritional prevention of cognitive decline and dementia". Acta Bio-Medica. 89 (2): 276–290. doi:10.23750/abm.v89i2.7401. PMC 6179018. PMID 29957766.
Reitz C, Rogaeva E, Beecham GW (October 2020). "Late-onset vs nonmendelian early-onset Alzheimer disease: A distinction without a difference?". Neurology. Genetics. 6 (5): e512. doi:10.1212/NXG.0000000000000512. PMC 7673282. PMID 33225065.
Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G (February 2013). "Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy". Nature Reviews. Neurology. 9 (2): 106–118. doi:10.1038/nrneurol.2012.263. PMC 3726719. PMID 23296339.
Huynh RA, Mohan C (2017). "Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid". Frontiers in Neurology. 8: 102. doi:10.3389/fneur.2017.00102. PMC 5357660. PMID 28373857.
Rajan KB, Weuve J, Barnes LL, McAninch EA, Wilson RS, Evans DA (May 2021). "Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060)". Alzheimer's & Dementia. 17 (12): 1966–1975. doi:10.1002/alz.12362. PMC 9013315. PMID 34043283. S2CID 235215290.
Rizzi L, Rosset I, Roriz-Cruz M (2014). "Global epidemiology of dementia: Alzheimer's and vascular types". Biomed Res Int. 2014: 908915. doi:10.1155/2014/908915. PMC 4095986. PMID 25089278.
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. (December 2005). "Global prevalence of dementia: a Delphi consensus study". Lancet. 366 (9503): 2112–2117. doi:10.1016/S0140-6736(05)67889-0. PMC 2850264. PMID 16360788.
Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. (February 2022). "Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019". Lancet Public Health. 7 (2): e105 – e125. doi:10.1016/S2468-2667(21)00249-8. PMC 8810394. PMID 34998485.{{cite journal}}: CS1 maint: overridden setting (link)
El-Hayek YH, Wiley RE, Khoury CP, Daya RP, Ballard C, Evans AR, et al. (2019). "Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders". Journal of Alzheimer's Disease. 70 (2): 323–341. doi:10.3233/JAD-190426. PMC 6700654. PMID 31256142.
Tahami Monfared AA, Byrnes MJ, White LA, Zhang Q (February 2022). "The Humanistic and Economic Burden of Alzheimer's Disease". Neurol Ther. 11 (2): 525–551. doi:10.1007/s40120-022-00335-x. PMC 9095804. PMID 35192176. S2CID 247014076.
Demirbas M, Hahn-Pedersen JH, Jørgensen HL (August 2023). "Comparison Between Burden of Care Partners of Individuals with Alzheimer's Disease Versus Individuals with Other Chronic Diseases". Neurology and Therapy. 12 (4): 1051–1068. doi:10.1007/s40120-023-00493-6. PMC 10310688. PMID 37222859.
Zhu CW, Sano M (2006). "Economic considerations in the management of Alzheimer's disease". Clinical Interventions in Aging. 1 (2): 143–154. doi:10.2147/ciia.2006.1.2.143. PMC 2695165. PMID 18044111.
Nandi A, Counts N, Bröker J, Malik S, Chen S, Han R, et al. (February 2024). "Cost of care for Alzheimer's disease and related dementias in the United States: 2016 to 2060". npj Aging. 10 (1) 13. doi:10.1038/s41514-024-00136-6. PMC 10853249. PMID 38331952.
McDade E, Llibre-Guerra JJ, Holtzman DM, Morris JC, Bateman RJ (July 2021). "The informed road map to prevention of Alzheimer Disease: A call to arms". Molecular Neurodegeneration. 16 (1) 49. doi:10.1186/s13024-021-00467-y. PMC 8293489. PMID 34289882.
Lemche E (November 2018). "Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review". Curr Genomics. 19 (7): 522–602. doi:10.2174/1389202919666171229145156. PMC 6194433. PMID 30386171.
Li Q, Yang X, Xu J, Guo Y, He X, Hu H, et al. (February 2023). "Early prediction of Alzheimer's disease and related dementias using real-world electronic health records". Alzheimer's & Dementia. 19 (8): 3506–3518. doi:10.1002/alz.12967. PMC 10976442. PMID 36815661. S2CID 257101613.
Cummings JL, Zhou Y, Lee G, Zhong K, Fonseca J, Leisgang-Osse AM, et al. (2025). "Alzheimer's disease drug development pipeline: 2025". Alzheimer's & Dementia: Translational Research & Clinical Interventions. 11 (2): e70098. doi:10.1002/trc2.70098. ISSN 2352-8737. PMC 12131090. PMID 40463637.

nia.nih.gov

"Study reveals how APOE4 gene may increase risk for dementia". National Institute on Aging. 16 March 2021. Archived from the original on 17 March 2021. Retrieved 17 March 2021.
"Alzheimer's Disease Fact Sheet". National Institute on Aging. Archived from the original on 23 March 2022. Retrieved 23 March 2022.
"Alzheimer's Disease Fact Sheet". National Institute on Aging. Archived from the original on 24 January 2021. Retrieved 25 January 2021.
Bertagnolli MM (5 August 2024). "Fiscal Year 2026 NIH Professional Judgment Budget for Alzheimer's Disease and Related Dementias Research: Advancing Progress in Dementia Research". US National Institutes of Health. Archived from the original on 30 November 2024. Retrieved 23 September 2024.
"How Is Alzheimer's Disease Treated?". U.S. National Institute on Aging. 1 April 2023. Archived from the original on 18 June 2021. Retrieved 10 July 2023.

dailymed.nlm.nih.gov

"Namzaric- memantine hydrochloride and donepezil hydrochloride capsule Namzaric- memantine hydrochloride and donepezil hydrochloride kit". DailyMed. 22 January 2019. Archived from the original on 20 January 2022. Retrieved 20 February 2022.
"Namenda- memantine hydrochloride tablet Namenda- memantine hydrochloride kit". DailyMed. 15 November 2018. Archived from the original on 27 January 2022. Retrieved 20 February 2022.
"Namenda XR- memantine hydrochloride capsule, extended release Namenda XR- memantine hydrochloride kit". DailyMed. 15 November 2019. Archived from the original on 21 February 2022. Retrieved 20 February 2022.

nytimes.com

"FDA Makes Alzheimer's Drug Leqembi Widely Accessible". The New York Times. 6 July 2023. Archived from the original on 7 July 2023. Retrieved 8 July 2023.
Ezra M (23 October 2020). "Why Are TikTok Teens Listening to an Album About Dementia?". The New York Times. Archived from the original on 23 October 2020. Retrieved 21 April 2021.
Grady D (24 October 2006). "Self-Portraits Chronicle a Descent Into Alzheimer's". The New York Times. Archived from the original on 24 October 2006. Retrieved 14 June 2021.

pitchfork.com

Powell M (14 June 2011). "The Caretaker: An Empty Bliss Beyond This World Album Review". Pitchfork. Archived from the original on 18 June 2011. Retrieved 19 February 2021.

semanticscholar.org

api.semanticscholar.org

Viña J, Sanz-Ros J (October 2018). "Alzheimer's disease: Only prevention makes sense". European Journal of Clinical Investigation (Review). 48 (10): e13005. doi:10.1111/eci.13005. PMID 30028503. S2CID 51703879.
Burns A, Iliffe S (February 2009). "Alzheimer's disease". BMJ. 338: b158. doi:10.1136/bmj.b158. PMID 19196745. S2CID 8570146.
Berchtold NC, Cotman CW (1998). "Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s". Neurobiology of Aging. 19 (3): 173–189. doi:10.1016/S0197-4580(98)00052-9. PMID 9661992. S2CID 24808582.
Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, et al. (January 2007). "Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline". European Journal of Neurology. 14 (1): e1-26. doi:10.1111/j.1468-1331.2006.01605.x. PMID 17222085. S2CID 2725064.
Bäckman L, Jones S, Berger AK, Laukka EJ, Small BJ (September 2004). "Multiple cognitive deficits during the transition to Alzheimer's disease". Journal of Internal Medicine. 256 (3): 195–204. doi:10.1111/j.1365-2796.2004.01386.x. PMID 15324363. S2CID 37005854.
Nygård L (2003). "Instrumental activities of daily living: a stepping-stone towards Alzheimer's disease diagnosis in subjects with mild cognitive impairment?". Acta Neurologica Scandinavica. Supplementum. 179 (s179): 42–46. doi:10.1034/j.1600-0404.107.s179.8.x. PMID 12603250. S2CID 25313065.
Deardorff WJ, Grossberg GT (2019). "Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia". Psychopharmacology of Neurologic Disease. Handbook of Clinical Neurology. Vol. 165. Elsevier. pp. 5–32. doi:10.1016/B978-0-444-64012-3.00002-2. ISBN 978-0-444-64012-3. PMID 31727229. S2CID 208037448.
Atri A (March 2019). "The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management". The Medical Clinics of North America (Review). 103 (2): 263–293. doi:10.1016/j.mcna.2018.10.009. PMID 30704681. S2CID 73432842.
Förstl H, Kurz A (1999). "Clinical features of Alzheimer's disease". European Archives of Psychiatry and Clinical Neuroscience. 249 (6): 288–290. doi:10.1007/s004060050101. PMID 10653284. S2CID 26142779.
Carlesimo GA, Oscar-Berman M (June 1992). "Memory deficits in Alzheimer's patients: a comprehensive review". Neuropsychology Review. 3 (2): 119–169. doi:10.1007/BF01108841. PMID 1300219. S2CID 19548915.
Jelicic M, Bonebakker AE, Bonke B (1995). "Implicit memory performance of patients with Alzheimer's disease: a brief review". International Psychogeriatrics. 7 (3): 385–392. doi:10.1017/S1041610295002134. PMID 8821346. S2CID 9419442.
Taler V, Phillips NA (July 2008). "Language performance in Alzheimer's disease and mild cognitive impairment: a comparative review". Journal of Clinical and Experimental Neuropsychology. 30 (5): 501–556. doi:10.1080/13803390701550128. PMID 18569251. S2CID 37153159.
Volicer L, Harper DG, Manning BC, Goldstein R, Satlin A (May 2001). "Sundowning and circadian rhythms in Alzheimer's disease". The American Journal of Psychiatry. 158 (5): 704–711. doi:10.1176/appi.ajp.158.5.704. PMID 11329390. S2CID 10492607.
Gold DP, Reis MF, Markiewicz D, Andres D (January 1995). "When home caregiving ends: a longitudinal study of outcomes for caregivers of relatives with dementia". Journal of the American Geriatrics Society. 43 (1): 10–16. doi:10.1111/j.1532-5415.1995.tb06235.x. PMID 7806732. S2CID 29847950.
Mashour GA, Frank L, Batthyany A, Kolanowski AM, Nahm M, Schulman-Green D, et al. (August 2019). "Paradoxical lucidity: A potential paradigm shift for the neurobiology and treatment of severe dementias". Alzheimer's & Dementia. 15 (8): 1107–1114. doi:10.1016/j.jalz.2019.04.002. hdl:2027.42/153062. PMID 31229433. S2CID 195063786.
Wang H, Kulas JA, Wang C, Holtzman DM, Ferris HA, Hansen SB (August 2021). "Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol". Proceedings of the National Academy of Sciences of the United States of America. 118 (33): e2102191118. Bibcode:2021PNAS..11802191W. doi:10.1073/pnas.2102191118. ISSN 0027-8424. PMC 8379952. PMID 34385305. S2CID 236998499.
Blennow K, de Leon MJ, Zetterberg H (July 2006). "Alzheimer's disease". Lancet. 368 (9533): 387–403. doi:10.1016/S0140-6736(06)69113-7. PMID 16876668. S2CID 47544338.
Selkoe DJ (June 1999). "Translating cell biology into therapeutic advances in Alzheimer's disease". Nature. 399 (6738 Suppl): A23 – A31. doi:10.1038/19866. PMID 10392577. S2CID 42287088.
Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, et al. (November 1996). "Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo". Neuron. 17 (5): 1005–1013. doi:10.1016/S0896-6273(00)80230-5. PMID 8938131. S2CID 18315650.
Carmona S, Zahs K, Wu E, Dakin K, Bras J, Guerreiro R (August 2018). "The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders". Lancet Neurol. 17 (8): 721–730. doi:10.1016/S1474-4422(18)30232-1. PMID 30033062. S2CID 51706988. Archived from the original on 27 March 2022. Retrieved 21 February 2022.
Tomiyama T, Nagata T, Shimada H, Teraoka R, Fukushima A, Kanemitsu H, et al. (March 2008). "A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia". Annals of Neurology. 63 (3): 377–387. doi:10.1002/ana.21321. PMID 18300294. S2CID 42311988.
Mudher A, Lovestone S (January 2002). "Alzheimer's disease-do tauists and baptists finally shake hands?". Trends in Neurosciences. 25 (1): 22–26. doi:10.1016/S0166-2236(00)02031-2. PMID 11801334. S2CID 37380445.
Irwin MR, Vitiello MV (March 2019). "Implications of sleep disturbance and inflammation for Alzheimer's disease dementia". The Lancet. Neurology. 18 (3): 296–306. doi:10.1016/S1474-4422(18)30450-2. PMID 30661858. S2CID 58546748.
Eikelenboom P, van Exel E, Hoozemans JJ, Veerhuis R, Rozemuller AJ, van Gool WA (2010). "Neuroinflammation – an early event in both the history and pathogenesis of Alzheimer's disease". Neuro-Degenerative Diseases. 7 (1–3): 38–41. doi:10.1159/000283480. PMID 20160456. S2CID 40048333.
Reisberg B, Franssen EH, Hasan SM, Monteiro I, Boksay I, Souren LE, et al. (1999). "Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer's and other dementing processes". European Archives of Psychiatry and Clinical Neuroscience. 249 (3): 28–36. doi:10.1007/pl00014170. PMID 10654097. S2CID 23410069.
Cai Z, Xiao M (2016). "Oligodendrocytes and Alzheimer's disease". The International Journal of Neuroscience. 126 (2): 97–104. doi:10.3109/00207454.2015.1025778. PMID 26000818. S2CID 21448714.
Zis P, Hadjivassiliou M (February 2019). "Treatment of Neurological Manifestations of Gluten Sensitivity and Coeliac Disease". Current Treatment Options in Neurology. 21 (3) 10. doi:10.1007/s11940-019-0552-7. PMID 30806821. S2CID 73466457.
Makhlouf S, Messelmani M, Zaouali J, Mrissa R (March 2018). "Cognitive impairment in celiac disease and non-celiac gluten sensitivity: review of literature on the main cognitive impairments, the imaging and the effect of gluten free diet". Acta Neurologica Belgica (Review). 118 (1): 21–27. doi:10.1007/s13760-017-0870-z. PMID 29247390. S2CID 3943047.
Gonzalez-Fernandez E, Huang J (September 2023). "Cognitive Aspects of COVID-19". Current Neurology and Neuroscience Reports. 23 (9): 531–538. doi:10.1007/s11910-023-01286-y. PMID 37490194. S2CID 260132167.
Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J (June 2004). "The importance of neuritic plaques and tangles to the development and evolution of AD". Neurology. 62 (11): 1984–1989. doi:10.1212/01.WNL.0000129697.01779.0A. PMID 15184601. S2CID 25017332.
Tiraboschi P, Sabbagh MN, Hansen LA, Salmon DP, Merdes A, Gamst A, et al. (April 2004). "Alzheimer disease without neocortical neurofibrillary tangles: "a second look"". Neurology. 62 (7): 1141–1147. doi:10.1212/01.wnl.0000118212.41542.e7. PMID 15079014. S2CID 22832110.
Kotzbauer PT, Trojanowsk JQ, Lee VM (October 2001). "Lewy body pathology in Alzheimer's disease". Journal of Molecular Neuroscience. 17 (2): 225–232. doi:10.1385/JMN:17:2:225. PMID 11816795. S2CID 44407971.
Hernández F, Avila J (September 2007). "Tauopathies". Cellular and Molecular Life Sciences. 64 (17): 2219–2233. doi:10.1007/s00018-007-7220-x. PMC 11136052. PMID 17604998. S2CID 261121643.
Van Broeck B, Van Broeckhoven C, Kumar-Singh S (2007). "Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches". Neuro-Degenerative Diseases. 4 (5): 349–365. doi:10.1159/000105156. PMID 17622778. S2CID 7949658.
Chen X, Yan SD (December 2006). "Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease". IUBMB Life. 58 (12): 686–694. doi:10.1080/15216540601047767. PMID 17424907. S2CID 85423830.
Greig NH, Mattson MP, Perry T, Chan SL, Giordano T, Sambamurti K, et al. (December 2004). "New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists". Annals of the New York Academy of Sciences. 1035 (1): 290–315. Bibcode:2004NYASA1035..290G. doi:10.1196/annals.1332.018. PMID 15681814. S2CID 84659695. Archived from the original on 3 June 2020. Retrieved 19 July 2019.
Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S (November 2008). "New insights into brain BDNF function in normal aging and Alzheimer disease". Brain Research Reviews. 59 (1): 201–220. doi:10.1016/j.brainresrev.2008.07.007. hdl:10533/142174. PMID 18708092. S2CID 6589846.
Sachdev PS, Blacker D, Blazer DG, Ganguli M, Jeste DV, Paulsen JS, et al. (November 2014). "Classifying neurocognitive disorders: the DSM-5 approach". Nature Reviews. Neurology. 10 (11): 634–642. doi:10.1038/nrneurol.2014.181. hdl:1959.4/unsworks_39077. PMID 25266297. S2CID 20635070. Archived from the original on 20 March 2022. Retrieved 27 November 2021.
Mendez MF (2006). "The accurate diagnosis of early-onset dementia". International Journal of Psychiatry in Medicine. 36 (4): 401–412. doi:10.2190/Q6J4-R143-P630-KW41. PMID 17407994. S2CID 43715976. Archived from the original on 3 June 2020. Retrieved 25 May 2020.
Sachs-Ericsson N, Blazer DG (January 2015). "The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment". Aging & Mental Health. 19 (1): 2–12. doi:10.1080/13607863.2014.920303. PMID 24914889. S2CID 46244321.
Tombaugh TN, McIntyre NJ (September 1992). "The mini-mental state examination: a comprehensive review". Journal of the American Geriatrics Society. 40 (9): 922–935. doi:10.1111/j.1532-5415.1992.tb01992.x. PMID 1512391. S2CID 25169596.
Pasquier F (January 1999). "Early diagnosis of dementia: neuropsychology". Journal of Neurology. 246 (1): 6–15. doi:10.1007/s004150050299. PMID 9987708. S2CID 2108587.
Harvey PD, Moriarty PJ, Kleinman L, Coyne K, Sadowsky CH, Chen M, et al. (2005). "The validation of a caregiver assessment of dementia: the Dementia Severity Scale". Alzheimer Disease and Associated Disorders. 19 (4): 186–194. doi:10.1097/01.wad.0000189034.43203.60. PMID 16327345. S2CID 20238911.
Geldmacher DS, Whitehouse PJ (May 1997). "Differential diagnosis of Alzheimer's disease". Neurology. 48 (5 Suppl 6): S2 – S9. doi:10.1212/WNL.48.5_Suppl_6.2S. PMID 9153154. S2CID 30018544.
Potter GG, Steffens DC (May 2007). "Contribution of depression to cognitive impairment and dementia in older adults". The Neurologist. 13 (3): 105–117. doi:10.1097/01.nrl.0000252947.15389.a9. PMID 17495754. S2CID 24569198.
Farina N, Rusted J, Tabet N (January 2014). "The effect of exercise interventions on cognitive outcome in Alzheimer's disease: a systematic review". International Psychogeriatrics (Review). 26 (1): 9–18. doi:10.1017/S1041610213001385. PMID 23962667. S2CID 24936334.
Barnard ND, Bush AI, Ceccarelli A, Cooper J, de Jager CA, Erickson KI, et al. (September 2014). "Dietary and lifestyle guidelines for the prevention of Alzheimer's disease". Neurobiology of Aging. 35 (Suppl 2): S74 – S78. doi:10.1016/j.neurobiolaging.2014.03.033. hdl:11343/52774. PMID 24913896. S2CID 8265377.
López-Ortiz S, Lista S, Valenzuela PL, Pinto-Fraga J, Carmona R, Caraci F, et al. (November 2022). "Effects of physical activity and exercise interventions on Alzheimer's disease: an umbrella review of existing meta-analyses". Journal of Neurology. 270 (2): 711–725. doi:10.1007/s00415-022-11454-8. hdl:2108/325384. PMID 36342524. S2CID 253382289.
Kivipelto M, Mangialasche F, Ngandu T (November 2018). "Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease". Nat Rev Neurol. 14 (11): 653–666. doi:10.1038/s41582-018-0070-3. PMID 30291317. S2CID 52925352.
Borges CR, Poyares D, Piovezan R, Nitrini R, Brucki S (November 2019). "Alzheimer's disease and sleep disturbances: a review". Arq Neuropsiquiatr. 77 (11): 815–824. doi:10.1590/0004-282X20190149. PMID 31826138. S2CID 209327994.
Uddin MS, Tewari D, Mamun AA, Kabir MT, Niaz K, Wahed MI, et al. (July 2020). "Circadian and sleep dysfunction in Alzheimer's disease". Ageing Research Reviews. 60 101046. doi:10.1016/j.arr.2020.101046. hdl:10072/414227. PMID 32171783. S2CID 212729131.
Fink HA, Linskens EJ, MacDonald R, Silverman PC, McCarten JR, Talley KM, et al. (May 2020). "Benefits and Harms of Prescription Drugs and Supplements for Treatment of Clinical Alzheimer-Type Dementia". Annals of Internal Medicine. 172 (10): 656–668. doi:10.7326/M19-3887. PMID 32340037. S2CID 216595473.
Lipton SA (February 2006). "Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond". Nature Reviews. Drug Discovery. 5 (2): 160–170. doi:10.1038/nrd1958. PMID 16424917. S2CID 21379258.
Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, et al. (March 2008). "Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline". Annals of Internal Medicine. 148 (5): 379–397. doi:10.7326/0003-4819-148-5-200803040-00009. PMID 18316756. S2CID 22235353.
Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, et al. (February 2009). "The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial". The Lancet. Neurology. 8 (2): 151–157. doi:10.1016/S1474-4422(08)70295-3. PMID 19138567. S2CID 23000439. See lay summary, January 2009.
Bottino CM, Carvalho IA, Alvarez AM, Avila R, Zukauskas PR, Bustamante SE, et al. (December 2005). "Cognitive rehabilitation combined with drug treatment in Alzheimer's disease patients: a pilot study". Clinical Rehabilitation. 19 (8): 861–869. doi:10.1191/0269215505cr911oa. PMID 16323385. S2CID 21290731.
Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, et al. (May 2001). "Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology". Neurology. 56 (9): 1154–1166. doi:10.1212/WNL.56.9.1154. PMID 11342679. S2CID 10711725.
Robinson L, Hutchings D, Dickinson HO, Corner L, Beyer F, Finch T, et al. (January 2007). "Effectiveness and acceptability of non-pharmacological interventions to reduce wandering in dementia: a systematic review". International Journal of Geriatric Psychiatry. 22 (1): 9–22. doi:10.1002/gps.1643. PMID 17096455. S2CID 45660235.
Zetteler J (November 2008). "Effectiveness of simulated presence therapy for individuals with dementia: a systematic review and meta-analysis". Aging & Mental Health. 12 (6): 779–785. doi:10.1080/13607860802380631. PMID 19023729. S2CID 39529938.
Chernoff R (April 2006). "Tube feeding patients with dementia". Nutrition in Clinical Practice. 21 (2): 142–146. doi:10.1177/0115426506021002142. PMID 16556924. S2CID 20841502.
Shega JW, Levin A, Hougham GW, Cox-Hayley D, Luchins D, Hanrahan P, et al. (April 2003). "Palliative Excellence in Alzheimer Care Efforts (PEACE): a program description". Journal of Palliative Medicine. 6 (2): 315–320. doi:10.1089/109662103764978641. PMID 12854952. S2CID 6072807.
Mölsä PK, Marttila RJ, Rinne UK (March 1995). "Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia". Acta Neurologica Scandinavica. 91 (3): 159–164. doi:10.1111/j.1600-0404.1995.tb00426.x. PMID 7793228. S2CID 19724937.
Bowen JD, Malter AD, Sheppard L, Kukull WA, McCormick WC, Teri L, et al. (August 1996). "Predictors of mortality in patients diagnosed with probable Alzheimer's disease". Neurology. 47 (2): 433–439. doi:10.1212/wnl.47.2.433. PMID 8757016. S2CID 24961809.
Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, et al. (April 2004). "Survival after initial diagnosis of Alzheimer disease". Annals of Internal Medicine. 140 (7): 501–509. doi:10.7326/0003-4819-140-7-200404060-00008. PMID 15068977. S2CID 27410149.
Jagger C, Clarke M, Stone A (January 1995). "Predictors of survival with Alzheimer's disease: a community-based study". Psychological Medicine. 25 (1): 171–177. doi:10.1017/S0033291700028191. PMID 7792352. S2CID 34066330.
Bermejo-Pareja F, Benito-León J, Vega S, Medrano MJ, Román GC (January 2008). "Incidence and subtypes of dementia in three elderly populations of central Spain". Journal of the Neurological Sciences. 264 (1–2): 63–72. doi:10.1016/j.jns.2007.07.021. PMID 17727890. S2CID 34341344.
Di Carlo A, Baldereschi M, Amaducci L, Lepore V, Bracco L, Maggi S, et al. (January 2002). "Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study". Journal of the American Geriatrics Society. 50 (1): 41–48. doi:10.1046/j.1532-5415.2002.50006.x. PMID 12028245. S2CID 22576935.
Massett HA, Mitchell AK, Alley L, Simoneau E, Burke P, Han SH, et al. (29 June 2021). "Facilitators, Challenges, and Messaging Strategies for Hispanic/Latino Populations Participating in Alzheimer's Disease and Related Dementias Clinical Research: A Literature Review". Journal of Alzheimer's Disease. 82 (1): 107–127. doi:10.3233/JAD-201463. PMID 33998537. S2CID 234745473.
Rajan KB, Weuve J, Barnes LL, McAninch EA, Wilson RS, Evans DA (May 2021). "Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060)". Alzheimer's & Dementia. 17 (12): 1966–1975. doi:10.1002/alz.12362. PMC 9013315. PMID 34043283. S2CID 235215290.
Li F, Qin W, Zhu M, Jia J (1 January 2021). "Model-Based Projection of Dementia Prevalence in China and Worldwide: 2020-2050". Journal of Alzheimer's Disease. 82 (4). IOS Press: 1823–1831. doi:10.3233/JAD-210493. PMID 34219732. S2CID 235735045.
Berrios GE (1990). "Alzheimer's Disease: A Conceptual History". Int. J. Geriatr. Psychiatry. 5 (6): 355–365. doi:10.1002/gps.930050603. S2CID 145155424.
Boller F, Forbes MM (June 1998). "History of dementia and dementia in history: an overview". Journal of the Neurological Sciences. 158 (2): 125–133. doi:10.1016/S0022-510X(98)00128-2. PMID 9702682. S2CID 42399340.
Amaducci LA, Rocca WA, Schoenberg BS (November 1986). "Origin of the distinction between Alzheimer's disease and senile dementia: how history can clarify nosology". Neurology. 36 (11): 1497–1499. doi:10.1212/wnl.36.11.1497. PMID 3531918. S2CID 7689479.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (July 1984). "Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease". Neurology. 34 (7): 939–944. doi:10.1212/wnl.34.7.939. PMID 6610841. S2CID 11646075.
Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. (August 2007). "Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria". The Lancet. Neurology. 6 (8): 734–746. doi:10.1016/S1474-4422(07)70178-3. PMID 17616482. S2CID 7356809.
Wong W (August 2020). "Economic burden of Alzheimer disease and managed care considerations". Am J Manag Care. 26 (8 Suppl): S177 – S183. doi:10.37765/ajmc.2020.88482. PMID 32840331. S2CID 221308149. Archived from the original on 25 February 2022. Retrieved 17 March 2022.
Tahami Monfared AA, Byrnes MJ, White LA, Zhang Q (February 2022). "The Humanistic and Economic Burden of Alzheimer's Disease". Neurol Ther. 11 (2): 525–551. doi:10.1007/s40120-022-00335-x. PMC 9095804. PMID 35192176. S2CID 247014076.
Kosaner Kließ M, Martins R, Connolly MP (2021). "Major Cost Drivers in Assessing the Economic Burden of Alzheimer's Disease: A Structured, Rapid Review". J Prev Alzheimers Dis. 8 (3): 362–370. doi:10.14283/jpad.2021.17. PMID 34101795. S2CID 233403683.
Schneider J, Murray J, Banerjee S, Mann A (August 1999). "EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer's disease: I—Factors associated with carer burden". International Journal of Geriatric Psychiatry. 14 (8): 651–661. doi:10.1002/(SICI)1099-1166(199908)14:8<651::AID-GPS992>3.0.CO;2-B. PMID 10489656. S2CID 27346798.
Murray J, Schneider J, Banerjee S, Mann A (August 1999). "EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer's disease: II—A qualitative analysis of the experience of caregiving". International Journal of Geriatric Psychiatry. 14 (8): 662–667. doi:10.1002/(SICI)1099-1166(199908)14:8<662::AID-GPS993>3.0.CO;2-4. PMID 10489657. S2CID 41741923.
Ritchie K, Lovestone S (November 2002). "The dementias". Lancet. 360 (9347): 1759–1766. doi:10.1016/S0140-6736(02)11667-9. PMID 12480441. S2CID 21404062.
Brodaty H, Hadzi-Pavlovic D (September 1990). "Psychosocial effects on carers of living with persons with dementia". The Australian and New Zealand Journal of Psychiatry. 24 (3): 351–361. doi:10.3109/00048679009077702. PMID 2241719. S2CID 11788466.
Donaldson C, Tarrier N, Burns A (April 1998). "Determinants of carer stress in Alzheimer's disease". International Journal of Geriatric Psychiatry. 13 (4): 248–256. doi:10.1002/(SICI)1099-1166(199804)13:4<248::AID-GPS770>3.0.CO;2-0. PMID 9646153. S2CID 22187694.
Pusey H, Richards D (May 2001). "A systematic review of the effectiveness of psychosocial interventions for carers of people with dementia". Aging & Mental Health. 5 (2): 107–119. doi:10.1080/13607860120038302. PMID 11511058. S2CID 32517015.
Galle SA, Geraedts IK, Deijen JB, Milders MV, Drent ML (2020). "The Interrelationship between Insulin-Like Growth Factor 1, Apolipoprotein E ε4, Lifestyle Factors, and the Aging Body and Brain". J Prev Alzheimers Dis. 7 (4): 265–273. doi:10.14283/jpad.2020.11. hdl:1765/130733. PMID 32920629. S2CID 214784366.
Li Q, Yang X, Xu J, Guo Y, He X, Hu H, et al. (February 2023). "Early prediction of Alzheimer's disease and related dementias using real-world electronic health records". Alzheimer's & Dementia. 19 (8): 3506–3518. doi:10.1002/alz.12967. PMC 10976442. PMID 36815661. S2CID 257101613.

theguardian.com

Plunkett J (7 August 2007). "Alzheimer's film-maker to face ITV lawyers". London: Guardian Media. Archived from the original on 15 January 2008. Retrieved 24 January 2008.
Gerrard N (19 July 2015). "Words fail us: dementia and the arts". The Guardian. Archived from the original on 19 July 2015. Retrieved 14 June 2021.

ucl.ac.uk

discovery.ucl.ac.uk

Carmona S, Zahs K, Wu E, Dakin K, Bras J, Guerreiro R (August 2018). "The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders". Lancet Neurol. 17 (8): 721–730. doi:10.1016/S1474-4422(18)30232-1. PMID 30033062. S2CID 51706988. Archived from the original on 27 March 2022. Retrieved 21 February 2022.

uclahealth.org

"Ask the Doctors - What is the cause of death in Alzheimer's disease?". www.uclahealth.org. Retrieved 18 March 2024.

uni-goettingen.de

resolver.sub.uni-goettingen.de

Heneka MT, van der Flier WM, Jessen F, Hoozemanns J, Thal DR, Boche D (December 2024). "Neuroinflammation in Alzheimer disease". Nat Rev Immunol. 25 (5): 321–352. doi:10.1038/s41577-024-01104-7. PMID 39653749.

web.archive.org

"Dementia diagnosis and assessment" (PDF). National Institute for Health and Care Excellence (NICE). Archived from the original (PDF) on 5 December 2014. Retrieved 30 November 2014.
"Study reveals how APOE4 gene may increase risk for dementia". National Institute on Aging. 16 March 2021. Archived from the original on 17 March 2021. Retrieved 17 March 2021.
"Alzheimer's Disease Fact Sheet". National Institute on Aging. Archived from the original on 23 March 2022. Retrieved 23 March 2022.
"Low-dose antipsychotics in people with dementia". National Institute for Health and Care Excellence (NICE). Archived from the original on 5 December 2014. Retrieved 29 November 2014.
"Information for Healthcare Professionals: Conventional Antipsychotics". US Food and Drug Administration. 16 June 2008. Archived from the original on 29 November 2014. Retrieved 29 November 2014.
"Alzheimer's Disease Fact Sheet". National Institute on Aging. Archived from the original on 24 January 2021. Retrieved 25 January 2021.
Bertagnolli MM (5 August 2024). "Fiscal Year 2026 NIH Professional Judgment Budget for Alzheimer's Disease and Related Dementias Research: Advancing Progress in Dementia Research". US National Institutes of Health. Archived from the original on 30 November 2024. Retrieved 23 September 2024.
"Alzheimer's disease – Symptoms". National Health Service (NHS). 10 May 2018. Archived from the original on 30 January 2021. Retrieved 25 January 2021.
"Alzheimer's disease – Causes". National Health Service (NHS). 24 April 2023. Archived from the original on 29 September 2020. Retrieved 10 July 2023.
Carmona S, Zahs K, Wu E, Dakin K, Bras J, Guerreiro R (August 2018). "The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders". Lancet Neurol. 17 (8): 721–730. doi:10.1016/S1474-4422(18)30232-1. PMID 30033062. S2CID 51706988. Archived from the original on 27 March 2022. Retrieved 21 February 2022.
Moan R (July 2009). "MRI Software Accurately IDs Preclinical Alzheimer's Disease". Diagnostic Imaging. Archived from the original on 21 February 2022. Retrieved 21 February 2022.
Greig NH, Mattson MP, Perry T, Chan SL, Giordano T, Sambamurti K, et al. (December 2004). "New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists". Annals of the New York Academy of Sciences. 1035 (1): 290–315. Bibcode:2004NYASA1035..290G. doi:10.1196/annals.1332.018. PMID 15681814. S2CID 84659695. Archived from the original on 3 June 2020. Retrieved 19 July 2019.
Sachdev PS, Blacker D, Blazer DG, Ganguli M, Jeste DV, Paulsen JS, et al. (November 2014). "Classifying neurocognitive disorders: the DSM-5 approach". Nature Reviews. Neurology. 10 (11): 634–642. doi:10.1038/nrneurol.2014.181. hdl:1959.4/unsworks_39077. PMID 25266297. S2CID 20635070. Archived from the original on 20 March 2022. Retrieved 27 November 2021.
Mendez MF (2006). "The accurate diagnosis of early-onset dementia". International Journal of Psychiatry in Medicine. 36 (4): 401–412. doi:10.2190/Q6J4-R143-P630-KW41. PMID 17407994. S2CID 43715976. Archived from the original on 3 June 2020. Retrieved 25 May 2020.
Dementia: Quick Reference Guide (PDF). London: (UK) National Institute for Health and Clinical Excellence. 2006. ISBN 978-1-84629-312-2. Archived from the original (PDF) on 27 February 2008. Retrieved 22 February 2008.
Fink HA, Hemmy LS, Linskens EJ, Silverman PC, MacDonald R, McCarten JR, et al. (2020). Diagnosis and Treatment of Clinical Alzheimer's-Type Dementia: A Systematic Review. AHRQ Comparative Effectiveness Reviews. Rockville (MD): Agency for Healthcare Research and Quality (US). PMID 32369312. Archived from the original on 7 July 2023. Retrieved 16 November 2021.
Commissioner Oo (16 May 2025). "FDA Clears First Blood Test Used in Diagnosing Alzheimer's Disease". FDA. Archived from the original on 16 May 2025. Retrieved 21 May 2025.
"Memantine". US National Library of Medicine (Medline). 4 January 2004. Archived from the original on 22 February 2010. Retrieved 3 February 2010.
"Namzaric- memantine hydrochloride and donepezil hydrochloride capsule Namzaric- memantine hydrochloride and donepezil hydrochloride kit". DailyMed. 22 January 2019. Archived from the original on 20 January 2022. Retrieved 20 February 2022.
Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, et al. (February 2009). "The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial". The Lancet. Neurology. 8 (2): 151–157. doi:10.1016/S1474-4422(08)70295-3. PMID 19138567. S2CID 23000439. See lay summary, January 2009.
"Namenda- memantine hydrochloride tablet Namenda- memantine hydrochloride kit". DailyMed. 15 November 2018. Archived from the original on 27 January 2022. Retrieved 20 February 2022.
"Namenda XR- memantine hydrochloride capsule, extended release Namenda XR- memantine hydrochloride kit". DailyMed. 15 November 2019. Archived from the original on 21 February 2022. Retrieved 20 February 2022.
"FDA Converts Novel Alzheimer's Disease Treatment to Traditional Approval". U.S. Food and Drug Administration (FDA) (Press release). 6 July 2023. Archived from the original on 6 July 2023. Retrieved 6 July 2023. This article incorporates text from this source, which is in the public domain.
"FDA Makes Alzheimer's Drug Leqembi Widely Accessible". The New York Times. 6 July 2023. Archived from the original on 7 July 2023. Retrieved 8 July 2023.
"FDA approves treatment for adults with Alzheimer's disease". U.S. Food and Drug Administration (FDA) (Press release). 2 July 2024. Archived from the original on 2 July 2024. Retrieved 2 July 2024.
"Treating Behavioral and Psychiatric Symptoms". Alzheimer's Association. 2006. Archived from the original on 25 September 2006. Retrieved 25 September 2006.
"Nutrition and Dementia: A Review of Available Research" (PDF). Alzheimer's Disease International. 2014. Archived (PDF) from the original on 8 May 2024.
"United States Life Tables, 2017" (PDF). National Vital Statistics Reports, CDC. Archived (PDF) from the original on 24 May 2021. Retrieved 10 June 2021.
Wong W (August 2020). "Economic burden of Alzheimer disease and managed care considerations". Am J Manag Care. 26 (8 Suppl): S177 – S183. doi:10.37765/ajmc.2020.88482. PMID 32840331. S2CID 221308149. Archived from the original on 25 February 2022. Retrieved 17 March 2022.
"The MetLife study of Alzheimer's disease: The caregiving experience" (PDF). MetLife Mature Market Institute. August 2006. Archived from the original (PDF) on 8 January 2011. Retrieved 5 February 2011.
"Thanmathra". Webindia123.com. Archived from the original on 6 November 2007. Retrieved 24 January 2008.
"Malcolm and Barbara: A love story". Dfgdocs. Archived from the original on 24 May 2008. Retrieved 24 January 2008.
"Malcolm and Barbara: A love story". BBC Cambridgeshire. Archived from the original on 10 November 2012. Retrieved 2 March 2008.
Plunkett J (7 August 2007). "Alzheimer's film-maker to face ITV lawyers". London: Guardian Media. Archived from the original on 15 January 2008. Retrieved 24 January 2008.
"The Caretaker: Persistent Repetition of Phrases". Fact. 26 August 2009. Archived from the original on 15 April 2021. Retrieved 9 April 2021.
Powell M (14 June 2011). "The Caretaker: An Empty Bliss Beyond This World Album Review". Pitchfork. Archived from the original on 18 June 2011. Retrieved 19 February 2021.
Ezra M (23 October 2020). "Why Are TikTok Teens Listening to an Album About Dementia?". The New York Times. Archived from the original on 23 October 2020. Retrieved 21 April 2021.
Gerrard N (19 July 2015). "Words fail us: dementia and the arts". The Guardian. Archived from the original on 19 July 2015. Retrieved 14 June 2021.
Grady D (24 October 2006). "Self-Portraits Chronicle a Descent Into Alzheimer's". The New York Times. Archived from the original on 24 October 2006. Retrieved 14 June 2021.

webindia123.com

"Thanmathra". Webindia123.com. Archived from the original on 6 November 2007. Retrieved 24 January 2008.

who.int

"Dementia Fact sheet". World Health Organization. 15 March 2023. Retrieved 10 July 2023.
"Dementia". www.who.int. Retrieved 24 July 2025.
"The top 10 causes of death". www.who.int. Retrieved 19 March 2024.

worldcat.org

search.worldcat.org

Gomperts SN (April 2016). "Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia". Continuum (Review). 22 (2 Dementia): 435–463. doi:10.1212/CON.0000000000000309. ISSN 1080-2371. PMC 5390937. PMID 27042903.
Simon RP, Greenberg DA, Aminoff MJ (2018). Clinical neurology (10th ed.). New York: McGraw Hill. p. 111. ISBN 978-1-259-86173-4. OCLC 1012400314.
Wang H, Kulas JA, Wang C, Holtzman DM, Ferris HA, Hansen SB (August 2021). "Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol". Proceedings of the National Academy of Sciences of the United States of America. 118 (33): e2102191118. Bibcode:2021PNAS..11802191W. doi:10.1073/pnas.2102191118. ISSN 0027-8424. PMC 8379952. PMID 34385305. S2CID 236998499.
Schramm C, Wallon D, Nicolas G, Charbonnier C (1 May 2022). "What contribution can genetics make to predict the risk of Alzheimer's disease?". Revue Neurologique. International meeting of the French society of neurology : NeuroDegenerative Disease : What will the future bring ?. 178 (5): 414–421. doi:10.1016/j.neurol.2022.03.005. ISSN 0035-3787. PMID 35491248.
Goldman JS, Van Deerlin VM (1 October 2018). "Alzheimer's Disease and Frontotemporal Dementia: The Current State of Genetics and Genetic Testing Since the Advent of Next-Generation Sequencing". Molecular Diagnosis & Therapy. 22 (5): 505–513. doi:10.1007/s40291-018-0347-7. ISSN 1179-2000. PMC 6472481. PMID 29971646.
Piaceri I (2013). "Genetics of familial and sporadic Alzheimer s disease". Frontiers in Bioscience. E5 (1) E605: 167–177. doi:10.2741/E605. ISSN 1945-0494. PMID 23276979.
Papadakis MA, McPhee SJ, Rabow MW (2021). Current medical diagnosis & treatment (60th ed.). New York: McGraw Hill. p. 1760. ISBN 978-1-260-46986-8. OCLC 1195972209.
Stern SD, Cifu AS, Altkorn D (2020). Symptom to diagnosis: an evidence-based guide (4th ed.). New York: McGraw-Hill Medical. pp. 209–210. ISBN 978-1-260-12111-7. OCLC 1121597721.
Jha A, Mukhopadhaya K (2021). Alzheimer's disease: diagnosis and treatment guide. Cham, Switzerland: Springer. p. 32. ISBN 978-3-030-56739-2. OCLC 1202472277.
Drislane F, Hovauimian A, Tarulli A, Boegle AK, McIiduff C, Caplan LR (2019). Blueprints neurology (5th ed.). Philadelphia: Wolters Kluwer. p. 146. ISBN 978-1-4963-8739-4. OCLC 1048659425.
Berkowitz A (2017). Clinical neurology and neuroanatomy: a localization-based approach. New York: McGraw Hill. p. 236. ISBN 978-1-259-83440-0. OCLC 948547621.
Bayley J (2000). Iris: A Memoir of Iris Murdoch. London: Abacus. ISBN 978-0-349-11215-2. OCLC 41960006.
Ogiwara H (2004). Ashita no Kioku (in Japanese). Tōkyō: Kōbunsha. ISBN 978-4-334-92446-1. OCLC 57352130.
Munro A (2001). Hateship, Friendship, Courtship, Loveship, Marriage: Stories. New York: A.A. Knopf. ISBN 978-0-375-41300-1. OCLC 46929223.
Cummings JL, Zhou Y, Lee G, Zhong K, Fonseca J, Leisgang-Osse AM, et al. (2025). "Alzheimer's disease drug development pipeline: 2025". Alzheimer's & Dementia: Translational Research & Clinical Interventions. 11 (2): e70098. doi:10.1002/trc2.70098. ISSN 2352-8737. PMC 12131090. PMID 40463637.

zenodo.org

Greig NH, Mattson MP, Perry T, Chan SL, Giordano T, Sambamurti K, et al. (December 2004). "New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists". Annals of the New York Academy of Sciences. 1035 (1): 290–315. Bibcode:2004NYASA1035..290G. doi:10.1196/annals.1332.018. PMID 15681814. S2CID 84659695. Archived from the original on 3 June 2020. Retrieved 19 July 2019.
Mendez MF (2006). "The accurate diagnosis of early-onset dementia". International Journal of Psychiatry in Medicine. 36 (4): 401–412. doi:10.2190/Q6J4-R143-P630-KW41. PMID 17407994. S2CID 43715976. Archived from the original on 3 June 2020. Retrieved 25 May 2020.